Name,Term,ES,NES,NOM p-val,FDR q-val,FWER p-val,Tag %,Gene %,Lead_genes
prerank,clathrin adaptor activity (GO:0035615),-0.7627547610910306,-2.201455056727691,0.0,0.004510059546879955,0.004,6/15,5.83%,DAB2;HIP1;AP2A2;AP2B1;HIP1R;LDLRAP1
prerank,lipoprotein particle binding (GO:0071813),-0.627693160407283,-1.8985076432611476,0.0,0.21930164546703781,0.29,8/20,10.39%,MSR1;CD36;THBS1;HSPD1;PLTP;LDLR;LPL;STAB2
prerank,death domain binding (GO:0070513),-0.7239909744896446,-1.8623156563506795,0.00702576112412178,0.22475130075285107,0.411,6/11,13.54%,BCL2;BCL2L1;MCL1;BAX;RIPK1;RACK1
prerank,"ATPase activity, coupled to transmembrane movement of ions, rotational mechanism (GO:0044769)",-0.6571390922639699,-1.8469975411887478,0.0,0.15446953948063843,0.446,5/16,4.11%,ATP6V0D1;ATP6V0D2;ATP6V1B2;ATP6V0A1;ATP6V0B
prerank,"proton-transporting ATPase activity, rotational mechanism (GO:0046961)",-0.6571390922639699,-1.8469975411887478,0.0,0.15446953948063843,0.446,5/16,4.11%,ATP6V0D1;ATP6V0D2;ATP6V1B2;ATP6V0A1;ATP6V0B
prerank,phosphatidylinositol-4-phosphate binding (GO:0070273),-0.5713968936015296,-1.8383684454097284,0.0026109660574412533,0.13793265447541198,0.467,6/24,5.60%,OSBPL8;GOLPH3L;SESTD1;OSBP;PLA2G4E;PLEKHA3
prerank,hyaluronic acid binding (GO:0005540),-0.7327325140067535,-1.8100398216765599,0.0045351473922902496,0.156402422143587,0.564,5/10,11.27%,LYVE1;CD44;IMPG2;STAB2;CHODL
prerank,voltage-gated potassium channel activity involved in cardiac muscle cell action potential repolarization (GO:0086008),0.6963160476891896,1.7856784690324787,0.006791171477079796,1.0,0.594,5/14,3.78%,KCNJ3;KCNH2;KCNA5;KCNE2;KCNJ8
prerank,low-density lipoprotein particle binding (GO:0030169),-0.6303902093891177,-1.7829950244387547,0.005063291139240506,0.17518762552411823,0.657,6/16,10.39%,MSR1;CD36;THBS1;PLTP;LDLR;STAB2
prerank,high voltage-gated calcium channel activity (GO:0008331),0.7466533454206274,1.7629721213593976,0.0036101083032490976,0.6545947732975795,0.684,6/10,16.41%,CACNB4;CACNB2;CACNA1S;CACNA1D;CACNA1B;CACNA1A
prerank,voltage-gated calcium channel activity (GO:0005245),0.5301703257798315,1.7473379569183909,0.0,0.5144235956939283,0.753,16/37,17.26%,CACNB4;CACNG5;CACNG2;CACNB2;CACNA1S;CACNA2D3;PKD2;CACNA1G;CACNA2D2;CACNG7;CACNA1D;CACNA1B;CACNA2D1;CACNA1A;OPRM1;CACNG3
prerank,phosphatidylinositol phosphate binding (GO:1901981),-0.3919103951715335,-1.7289012926638336,0.0,0.2519369374659886,0.823,21/100,8.39%,IQGAP1;IQGAP2;OSBPL8;DENND1A;HIP1;KIF16B;GOLPH3L;SNX24;SESTD1;DENND1B;OSBP;PLA2G4E;SH3PXD2B;GBF1;ZFYVE16;HIP1R;PLEKHA3;ARAP1;CYTH3;GAB2;RACGAP1
prerank,nucleotide diphosphatase activity (GO:0004551),0.6573773394757332,1.693002222404992,0.006700167504187605,0.6874401647492602,0.934,6/14,12.52%,NUDT12;FHIT;NUDT17;NUDT10;NUDT3;ENPP4
prerank,"phosphatidylinositol-3,4,5-trisphosphate binding (GO:0005547)",-0.4773568915260762,-1.6861028214939984,0.005649717514124294,0.3292343469222367,0.917,11/34,8.39%,IQGAP1;IQGAP2;KIF16B;PLA2G4E;GBF1;ZFYVE16;HIP1R;ARAP1;CYTH3;GAB2;RACGAP1
prerank,voltage-gated potassium channel activity involved in ventricular cardiac muscle cell action potential repolarization (GO:1902282),0.6878473614211404,1.6842727604145546,0.017006802721088437,0.6017645802865663,0.951,4/11,3.78%,KCNJ3;KCNH2;KCNE2;KCNJ8
prerank,"N-acetyllactosaminide beta-1,3-N-acetylglucosaminyltransferase activity (GO:0008532)",0.6680340530532092,1.6684829557364669,0.01631321370309951,0.5895208052571606,0.973,5/12,10.07%,B3GNT9;B4GAT1;B3GNT6;B3GALT2;B3GALNT1
prerank,sequence-specific mRNA binding (GO:1990825),-0.6729042649665701,-1.6670623251833758,0.017977528089887642,0.3477870918764474,0.945,6/10,20.95%,ETF1;SHFL;LARP6;SSB;TYMS;DHFR
prerank,protein tyrosine kinase binding (GO:1990782),-0.4070052513691485,-1.6649908841645633,0.0,0.3239726107842101,0.947,35/71,30.37%,NEDD9;CBLB;GAS6;ITGAX;CASS4;CRK;PTPN1;PCNA;NCK1;BLNK;BANK1;SOCS5;CBL;CEACAM1;RACK1;SHC1;ELMO2;SQSTM1;CD247;PITPNM3;ACVR1;DUSP3;NOX4;ANGPT1;RNF41;BMPR2;PHYHIP;PIK3R2;PTPN14;HSP90AA1;SHC4;DUSP22;ANGPT4;LRP4;CD4
prerank,protein serine/threonine kinase activator activity (GO:0043539),-0.46633294747196624,-1.6566175664313594,0.005681818181818182,0.31865305336994143,0.956,11/34,14.94%,IQGAP1;STK3;ETAA1;FAM20A;CAB39L;SPRY2;CALM3;IGF2;CALM2;MTCP1;INCENP
prerank,chloride transmembrane transporter activity (GO:0015108),0.6148578225749175,1.6533943019169128,0.010416666666666666,0.581039600891703,0.986,6/16,10.38%,SLC4A8;SLC1A1;SLC26A4;CLCN6;CFTR;SLC26A7
prerank,intracellular cyclic nucleotide activated cation channel activity (GO:0005221),0.6738269681294564,1.6482361527428302,0.0273224043715847,0.5351254445314311,0.99,2/11,7.88%,HCN1;CNGB1
prerank,bicarbonate transmembrane transporter activity (GO:0015106),0.626800017144742,1.6452112445080829,0.010362694300518135,0.4889285813589773,0.991,5/15,11.13%,SLC4A8;SLC26A4;CFTR;SLC26A7;SLC39A8
prerank,GABA receptor activity (GO:0016917),0.5729510223596335,1.6358380076495385,0.011182108626198083,0.47491660372246997,0.993,9/21,15.12%,GABRQ;GABBR1;GABRG1;GABRD;GABRG2;GABRA2;GABBR2;GABRB1;GABRR2
prerank,chemokine receptor activity (GO:0004950),0.54531660719025,1.6264614563241893,0.011666666666666667,0.468414814326273,0.996,10/24,16.07%,ACKR4;ACKR3;CCR1;GPR17;CXCR6;CX3CR1;CXCR4;CCR6;ACKR2;CCR9
prerank,C-C chemokine binding (GO:0019957),0.5530081691933084,1.6227750924303697,0.008403361344537815,0.4445693124657059,0.996,9/22,16.07%,ACKR4;ACKR3;CCR1;CXCR6;CX3CR1;CXCR4;CCR6;ACKR2;CCR9
prerank,protein phosphatase regulator activity (GO:0019888),-0.42166767886545026,-1.617316250566831,0.0030120481927710845,0.3978516814569103,0.985,20/53,14.92%,PPP2R5C;PPP2R1B;PPP2R2A;ENSA;PPP2R5A;PPP4R1;PPP6R1;PTPA;SHOC2;LMTK2;PPP6R3;BOD1;CABIN1;PPP2R2C;PPP4R2;CALM3;CALM2;PTN;ARPP19;PPP1R2
prerank,inhibitory extracellular ligand-gated ion channel activity (GO:0005237),0.6382145495861502,1.6161707040520326,0.017543859649122806,0.4365625810717426,0.997,6/13,9.82%,GLRA3;GABRG1;GABRG2;GLRB;GABRA2;GLRA2
prerank,GTPase inhibitor activity (GO:0005095),-0.58502665908282,-1.6077471021065888,0.017897091722595078,0.396434234170748,0.987,2/13,0.11%,IQGAP1;IQGAP2
prerank,C-C chemokine receptor activity (GO:0016493),0.5508182196442472,1.5957962632483178,0.01192504258943782,0.48256951384340485,1.0,9/21,16.07%,ACKR4;ACKR3;CCR1;CXCR6;CX3CR1;CXCR4;CCR6;ACKR2;CCR9
prerank,voltage-gated cation channel activity (GO:0022843),0.4099348537509772,1.586179640994861,0.004103967168262654,0.4893192307721742,1.0,25/97,17.26%,HCN1;KCNMA1;CACNB4;CACNG5;CACNG2;KCNH2;KCND2;KCNA5;CACNB2;CACNA1S;KCNH7;KCNC1;CACNA2D3;PKD2;GRIN1;GRIN2B;CACNA2D2;CACNG7;CACNA1D;CACNA1B;CACNA2D1;KCNC3;CACNA1A;OPRM1;CACNG3
prerank,double-stranded RNA binding (GO:0003725),-0.385910684352962,-1.5777557267627098,0.0034129692832764505,0.46058983122511543,0.998,26/70,17.50%,RFTN1;DDX60;OAS2;MBNL1;IFIH1;ACTN1;EIF4B;ZBP1;DHX33;TLR7;MSN;OASL;ZNF346;HSPD1;TFRC;ILF2;TLR8;VIM;RC3H1;AGO2;OAS3;LRRFIP1;PRKRIP1;RC3H2;DUS2;SLC3A2
prerank,"phosphatidylinositol-3,5-bisphosphate binding (GO:0080025)",-0.48260888829473636,-1.5768106257066397,0.03178484107579462,0.43661355878104036,0.998,7/23,5.30%,HIP1;KIF16B;SESTD1;PLA2G4E;SH3PXD2B;GBF1;HIP1R
prerank,protein phosphatase inhibitor activity (GO:0004864),-0.471905985755823,-1.5539794689616675,0.028423772609819122,0.48420500413030626,0.998,9/26,15.27%,ENSA;LMTK2;BOD1;CABIN1;PTN;PPP1R1A;ARPP19;PPP1R2;PPP1R14C
prerank,copper ion binding (GO:0005507),0.46177991324775036,1.5533618379368155,0.02723146747352496,0.5994862203865731,1.0,15/42,18.25%,LACC1;ANG;COA6;GPC1;PRNP;COMMD1;S100A13;AOC2;MOXD1;DCT;ACR;AOC1;ATOX1;IL1A;SNCB
prerank,myosin V binding (GO:0031489),0.5796262734434725,1.5465007481741249,0.03398926654740608,0.5968772295784289,1.0,4/15,10.81%,RAB6B;RAB3A;RAB8A;RAB3D
prerank,fatty acid synthase activity (GO:0004312),0.6663008358730548,1.5405163103038528,0.03208556149732621,0.5899320151657887,1.0,5/10,20.59%,CBR4;ELOVL6;OXSM;ELOVL4;ELOVL5
prerank,phosphotyrosine residue binding (GO:0001784),-0.43229993795574767,-1.538960891166664,0.016713091922005572,0.5072036703576707,0.999,12/37,10.70%,SH3BP2;STAP1;ABL2;CRK;RASA1;LDLRAP1;CRKL;SYK;BCAR3;HCK;LCK;GRB2
prerank,tumor necrosis factor receptor binding (GO:0005164),-0.575583056676339,-1.5368657885752144,0.04578313253012048,0.48787569148373905,0.999,6/12,23.57%,STAT1;TNF;TRAF1;TRAF4;TRIM37;BABAM2
prerank,fibroblast growth factor receptor binding (GO:0005104),0.5319798903433789,1.5354232506893093,0.03801652892561983,0.5816239518144906,1.0,6/21,10.73%,FGF10;FGF16;FGF9;KLB;FGF7;FGF2
prerank,phosphatase inhibitor activity (GO:0019212),-0.5105341704152062,-1.5352612141564717,0.04884318766066838,0.4692609576158429,0.999,8/20,14.92%,ENSA;LMTK2;BOD1;CABIN1;PTN;TESC;ARPP19;PPP1R2
prerank,ligand-gated anion channel activity (GO:0099095),0.5633826138020317,1.5300088495113526,0.03350083752093802,0.578171411779021,1.0,8/17,14.53%,GLRA3;GABRG1;GABRG2;GLRB;GABRA2;GLRA2;CFTR;GABRB1
prerank,inward rectifier potassium channel activity (GO:0005242),0.514303625663445,1.5298796074033452,0.022653721682847898,0.5512562546524863,1.0,9/24,16.51%,KCNJ3;KCNH2;KCNE2;KCNJ8;KCNJ13;KCNK6;ABCC8;KCNJ5;KCNN3
prerank,O-acyltransferase activity (GO:0008374),0.4956409184318905,1.529558999240254,0.026101141924959218,0.5272505411392069,1.0,7/30,11.35%,PRDX6;DGAT2;AWAT2;PLA2G4C;SOAT2;LPCAT1;LPCAT2
prerank,protein kinase activator activity (GO:0030295),-0.3764896507130313,-1.5193658209446637,0.010238907849829351,0.49359526700000955,1.0,24/60,22.66%,IQGAP1;STK3;GAS6;MARK2;ETAA1;FAM20A;CD24;PRKAG2;CAB39L;GPRC5B;SPRY2;AGAP2;CALM3;IGF2;CALM2;MTCP1;INCENP;RGCC;TPX2;AFAP1L2;LTF;EPO;DUSP19;PARP16
prerank,calcium ion transmembrane transporter activity (GO:0015085),0.4329148424157394,1.5191894581348366,0.021897810218978103,0.5434675303272576,1.0,20/55,18.79%,ATP2A3;TRPC3;ATP2A2;ITPR2;CACNB2;SLC24A5;PKD1L1;TRPM2;PKD2;GRIN1;ATP2C1;PANX1;CACNA1D;PKD1;ATP2B3;SLC24A3;CHRNA7;SLC24A4;TRPV6;PKD2L2
prerank,transmitter-gated ion channel activity (GO:0022824),0.4915752454459812,1.514066922615018,0.02923076923076923,0.5395588013588294,1.0,10/29,9.82%,GLRA3;GABRG1;GRIA2;GABRG2;GRIK2;GRIK5;GABRA2;GRID2;GRIA4;GLRA2
prerank,calcium channel activity (GO:0005262),0.39681732536052006,1.5046182641558878,0.012711864406779662,0.554800296622135,1.0,28/84,18.79%,CACNB4;CACNG5;CACNG2;TRPC3;CACNB2;SLC24A5;CACNA1S;PKD1L1;CACNA2D3;TRPM2;PKD2;GRIN1;CACNA2D2;CACNG7;TRPC6;PANX1;CACNA1D;PKD1;CACNA1B;CACNA2D1;SLC24A3;CACNA1A;OPRM1;CACNG3;CHRNA7;SLC24A4;TRPV6;PKD2L2
prerank,heparan sulfate sulfotransferase activity (GO:0034483),0.5669362426225423,1.5013871354886632,0.05601317957166392,0.5457032263396783,1.0,4/15,12.08%,HS3ST5;HS3ST6;HS6ST3;HS6ST1
prerank,GABA-A receptor activity (GO:0004890),0.5484821641654994,1.4974658372580048,0.039936102236421724,0.5417347871253205,1.0,7/18,15.12%,GABRQ;GABRG1;GABRD;GABRG2;GABRA2;GABRB1;GABRR2
prerank,adenylate cyclase binding (GO:0008179),-0.6048621405417374,-1.4910317219130653,0.053117782909930716,0.5655222492696431,1.0,5/10,17.21%,AKAP12;ADCY5;CALM3;CALM2;AKAP5
prerank,voltage-gated potassium channel activity (GO:0005249),0.3963492725480624,1.483163447938057,0.013888888888888888,0.5770082751803298,1.0,20/80,19.18%,HCN1;KCNMA1;KCNJ3;KCNH2;KCND2;KCNA5;KCNE2;KCNJ8;KCNH7;KCNC1;KCNJ13;PKD2;KCNK6;KCNJ5;KCNC3;KCNT2;KCNN3;KCNT1;KCNQ4;KCNK2
prerank,cadherin binding (GO:0045296),-0.28489024807728053,-1.476871554238074,0.0,0.5881869325722608,1.0,82/315,15.94%,IQGAP1;EHD4;AHNAK;SLK;CDH12;EIF2A;CHMP4B;STK38;PDLIM1;FXYD5;RPS26;TRIM25;MARK2;OLA1;PDLIM5;AFDN;P2RX4;STX5;RAB1A;DHX29;PTPN1;ATIC;ENO1;SNX1;SH3GLB1;IDH1;CTNNA1;NCK1;STK24;CLINT1;ARHGAP18;CRKL;TBC1D2;PICALM;DIAPH3;ASAP1;PLEC;RPL6;SNX9;EPS15;ANXA1;GAPVD1;HNRNPK;PAICS;GLOD4;PSEN1;RPL15;DDX6;USP8;EEF1D;FMNL2;LDHA;ARVCF;CEMIP2;MAPRE1;STAT1;RAB10;RPL14;TMPO;CTNNB1;TES;SHTN1;RPL23A;CBL;TBC1D10A;PACSIN2;KDR;VASP;LRRFIP1;LARP1;RACK1;TAGLN2;YKT6;VCL;EGFR;STXBP6;CDH2;CDH24;MYH9;EPHA2;CAPZB;PI4KA
prerank,transmembrane receptor protein serine/threonine kinase activity (GO:0004675),0.5283547653921508,1.4735572863095088,0.05016722408026756,0.596066487121661,1.0,7/18,19.35%,TGFBR3;TGFBR1;ACVR1B;AMHR2;ENG;LTBP4;BMPR1B
prerank,protein phosphatase activator activity (GO:0072542),-0.5545114812465498,-1.469648205183079,0.07328605200945626,0.5886980726542406,1.0,6/13,17.80%,PPP2R5C;PPP2R5A;PTPA;CALM3;CALM2;PPP1R15A
prerank,glycine binding (GO:0016594),0.5914727386505498,1.4679364883416852,0.06260575296108291,0.5968917428693218,1.0,5/11,9.82%,GLRA3;GLRB;GRIN1;GRIN2B;GLRA2
prerank,poly(A) binding (GO:0008143),0.5109005027792357,1.4669836064442052,0.05396290050590219,0.5809799091307731,1.0,12/21,30.10%,PABPC1L;PABPC4L;ZC3H14;DDX1;KHDRBS2;RBMS3;TIA1;HNRNPDL;DDX3X;PABPC4;ELAVL4;RBMS2
prerank,glycerophospholipid flippase activity (GO:0140333),0.5986035085170087,1.4628402075629672,0.07952622673434856,0.5790445903193739,1.0,9/11,29.07%,ATP8A2;ABCB4;ATP11A;ATP8B1;ATP8A1;ATP8B2;ATP10B;ABCA3;ABCA4
prerank,cation channel activity (GO:0005261),0.3793742991335232,1.4624485609595954,0.01646090534979424,0.5624230068465337,1.0,27/94,18.79%,HCN1;TMEM63C;TRPC3;CACNB2;SLC24A5;PKD1L1;TRPM3;TRPM2;KCNK3;TMEM63A;PKD2;GRIN1;TMEM63B;TRPC6;PANX1;CACNA1D;PKD1;UNC80;ABCC8;SLC24A3;ASIC3;KCNK9;CHRNA7;KCNQ4;SLC24A4;TRPV6;PKD2L2
prerank,sodium channel activity (GO:0005272),0.446029132463069,1.4617550025312687,0.024390243902439025,0.5484391212238376,1.0,18/37,28.45%,HCN1;SCNN1A;GRIK2;GRIK5;PKD2;CACNA1G;ASIC1;ASIC2;SCN2A;ASIC3;SCN1B;SCN8A;GRIK3;GRIK4;SCN7A;KCNK1;CACNA1H;SCN1A
prerank,outward rectifier potassium channel activity (GO:0015271),0.5994453632334173,1.4584565764567006,0.0782312925170068,0.5447973218733898,1.0,6/11,19.18%,KCND2;KCNA5;PKD2;KCNT2;KCNT1;KCNK2
prerank,SUMO transferase activity (GO:0019789),-0.4955145613667765,-1.4552544178065288,0.07211538461538461,0.6179648898369169,1.0,9/16,28.26%,NSMCE2;RANBP2;EGR2;PIAS2;MUL1;HDAC4;PIAS4;PIAS3;MDM2
prerank,ligand-gated cation channel activity (GO:0099094),0.3925842508539186,1.4538208729776907,0.025974025974025976,0.5462923636126168,1.0,17/75,10.57%,KCNJ3;KCNH2;SCNN1A;KCNE2;KCNJ8;GRIA2;TRPM2;GRIK2;GRIK5;GRIA1;KCNJ13;GRIN1;GRIA4;GRIN2B;ASIC1;ASIC2;KCNK6
prerank,core promoter sequence-specific DNA binding (GO:0001046),-0.40351368045884906,-1.4523804458437417,0.04310344827586207,0.6053919745473955,1.0,12/35,14.22%,NR3C1;POU2F1;SMARCA4;TAF1;H3-3A;STAT1;AGO2;HDAC1;FOS;NPM1;UBTF;FOXP1
prerank,non-membrane spanning protein tyrosine kinase activity (GO:0004715),-0.40931555172917145,-1.450547962463691,0.042606516290726815,0.5901735064202912,1.0,15/35,20.17%,PEAK1;ABL2;CSK;TEC;DYRK1A;SYK;LYN;FYN;HCK;LCK;FRK;PTK2B;ZAP70;PKDCC;MELK
prerank,"oxidoreductase activity, acting on NAD(P)H, oxygen as acceptor (GO:0050664)",-0.5255578565003879,-1.4369575778130448,0.07936507936507936,0.6157397676201538,1.0,7/14,25.68%,CYBB;KMO;CYBA;MICAL1;CYB5R4;NOX4;AIFM1
prerank,tumor necrosis factor receptor superfamily binding (GO:0032813),-0.4306663836518302,-1.4360126922313166,0.058823529411764705,0.5986728210187566,1.0,13/28,25.80%,RIPK1;PIDD1;STAT1;EDA;SIVA1;TNF;TRAF1;TRAF4;TRIM37;MYD88;BABAM2;FADD;TMBIM1
prerank,steroid hydroxylase activity (GO:0008395),0.5298793320781517,1.434255691919515,0.07216494845360824,0.6051453925623693,1.0,4/16,15.41%,CYP2S1;CYP2U1;CYP39A1;CYP27A1
prerank,phospholipase C activity (GO:0004629),0.4816479864908165,1.4337854279177176,0.06896551724137931,0.590876174758626,1.0,5/25,7.56%,PLCH1;PLCL1;PLCD1;PLCG1;CCR1
prerank,poly-purine tract binding (GO:0070717),0.4666630325030021,1.4318340024244096,0.05825242718446602,0.5839101623692425,1.0,14/27,30.10%,PABPC1L;PATL1;PABPC4L;ZC3H14;DDX1;KHDRBS2;RBMS3;TIA1;HNRNPDL;DDX3X;MCRS1;PABPC4;ELAVL4;RBMS2
prerank,G protein-coupled chemoattractant receptor activity (GO:0001637),0.5410841662671045,1.4243019029549562,0.06747404844290658,0.5981099522236328,1.0,7/15,16.07%,ACKR4;CCR1;GPR17;CX3CR1;CCR6;ACKR2;CCR9
prerank,beta-tubulin binding (GO:0048487),0.4509834532747349,1.4152932565919294,0.05864197530864197,0.6171458367712558,1.0,14/31,24.87%,DLEC1;PDCD5;MAP1S;EMD;LRPPRC;FGF13;PEX14;UXT;TAOK1;EML4;TTLL7;GABARAP;SPAST;TBCD
prerank,cadherin binding involved in cell-cell adhesion (GO:0098641),-0.47746399736466477,-1.409227238019999,0.09647058823529411,0.670907729046352,1.0,6/18,19.60%,PDLIM1;PDLIM5;ANXA1;RAB10;STXBP6;TRIM29
prerank,chloride channel activity (GO:0005254),0.3949273411950649,1.4055409475339613,0.04190751445086705,0.639747158382467,1.0,17/59,16.60%,GABRQ;GLRA3;GABRG1;GABRD;GABRG2;GLRB;GABRA2;ANO2;CLCN6;GLRA2;CFTR;SLC26A7;SLC1A4;CLCC1;GABRB1;GABRR2;ANO3
prerank,MAP-kinase scaffold activity (GO:0005078),-0.5510603992689154,-1.4053035369267048,0.10526315789473684,0.6647757302420634,1.0,5/11,25.88%,IQGAP1;SH3RF1;MAPK8IP3;DUSP19;KSR1
prerank,mechanosensitive ion channel activity (GO:0008381),0.5516900494789113,1.4042656228375232,0.09243697478991597,0.6302485168759767,1.0,4/12,10.83%,TMC3;TMC8;TMEM63A;TMEM63B
prerank,amino acid:sodium symporter activity (GO:0005283),0.5812594907736398,1.4032842654862616,0.09298245614035087,0.619352214992191,1.0,4/11,14.19%,SLC38A2;SLC1A1;SLC1A3;SLC6A1
prerank,active ion transmembrane transporter activity (GO:0022853),0.43321994685685666,1.4015666903437665,0.08056872037914692,0.6113252106621729,1.0,12/37,24.46%,SLCO2B1;UQCRC1;SLC22A8;NDUFA4;UQCR11;SLC22A4;COX4I1;COX6B1;UQCR10;SLCO4A1;COX10;SLC16A7
prerank,histone methyltransferase activity (H3-K4 specific) (GO:0042800),-0.4903928231344912,-1.3998366082502074,0.08633093525179857,0.6647554435158818,1.0,9/15,23.38%,SETD3;PRDM9;WDR82;KMT2C;KMT2D;RBBP5;KMT2B;SETD1A;KMT2A
prerank,phosphatidylinositol-5-phosphate binding (GO:0010314),-0.49014245311714344,-1.3990433782733636,0.09954751131221719,0.6482215732563418,1.0,8/15,26.63%,SESTD1;PLA2G4E;SH3PXD2B;LANCL2;PLEKHF1;VEPH1;SAP30L;SNX3
prerank,growth factor activity (GO:0008083),0.37262892735412007,1.3989650565425276,0.036231884057971016,0.6076900256764409,1.0,16/74,16.97%,FGF10;FGF16;FGF9;FGF7;IL6;AREG;IL2;CLCF1;FGF2;NRG3;PDGFB;INHA;THPO;IL7;AGT;ANGPTL3
prerank,peptidase activator activity involved in apoptotic process (GO:0016505),0.5496572341760986,1.3981141346147015,0.08277027027027027,0.5981266849672552,1.0,4/14,8.47%,ATP2A3;EBAG9;BCL2L13;NOD1
prerank,kinase inhibitor activity (GO:0019210),-0.3998113907699538,-1.3978673735159706,0.06666666666666667,0.633727795758732,1.0,15/33,23.28%,GMFG;NCK1;TAOK3;SMCR8;NPM1;QARS1;PRKRIP1;SPRY4;DUS2;LRP6;SOCS1;WARS1;GSKIP;DUSP19;ITPRIP
prerank,signaling receptor complex adaptor activity (GO:0030159),-0.3806659409018387,-1.3957029941375403,0.06944444444444445,0.6237036515039405,1.0,12/38,15.65%,STAP1;DLG5;FRS2;NCK1;LDLRAP1;GAB2;BLNK;SORBS1;LRRK2;MAPK8IP3;SHC1;NUP62
prerank,phosphatidylinositol-3-phosphate binding (GO:0032266),-0.3891272398214784,-1.3916303994438508,0.04607046070460705,0.6207121818270123,1.0,6/38,4.21%,DENND1A;HIP1;KIF16B;SESTD1;PLA2G4E;SH3PXD2B
prerank,voltage-gated ion channel activity (GO:0005244),0.5361510547821045,1.3893968288976353,0.09523809523809523,0.6180677681327116,1.0,4/14,8.98%,HCN1;KCND2;VDAC1;PKD2
prerank,syntaxin-1 binding (GO:0017075),0.48069612455432215,1.3891908873965666,0.08983050847457627,0.6061716595419974,1.0,9/22,19.10%,SNAP25;SYT1;SYNPR;UNC13B;CPLX2;STXBP2;VAMP3;STXBP5;UNC13C
prerank,"inositol 1,4,5 trisphosphate binding (GO:0070679)",0.572690210355288,1.3873472570894714,0.09803921568627451,0.600783844654488,1.0,5/11,11.85%,TRPC3;CYTH2;ITPR2;TRPC6;ITPR3
prerank,semaphorin receptor activity (GO:0017154),-0.5402420015036506,-1.381744261714336,0.11363636363636363,0.6346128525570295,1.0,3/11,0.72%,PLXNC1;NRP1;NRP2
prerank,protein kinase inhibitor activity (GO:0004860),-0.37736060361472096,-1.3816245007524346,0.04143646408839779,0.6187165664280636,1.0,22/42,27.81%,GMFG;NCK1;CIT;CIB1;TAOK3;SMCR8;SPRY2;RACK1;NPM1;QARS1;PRKRIP1;SPRY4;DUS2;INKA1;INKA2;SOCS1;GSKIP;DUSP19;ITPRIP;CAMK2N2;SPRED1;DNAJC3
prerank,receptor tyrosine kinase binding (GO:0030971),-0.351177557891903,-1.3776030287015801,0.04871060171919771,0.6153976251717699,1.0,16/56,16.84%,CBLB;GAS6;STAP1;ITGAX;FRS2;PTPN1;PCNA;NCK1;GAB2;BLNK;SOCS5;CBL;RACK1;SHC1;ELMO2;SQSTM1
prerank,titin binding (GO:0031432),0.5368405987046835,1.377332762803781,0.10535714285714286,0.623527259980262,1.0,4/13,9.00%,CAPN3;TRIM63;MYBPC3;ACTN2
prerank,potassium channel activity (GO:0005267),0.35952529294572466,1.3751061545499912,0.040983606557377046,0.6190448859083824,1.0,22/89,19.18%,HCN1;KCNMA1;KCNK12;KCNH2;KCND2;KCNA5;KCNH7;KCNC1;KCNK3;GRIK2;GRIK5;PKD2;KCNK6;KCNN4;ABCC8;KCNC3;KCNMB3;KCNT2;KCNT1;KCNK9;KCNQ4;KCNK2
prerank,alcohol dehydrogenase (NADP+) activity (GO:0008106),0.5647443912194434,1.3725461501137335,0.10424028268551237,0.6167915869097962,1.0,3/11,6.31%,RDH14;AKR1C1;AKR1B1
prerank,chemoattractant activity (GO:0042056),0.45859144484804093,1.3639516811434014,0.08585055643879173,0.6374096258661577,1.0,8/26,19.31%,FGF10;FGF7;BMP4;FGF2;PDGFB;HMGB1;CCL15;CCL5
prerank,calcium activated cation channel activity (GO:0005227),0.5100714580162019,1.3632602800116513,0.10684474123539232,0.6282091156832588,1.0,6/17,16.26%,KCNMA1;TMEM63C;TMEM63A;TMEM63B;KCNN4;KCNMB3
prerank,protein phosphorylated amino acid binding (GO:0045309),-0.3743301423629272,-1.3603103246871042,0.06686046511627906,0.6573136785946627,1.0,13/42,10.70%,SH3BP2;STAP1;ABL2;CRK;FBXW7;RASA1;LDLRAP1;CRKL;SYK;BCAR3;HCK;LCK;GRB2
prerank,anion channel activity (GO:0005253),0.38095812916255134,1.353255748650131,0.07922272047832586,0.653999987536885,1.0,17/61,16.60%,GABRQ;GLRA3;GABRG1;GABRD;VDAC1;GABRG2;GLRB;GABRA2;ANO2;GLRA2;CFTR;SLC26A7;SLC1A4;CLCC1;GABRB1;GABRR2;ANO3
prerank,transmembrane receptor protein phosphatase activity (GO:0019198),0.49951258032422396,1.3509554717087968,0.12331081081081081,0.6396955039358166,1.0,4/16,4.65%,PTPRD;PTPRT;PTPRO;PTPRU
prerank,transmembrane receptor protein tyrosine phosphatase activity (GO:0005001),0.49951258032422396,1.3509554717087968,0.12331081081081081,0.6396955039358166,1.0,4/16,4.65%,PTPRD;PTPRT;PTPRO;PTPRU
prerank,semaphorin receptor binding (GO:0030215),0.44775060398684147,1.3484558325505174,0.10423452768729642,0.6381367936706811,1.0,10/23,19.01%,SH3BP1;SEMA7A;SEMA6C;SEMA6B;RIT2;SEMA3D;SEMA4F;SEMA4B;SEMA3C;PLXNB1
prerank,kinase binding (GO:0019900),-0.25522101418009574,-1.347084095688508,0.0,0.6864149556796045,1.0,112/434,17.80%,IQGAP1;SASH1;SP100;MAP3K1;NR3C1;PTPN22;STAP1;AP2A2;BCL2L1;CRK;PTPN23;TPCN2;PTPRC;CDK5RAP2;PPP2R5A;CNOT9;TRIM14;ATG13;PRKAB1;LYST;KIF11;PRKACA;PTPN1;EEF1A1;IFNAR2;ESR1;BORA;LIMS1;TUBA4A;PRC1;CEP250;PPP1R12A;MSN;UTRN;RPS7;SMAD3;FAS;NOD2;ERCC6L2;TFRC;BCAR3;CCND1;CAV1;UBQLN1;PDCD10;CD24;KIF13B;TEX14;CIT;PRKAG2;EIF4ENIF1;BLNK;HIF1A;CD226;HSF1;RACGAP1;CDKN2C;SIKE1;SMCR8;WDCP;MAPRE1;ADCY6;GPRC5B;PGAM1;SPRY2;LCK;AGAP2;GRB2;CTNNB1;GHR;ATF5;BARD1;CALM3;CCNA2;CSPG4;SKAP1;CEACAM1;IRAK4;FAM83H;EMP2;CCND2;TRIM5;CEP68;CALM2;RB1;PTN;MTCP1;SIK1;NPM1;QARS1;PRKRIP1;EGFR;SHC1;PRKAB2;HSPB1;TNS2;CDC25A;CHP1;RELB;PLK1;KIF20A;PEBP1;BCAR1;SQSTM1;SLC12A7;PFKL;MAP2K7;GSN;RGCC;DCTN2;FLNA;PPP1R15A
prerank,ligand-gated ion channel activity (GO:0015276),0.4404541086351094,1.3466659992273355,0.09287925696594428,0.6333146605260682,1.0,9/30,9.57%,GRIA2;GRIK2;GRIK5;GRIA1;CNGB1;GRID2;GRIN1;GRIA4;GRIN2B
prerank,transforming growth factor beta-activated receptor activity (GO:0005024),0.5366371588038678,1.3436164527781222,0.11816578483245149,0.6338227744090656,1.0,5/12,19.35%,TGFBR3;TGFBR1;ENG;LTBP4;BMPR1B
prerank,vinculin binding (GO:0017166),-0.5311675930254667,-1.341574660828433,0.13202933985330073,0.6890951447209606,1.0,6/11,10.51%,PXN;ACTN1;CTNNA1;UTRN;DAG1;SORBS3
prerank,phospholipase A2 activity (GO:0004623),0.4434951602998718,1.3413902748607411,0.1024390243902439,0.6309419130291043,1.0,5/26,6.60%,PRDX6;PLAAT5;PLA2G3;PLA2G4C;PNPLA3
prerank,ligand-gated channel activity (GO:0022834),0.4404600997651722,1.3411602550965045,0.09582689335394126,0.6217493818458988,1.0,9/29,9.57%,GRIA2;GRIK2;GRIK5;GRIA1;CNGB1;GRID2;GRIN1;GRIA4;GRIN2B
prerank,protein kinase binding (GO:0019901),-0.2502949162716295,-1.338549040502333,0.0,0.6838377787956731,1.0,117/479,17.43%,IQGAP1;NEDD9;SASH1;MAP3K1;NR3C1;DUSP16;STAP1;AP2A2;BCL2L1;CASS4;CSK;CRK;PTPN23;STK38;NBR1;TPCN2;PTPRC;PDLIM5;CDK5RAP2;PJA2;TRIM14;ATG13;PRKAB1;LYST;KIF11;PRKACA;RARA;PTPN1;EEF1A1;IFNAR2;TOP2A;MAPKAPK2;ESR1;BORA;LIMS1;TUBA4A;PRC1;CEP250;ADAM9;PPP1R12A;MSN;UTRN;RPS7;SMAD3;NOD2;ERCC6L2;TFRC;CCND1;CAV1;PDCD10;CD24;KIF13B;TEX14;RNF13;CIT;PRKAG2;BLNK;HIF1A;YWHAG;CD226;HSF1;BANK1;RACGAP1;CDKN2C;SIKE1;SMCR8;MAPRE1;MAD2L2;MAP3K11;ADCY6;GPRC5B;PGAM1;SPRY2;LCK;AGAP2;GRB2;GHR;MAPKAPK3;CALM3;CCNA2;CSPG4;SKAP1;PRKCSH;CEACAM1;IRAK4;FAM83H;CAVIN3;EMP2;CCND2;TRIM5;MAPK8IP3;CEP68;CALM2;PTN;RACK1;MTCP1;DUSP1;SIK1;NPM1;QARS1;PRKRIP1;SHC1;PRKAB2;HSPB1;CDC25A;RELB;PARD6A;MAPK7;PLK1;KIF20A;PEBP1;BCAR1;SQSTM1;SLC12A7;MAP2K7;RGCC;DCTN2
prerank,RNA polymerase II core promoter sequence-specific DNA binding (GO:0000979),-0.5051987113056371,-1.337964378492881,0.14356435643564355,0.6710968605757373,1.0,6/12,14.04%,POU2F1;TAF1;H3-3A;STAT1;HDAC1;FOS
prerank,neurotransmitter receptor activity involved in regulation of postsynaptic membrane potential (GO:0099529),0.4841054592840835,1.3378827240031068,0.10810810810810811,0.6235130868446247,1.0,6/19,7.91%,GABRG1;GABRG2;GRIK2;GRIK5;GABRA2;GRID2
prerank,phosphatase activator activity (GO:0019211),-0.5026038121887221,-1.3369589230247543,0.14043583535108958,0.6598168094698996,1.0,7/14,17.80%,PPP2R5C;PPP2R5A;FRS2;CALM3;CALM2;BMP2;PPP1R15A
prerank,guanyl-nucleotide exchange factor activity (GO:0005085),-0.2811957647529785,-1.3316288754512193,0.01646090534979424,0.6624030011087729,1.0,29/147,10.14%,VAV3;FGD4;DENND1A;ITSN1;FGD6;RIC1;RCC1L;DENND4C;DENND1B;DOCK2;RIC8A;LAMTOR5;CCDC88C;ARHGEF18;ARHGEF6;RASGRP4;HPS1;DENND6B;GAPVD1;CYTH3;FGD1;EIF2B2;SMCR8;RASGRP2;EEF1D;DENND2A;RABGEF1;ABR;CYTH1
prerank,sterol transfer activity (GO:0120015),-0.46190595033434295,-1.3314080589843955,0.12385321100917432,0.6491432061355602,1.0,7/17,16.15%,NPC2;OSBP;PLTP;OSBPL2;ABCG1;GRAMD1C;GRAMD1B
prerank,P-type ion transporter activity (GO:0015662),0.5374043226413011,1.3238418750574608,0.14111498257839722,0.6641814996866182,1.0,4/12,12.75%,ATP2A3;ATP2A2;ATP2C1;ATP2B3
prerank,protein phosphatase binding (GO:0019903),-0.2911703405845911,-1.3228998829130079,0.026515151515151516,0.6633469215176292,1.0,34/117,17.80%,IQGAP1;PXN;KIF3A;VCP;ENSA;MET;TBK1;PPP6R1;PTPA;AP3B1;SHOC2;PPP6R3;BOD1;MTMR4;AKAP11;CDC27;LCK;CTNNB1;FOXO1;PPP1R3C;SKAP1;CEACAM1;PPP1R3F;PPP1R3E;RACK1;ARPP19;EGFR;LILRB1;ITGA1;MTMR3;RPA2;AKAP5;MAP2K7;PPP1R15A
prerank,acetylglucosaminyltransferase activity (GO:0008375),0.38677213039592995,1.3226552453648206,0.091324200913242,0.6581694957987227,1.0,18/46,23.38%,HEXB;B3GNT9;B4GAT1;B3GNT6;B3GALT2;PIGQ;PIGP;OGT;B3GALNT1;MGAT5B;MGAT4B;POMGNT1;GCNT7;GCNT4;GCNT1;LARGE1;EXT2;RFNG
prerank,chemokine binding (GO:0019956),0.41790652188428645,1.3178786162513898,0.11475409836065574,0.6656905361865538,1.0,11/30,16.07%,ACKR4;ACKR3;CCR1;CXCR6;CX3CR1;FGF2;CXCR4;CCR6;HMGB1;ACKR2;CCR9
prerank,mRNA 5'-UTR binding (GO:0048027),-0.40909445913811554,-1.3173212094092495,0.11282051282051282,0.6680751206793277,1.0,8/24,13.81%,RPL5;RPS14;RPS13;RPS7;LARP6;SYNCRIP;LARP1;RPL41
prerank,glutamate receptor activity (GO:0008066),0.4682961465323879,1.3139642623033434,0.14942528735632185,0.6704324019843053,1.0,7/19,9.38%,GRIA2;GRM3;GRIK2;GRIK5;GRIA1;GRID2;GRIA4
prerank,actin monomer binding (GO:0003785),-0.4163561293019794,-1.3046455506807753,0.11139896373056994,0.6988602565510894,1.0,9/22,21.28%,MTSS1;ABL2;PRKCE;ABITRAM;COBL;PFN2;LIMA1;TMSB4X;MYL4
prerank,ionotropic glutamate receptor binding (GO:0035255),0.5521433520439377,1.302524553518195,0.15808170515097691,0.7037589405797134,1.0,4/10,17.85%,IGSF11;SHANK3;GNAS;SHANK1
prerank,cyclic nucleotide binding (GO:0030551),0.4557796244673626,1.3008585860781339,0.131175468483816,0.6999174482624941,1.0,10/21,31.66%,HCN1;PDE4A;CNGB1;SLC19A1;POPDC3;PDE11A;RAPGEF2;KCNH1;RAPGEF4;PDE10A
prerank,CXCR chemokine receptor binding (GO:0045236),-0.507919306850443,-1.2963942031520734,0.16778523489932887,0.7128279211715314,1.0,2/11,5.70%,ITCH;PF4
prerank,cysteine-type endopeptidase activator activity involved in apoptotic process (GO:0008656),0.5332590679848924,1.2949804747940181,0.14209591474245115,0.7122126658996847,1.0,3/12,8.47%,ATP2A3;BCL2L13;NOD1
prerank,poly-pyrimidine tract binding (GO:0008187),0.44110329486716615,1.2942543777478221,0.1456953642384106,0.7050322386527621,1.0,5/23,6.02%,PABPC1L;PATL1;PABPC4L;HNRNPH1;PTBP1
prerank,ionotropic glutamate receptor activity (GO:0004970),0.48502312002416353,1.2931518683156447,0.15525876460767946,0.6993413117965797,1.0,7/17,9.57%,GRIA2;GRIK2;GRIK5;GRIA1;GRIN1;GRIA4;GRIN2B
prerank,tRNA (guanine) methyltransferase activity (GO:0016423),-0.47939026149011776,-1.290294323509871,0.14893617021276595,0.7207585728693059,1.0,5/13,8.68%,TARBP1;TRMT10C;THUMPD3;WDR4;TRMT1L
prerank,neuropeptide binding (GO:0042923),0.47295295054088893,1.2894586277250162,0.1497504159733777,0.7036690639134328,1.0,5/18,22.73%,NMUR1;MC4R;OPRM1;OPRD1;SSTR2
prerank,water transmembrane transporter activity (GO:0005372),-0.5102250891978909,-1.2830952057613156,0.18791946308724833,0.7324670782618,1.0,5/11,36.43%,AQP11;PDPN;AQP1;SLC5A1;SLC4A11
prerank,chemokine receptor binding (GO:0042379),-0.37073129130442983,-1.2813964626412695,0.10734463276836158,0.7247255686422734,1.0,6/35,15.58%,ITCH;CXCL16;CCL25;PF4;CCRL2;CCL28
prerank,ephrin receptor activity (GO:0005003),0.4713431591623097,1.2796573924317636,0.15630252100840336,0.721332518270935,1.0,7/17,20.51%,EFNA4;EFNB3;EPHA1;EFNA3;EPHA4;EPHB2;EPHA5
prerank,transmembrane-ephrin receptor activity (GO:0005005),0.4713431591623097,1.2796573924317636,0.15630252100840336,0.721332518270935,1.0,7/17,20.51%,EFNA4;EFNB3;EPHA1;EFNA3;EPHA4;EPHB2;EPHA5
prerank,DNA secondary structure binding (GO:0000217),-0.3764364701849109,-1.277186672809596,0.12668463611859837,0.7258377083259928,1.0,11/31,20.30%,RAD51B;RBBP8;LIN54;HMGB2;CLSPN;YY1;HMGA2;FANCM;XPC;NEIL3;HMGA1
prerank,ubiquitin-like protein conjugating enzyme activity (GO:0061650),-0.36718830137334435,-1.2748882034339961,0.10614525139664804,0.7213523749827689,1.0,13/34,16.38%,UBE2D3;UBE2K;BIRC6;TAF1;UBE2Q1;CDC34;UBE2L3;UFC1;UBE2Q2;AKTIP;UBE2E3;UBE2L6;UBE2C
prerank,Tat protein binding (GO:0030957),-0.5006462521990969,-1.2713039173173084,0.189010989010989,0.7208319310271928,1.0,2/10,3.30%,MDFIC;SMARCA4
prerank,platelet-derived growth factor binding (GO:0048407),0.5173767091289332,1.2692495311904024,0.1889483065953654,0.752434026963323,1.0,5/11,21.50%,COL5A1;COL2A1;PDGFB;PDGFRB;COL6A1
prerank,adenylyltransferase activity (GO:0070566),-0.41512044337636095,-1.2677274255621813,0.14427860696517414,0.7203291292396022,1.0,9/21,19.83%,OAS2;OASL;FLAD1;TENT2;OAS3;FICD;NMNAT3;TENT4B;TENT4A
prerank,voltage-gated sodium channel activity (GO:0005248),0.4384356670844317,1.266323762375846,0.16666666666666666,0.7541392027170466,1.0,10/22,28.45%,HCN1;PKD2;CACNA1G;SCN2A;SCN1B;SCN3B;SCN8A;SCN7A;CACNA1H;SCN1A
prerank,cAMP binding (GO:0030552),0.5202898315321645,1.2660769751937826,0.1797945205479452,0.7454363774319925,1.0,2/11,4.42%,HCN1;PDE4A
prerank,purinergic nucleotide receptor activity (GO:0001614),0.4754214816333381,1.2656486642163776,0.1702127659574468,0.737853214516118,1.0,4/15,12.98%,GPR34;P2RY12;P2RY1;GPR171
prerank,extracellular ligand-gated ion channel activity (GO:0005230),0.5379827990355067,1.264744632548234,0.1836734693877551,0.7325019172364381,1.0,3/10,7.87%,GABRG1;GABRG2;GABRA2
prerank,ubiquitin conjugating enzyme activity (GO:0061631),-0.3723612149204685,-1.2643428101670935,0.12154696132596685,0.7199934228298275,1.0,12/31,16.38%,UBE2D3;UBE2K;BIRC6;TAF1;UBE2Q1;CDC34;UBE2L3;UBE2Q2;AKTIP;UBE2E3;UBE2L6;UBE2C
prerank,"2 iron, 2 sulfur cluster binding (GO:0051537)",-0.48122810471235195,-1.2611091691189285,0.17783505154639176,0.7177648865755837,1.0,4/12,7.43%,XDH;CIAPIN1;SDHB;CISD2
prerank,ribosomal small subunit binding (GO:0043024),-0.4293429489396566,-1.2603049408977105,0.15632183908045977,0.7085885491315749,1.0,7/17,18.10%,EIF4B;DHX29;PIM1;LARP1;NPM1;CPEB2;EIF1B
prerank,DNA polymerase binding (GO:0070182),-0.4149957285484342,-1.2588135324165681,0.15942028985507245,0.7022807008713073,1.0,7/18,19.27%,SMARCA4;PCNA;RTEL1;CDT1;FANCI;SMG6;NAT10
prerank,polyubiquitin modification-dependent protein binding (GO:0031593),-0.32460700146070487,-1.2586335659095482,0.11073825503355705,0.6920298791444981,1.0,16/49,17.31%,VCP;ZRANB3;TNIP3;UBL7;UBQLN1;EPS15;BAG6;ABRAXAS1;ATRIP;RAD23B;WDR81;FAAP20;OPTN;SQSTM1;UIMC1;BRCC3
prerank,poly(U) RNA binding (GO:0008266),0.44539635121764676,1.257218720861067,0.1574539363484087,0.7528150180886755,1.0,4/20,3.76%,PABPC1L;PATL1;PABPC4L;HNRNPH1
prerank,mitogen-activated protein kinase binding (GO:0051019),-0.36947505127879965,-1.2571125247541741,0.12602739726027398,0.686483102183747,1.0,18/29,39.56%,DUSP16;NBR1;MAPKAPK2;MAPKAPK3;DUSP1;MAPK7;TNIP1;DUSP7;GCH1;PPM1D;PRMT1;DUSP4;DUSP8;DUSP9;NFATC1;DUSP6;PTPRJ;MAPK14
prerank,ion channel activity (GO:0005216),0.33566000897018683,1.2559718318777848,0.13783403656821377,0.7481035349444226,1.0,19/80,12.63%,TMC3;TMC8;GRIA2;TRPM3;TRPM2;KCNK3;TMEM63A;GRIK2;GRIK5;GRIA1;CNGB1;GRID2;PKD2;GRIN1;GRIA4;GRIN2B;TMEM63B;TRPC6;UNC80
prerank,gated channel activity (GO:0022836),0.47470848511457175,1.2542053804770839,0.1837748344370861,0.7452885872523543,1.0,4/14,10.83%,TMC3;TMC8;TMEM63A;TMEM63B
prerank,ribosome binding (GO:0043022),-0.33328152336283734,-1.2534719505744678,0.11918604651162791,0.6878524151347519,1.0,21/46,25.81%,EIF2A;ETF1;SHFL;IGHMBP2;NAA10;NAA16;BAG6;CPEB4;ZC3H12A;EIF2S1;SRP72;SEC61A1;RACK1;GTPBP6;NOMO1;CPEB2;EFL1;CPEB3;PYM1;MRPS27;SERBP1
prerank,GTPase activator activity (GO:0005096),-0.24249146159180263,-1.252923215670792,0.012738853503184714,0.6791341905742069,1.0,60/313,12.63%,IQGAP1;VAV3;ARHGAP15;IQGAP2;FGD4;DENND1A;ITSN1;ARHGAP10;FGD6;RIC1;NRP1;TBC1D1;STARD8;ARHGEF10L;RCC1L;DENND4C;DENND1B;ARHGAP17;DOCK2;ARHGAP19;RANBP2;RIC8A;RASA4;LAMTOR5;CCDC88C;ARHGEF18;RASA1;ARHGEF6;RABGAP1;RASGRP4;ARHGAP18;TBC1D2;ASAP1;ARAP1;ARHGAP30;HPS1;DENND6B;GAPVD1;CYTH3;FGD1;RACGAP1;ARHGAP24;EIF2B2;SMCR8;RASGRP2;EEF1D;DENND2A;RABGEF1;SEC23A;ABR;CYTH1;AGAP2;RALGAPA2;RANBP3;ARHGAP39;ARHGAP28;TBC1D10C;LRRK2;TBC1D10A;DENND5A
prerank,SH2 domain binding (GO:0042169),-0.36385397815999604,-1.2474315364434259,0.15267175572519084,0.6861591329742144,1.0,14/31,21.10%,CRK;SH3PXD2B;BLNK;DAG1;LCK;SKAP1;SLAMF1;RACK1;NLK;LILRB1;NUP62;SQSTM1;AFAP1L2;LAX1
prerank,NAD binding (GO:0051287),-0.3714694983541601,-1.2403996942667939,0.13672922252010725,0.697702943743237,1.0,11/26,22.42%,HSD17B8;CRYZ;SORD;PARP9;ALDH1A1;NUDT6;ZC3HAV1;GRHPR;SIRT2;ALDH2;ALDH1B1
prerank,chemokine activity (GO:0008009),-0.36444490403444507,-1.2400281707753669,0.15774647887323945,0.6892337428964045,1.0,11/31,37.19%,CXCL16;CCL25;PF4;CCL28;CXCL12;CCL7;CCL24;CKLF;CCL8;CXCL9;CXCL1
prerank,pyrophosphate hydrolysis-driven proton transmembrane transporter activity (GO:0009678),-0.4013374067664746,-1.2399492888284058,0.15649867374005305,0.6797326717785307,1.0,5/22,4.11%,ATP6V0D1;ATP6V0D2;ATP6V1B2;ATP6V0A1;ATP6V0B
prerank,leak channel activity (GO:0022840),0.4444524375057977,1.2382856303947218,0.18244406196213425,0.7983253354926806,1.0,6/18,19.18%,KCNK12;KCNK3;KCNK6;PANX1;KCNK9;KCNK2
prerank,exoribonuclease activity (GO:0004532),-0.46441188027978464,-1.2358826182768898,0.17091836734693877,0.6826476241930243,1.0,6/12,24.38%,EXOSC8;ZC3H12A;EXOSC10;EXOSC9;EXOSC1;EXOSC7
prerank,cAMP response element binding (GO:0035497),-0.49729088832200163,-1.2328600009422297,0.2222222222222222,0.6818839345056721,1.0,5/10,28.35%,CREB5;CREB3L1;HMGA2;ATF2;CREB1
prerank,hydro-lyase activity (GO:0016836),0.3700773635758125,1.2326101759046677,0.14992503748125938,0.810838998666973,1.0,6/41,4.79%,IREB2;CYP2S1;ECHDC1;CA1;CA3;CA4
prerank,metallocarboxypeptidase activity (GO:0004181),-0.3622829193505802,-1.2314147946859728,0.15267175572519084,0.6776364469187133,1.0,7/26,9.95%,CPD;CPA6;PEPD;AGTPBP1;CPE;AGBL5;CPM
prerank,phosphatase binding (GO:0019902),-0.27484097025465654,-1.2293250855153945,0.0948905109489051,0.675216048295221,1.0,28/105,17.21%,IQGAP1;PXN;KIF3A;VCP;MET;TBK1;PPP6R1;AP3B1;SHOC2;PPP6R3;PPP3R1;SMAD3;MTMR4;CRY2;CDC27;LCK;CTNNB1;PPP1R3C;SKAP1;CRY1;CEACAM1;PPP1R3F;RACK1;EGFR;ITGA1;MTMR3;RPA2;MAP2K7
prerank,DNA replication origin binding (GO:0003688),-0.3859529949972408,-1.2263794508782675,0.19638242894056848,0.6749808526460438,1.0,9/23,15.38%,ORC5;HSPD1;ORC2;GRWD1;MCM2;ORC4;MCM9;MCM8;KAT7
prerank,calcium-activated potassium channel activity (GO:0015269),0.5060207893640131,1.22259333313169,0.2191780821917808,0.8416438804848501,1.0,5/11,22.48%,KCNMA1;KCNN4;KCNMB3;KCNN3;KCNN2
prerank,potassium ion leak channel activity (GO:0022841),0.45626168963733693,1.2215119616803682,0.22372881355932203,0.8362747874733292,1.0,5/15,19.18%,KCNK12;KCNK3;KCNK6;KCNK9;KCNK2
prerank,phosphatidylinositol phospholipase C activity (GO:0004435),0.4202130578996471,1.2164481357655088,0.20032051282051283,0.8476803495367916,1.0,4/23,7.56%,PLCH1;PLCD1;PLCG1;CCR1
prerank,"DNA binding, bending (GO:0008301)",0.4784958119958851,1.215879743535893,0.21237458193979933,0.8409859446310449,1.0,6/14,15.27%,HHEX;TFAM;FOXD1;FOXC1;HMGB1;HMGB3
prerank,cysteine-type peptidase activity (GO:0008234),0.3195888088861017,1.213828080598214,0.13916786226685796,0.8403865271103907,1.0,23/73,21.54%,USP10;CAPN3;USP35;OTULINL;LGMN;USP11;USP50;USP30;ATG4A;GGH;USP12;CASP3;SFRP1;CASP4;USP33;CASP7;OTUD7B;CTSK;USP48;CASP8;USP49;CASP2;CTSS
prerank,acylglycerol O-acyltransferase activity (GO:0016411),0.4250967630246434,1.2132237871420983,0.20294599018003273,0.8336252872665996,1.0,6/20,14.00%,DGAT2;PNPLA3;LPCAT1;LPCAT2;AGPAT1;ABHD5
prerank,acetylgalactosaminyltransferase activity (GO:0008376),0.3966444648716736,1.2127854644936067,0.2066772655007949,0.8264921218354757,1.0,7/26,19.65%,B3GNT9;B3GNT6;B3GALT2;B3GALNT1;CSGALNACT1;B4GALNT3;CHSY1
prerank,"oxidoreductase activity, acting on single donors with incorporation of molecular oxygen, incorporation of two atoms of oxygen (GO:0016702)",0.45932902300634804,1.2086019042826515,0.23652173913043478,0.835328089999935,1.0,3/16,4.32%,IDO2;ALOX12;BCO2
prerank,N-acyltransferase activity (GO:0016410),0.38471964667998687,1.2077360624594646,0.19480519480519481,0.8301776168221532,1.0,11/32,17.17%,PLAAT5;SAT2;TLCD3B;SMARCE1;NAT8L;CERS4;CERS5;CERS6;CERS1;ESCO1;NMT1
prerank,carboxypeptidase activity (GO:0004180),-0.3369484377852332,-1.2049083945521328,0.18487394957983194,0.7318743058850877,1.0,8/35,9.95%,CPD;CPA6;PEPD;AGTPBP1;CPE;AGBL5;CTSA;CPM
prerank,transcription regulatory region nucleic acid binding (GO:0001067),-0.24652265581071126,-1.2042861816417563,0.045,0.7245873232272584,1.0,49/188,18.14%,ARID4B;SOX6;LIN54;ATF3;GABPB2;CDK5RAP2;HMGB2;TCF12;PPARG;CIITA;SOX11;AHR;PROX1;NFKB1;ETV5;YY1;SMAD3;SP1;CEBPB;PRDM9;EGR2;BCOR;YAP1;TBL1X;BRCA1;HSF1;CRY2;HINFP;MZF1;CTCF;ATF5;SMAD6;FOXJ1;TCF7;NR1H3;AHRR;CREB3L1;ZBTB20;FOS;KMT2D;TNF;FOXK2;KLF11;ARID5B;SMAD4;GATA3;HMGA2;GLIS2;PER2
prerank,protein tyrosine/serine/threonine phosphatase activity (GO:0008138),-0.3770393451923176,-1.2019905786818634,0.19143576826196473,0.7224944126017628,1.0,10/22,25.32%,DUSP16;MTMR2;DUSP18;CDKN3;DUSP1;MTMR3;PPM1F;DUSP19;DUSP3;DUSP7
prerank,alpha-tubulin binding (GO:0043014),0.3795645930923133,1.1968193761591828,0.20430107526881722,0.8648515397030565,1.0,9/31,18.28%,DIP2B;DLEC1;BEX4;ARL4C;TBCE;DNAL1;TAOK1;EML4;TTLL7
prerank,sodium-independent organic anion transmembrane transporter activity (GO:0015347),0.5067268189825609,1.1961591223394712,0.24035087719298245,0.8589305939375184,1.0,1/10,0.83%,SLCO2B1
prerank,endopeptidase inhibitor activity (GO:0004866),0.3187673348395549,1.194182893550124,0.180028129395218,0.8579926213674295,1.0,10/82,7.98%,GAPDH;SPOCK3;BIN1;CST3;SPOCK2;PRNP;PSMF1;SERPINH1;SPINT2;UBE2Z
prerank,chloride channel inhibitor activity (GO:0019869),0.507123001657158,1.1941788329012561,0.2643478260869565,0.8493540662716297,1.0,7/10,35.74%,CFTR;WNK1;VTI1B;WNK4;STX8;WNK3;STX7
prerank,heme binding (GO:0020037),0.33030612930580217,1.1935021206228007,0.18906942392909898,0.843432643587383,1.0,14/65,17.32%,CYP2S1;CYP2U1;SLC48A1;HEBP2;ABCB6;PGRMC2;FLVCR1;SDHC;PXDN;HEBP1;CYP27A1;PGRMC1;BACH1;CYB5B
prerank,acetylcholine receptor activity (GO:0015464),-0.37752807764467733,-1.1932616232458908,0.21794871794871795,0.7429477467319685,1.0,9/22,35.54%,CHRM2;CHRNB2;CHRNA4;CHRNA5;HRH3;CHRNA3;CHRNB4;CHRM1;CHRNB3
prerank,G protein-coupled photoreceptor activity (GO:0008020),-0.45466574464778897,-1.1919261443973184,0.22119815668202766,0.7380350530110346,1.0,8/12,35.08%,GPR88;OPN3;RRH;GPR52;OPN1MW;OPN1MW3;OPN5;OPN4
prerank,nuclear import signal receptor activity (GO:0061608),-0.42702856546883716,-1.1879508875373328,0.24937655860349128,0.7424548027235672,1.0,5/15,21.12%,KPNB1;KPNA2;HIKESHI;KPNA3;RANBP6
prerank,GDP-dissociation inhibitor activity (GO:0005092),0.4638269426796567,1.1866090052533902,0.25894378194207834,0.8629942246516471,1.0,5/13,15.54%,ARHGDIG;ARHGDIA;ITGB1BP1;GDI1;SH3BP4
prerank,RNA cap binding (GO:0000339),0.4372115161166444,1.1862252544255156,0.22657580919931858,0.8558759763665643,1.0,7/16,18.82%,LSM1;NCBP3;SNUPN;CYFIP1;GEMIN5;EIF4A1;EIF3D
prerank,UDP-glycosyltransferase activity (GO:0008194),0.32401756192392345,1.185271836283486,0.16299559471365638,0.8514739930821305,1.0,21/70,23.38%,HEXB;B3GNT9;B4GAT1;B3GNT6;B3GALT2;GXYLT1;OGT;B3GALNT1;CSGALNACT1;MGAT4B;POMGNT1;GCNT7;B3GAT3;B4GALNT3;GCNT4;CHSY1;GCNT1;LARGE1;UGT1A6;EXT2;RFNG
prerank,acidic amino acid transmembrane transporter activity (GO:0015172),0.44846719475884933,1.1840993256599777,0.253781512605042,0.8479484400935783,1.0,5/15,11.60%,SLC1A1;SLC25A18;SLC38A7;SLC1A3;SLC1A4
prerank,RNA polymerase core enzyme binding (GO:0043175),0.37259835761033955,1.181828746181257,0.21417565485362094,0.8484200323363169,1.0,12/33,23.51%,MAF1;CTR9;SMYD2;ELP2;RRN3;SPTY2D1;CCAR2;PAF1;ELOF1;SCAF8;ELP4;GTF2B
prerank,histone acetyltransferase activity (GO:0004402),-0.3451687703075303,-1.1815580747163277,0.19302949061662197,0.7539678462979857,1.0,9/30,15.38%,BAZ1A;EPC1;KAT6B;EPC2;TAF1;EP300;HAT1;KAT5;KAT7
prerank,diacylglycerol kinase activity (GO:0004143),0.479382739076699,1.176396883161381,0.25749559082892415,0.8617049110508292,1.0,5/11,20.69%,DGKI;DGKQ;DGKZ;DGKE;DGKH
prerank,snoRNA binding (GO:0030515),-0.3445388523644289,-1.1757290594662588,0.2346368715083799,0.7640792549005789,1.0,11/30,19.48%,UTP6;BYSL;NOP58;NUDT5;TSR1;WDR3;TBL3;DDX21;NOP10;NUDT7;DKC1
prerank,RNA methyltransferase activity (GO:0008173),-0.39310456900205204,-1.1747344657108931,0.22580645161290322,0.758512426499087,1.0,8/19,16.76%,FTSJ3;MRM2;LCMT2;METTL8;TRDMT1;TRMT13;TRMT9B;FBL
prerank,amino acid transmembrane transporter activity (GO:0015171),-0.30679796357706834,-1.173824054101267,0.1951219512195122,0.7527472932677692,1.0,6/47,4.50%,SLC38A6;SLC1A5;SLC7A1;SLC43A2;SLC6A6;SLC7A11
prerank,DNA-directed 5'-3' RNA polymerase activity (GO:0003899),0.39023855457729173,1.172681789616478,0.22644628099173553,0.86874914670499,1.0,13/27,27.31%,POLR2L;POLR2F;POLR3F;POLR2G;POLR3A;POLR1F;PRIM1;POLR3B;POLR2C;POLR3K;POLR2D;POLR1A;POLRMT
prerank,phosphatidylinositol binding (GO:0035091),-0.26948482382416744,-1.1692667644372006,0.15867158671586715,0.7588304787037791,1.0,14/91,6.79%,DENND1A;HIP1;SNX24;SESTD1;DENND1B;SNX8;PLEKHF2;SNX1;FCHO2;ZFYVE16;HIP1R;PICALM;ITPR1;SNX9
prerank,insulin-like growth factor I binding (GO:0031994),0.4706451820313211,1.168943990742788,0.2651006711409396,0.8754401948502337,1.0,5/13,16.96%,IGFBP6;LRP2;IGFBP2;INSR;ITGA6
prerank,"endodeoxyribonuclease activity, producing 5'-phosphomonoesters (GO:0016888)",0.4574744062855896,1.168196206769054,0.2391681109185442,0.8708209211576099,1.0,4/13,14.96%,DNASE1;DNASE1L2;FAN1;FEN1
prerank,sterol binding (GO:0032934),-0.297297787112389,-1.16499319875696,0.19148936170212766,0.7641604018053051,1.0,19/56,21.48%,OSBPL8;NPC2;OSBP;STARD3NL;OSBPL9;OSBPL1A;GPR183;CAV1;ERLIN2;OSBPL2;ABCG1;OSBP2;NR1H3;GRAMD1C;GRAMD1B;SULT2B1;VDAC2;INSIG1;PTCH1
prerank,anion:anion antiporter activity (GO:0015301),0.42421647323172035,1.164369580093285,0.2668918918918919,0.8776574573689165,1.0,5/17,14.50%,SLC25A4;SLC26A4;SLC26A7;SLC25A5;SLC19A1
prerank,carboxylic acid binding (GO:0031406),0.3573812079917086,1.1642303769592932,0.23407407407407407,0.870409124971527,1.0,8/38,11.49%,GLRA3;AKR1C1;EPDR1;GLRB;GRIN1;GRIN2B;GLRA2;MAG
prerank,ubiquitin-ubiquitin ligase activity (GO:0034450),-0.46140969701848134,-1.160744172237011,0.2766884531590414,0.7693072078210259,1.0,2/11,2.72%,PRPF19;UBE2K
prerank,"hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in cyclic amidines (GO:0016814)",0.49348135066311294,1.1605882358083466,0.2864583333333333,0.8772511706308664,1.0,4/10,6.06%,LACC1;ADARB2;APOBEC2;ADA
prerank,acetylcholine-gated cation-selective channel activity (GO:0022848),-0.44598596215095443,-1.158339054864284,0.29055690072639223,0.768476562958787,1.0,6/11,35.22%,CHRNB2;CHRNA4;CHRNA5;CHRNA3;CHRNA9;CHRNB4
prerank,FMN binding (GO:0010181),0.47381684672052315,1.157092223071674,0.28520499108734404,0.8835627277411852,1.0,2/11,4.43%,PPCDC;NDOR1
prerank,mRNA binding (GO:0003729),-0.2311445913381135,-1.1563819240801074,0.08125,0.7663755855856205,1.0,68/249,20.95%,RBM47;HNRNPLL;NOVA2;SRSF4;EIF2A;CELF1;NOCT;RPS26;ZC3H12D;HNRNPM;RPL5;NCBP1;ETF1;PURB;RBM8A;RPS14;DHX33;SAMD4A;PUM2;EIF2S2;RPS13;SLC4A1AP;SHFL;RPS7;RPS5;HNRNPAB;LUC7L;HNRNPK;EIF4ENIF1;DDX6;LARP6;CPEB4;AQR;ZC3H12A;CRYZ;SSB;DCP1B;RC3H1;ZC3H12B;RBPMS;HNRNPA2B1;LUC7L2;CSTF2;AGO2;SYNCRIP;TYMS;NSRP1;LARP1;RPL41;PCF11;RC3H2;RBMX;LARP4B;FXR2;UPF3B;CPEB2;EIF3A;CELF3;RNF20;SNRNP35;SRBD1;CELF2;RPL26;HNRNPC;HNRNPU;PUM1;PTBP3;DHFR
prerank,insulin-like growth factor binding (GO:0005520),0.446506034221986,1.1555832438538856,0.25882352941176473,0.8815745268753292,1.0,6/15,16.96%,IGFBP6;LRP2;IGFBP2;INSR;IGFALS;ITGA6
prerank,syntaxin binding (GO:0019905),0.31976384987085343,1.1546986871492286,0.23222060957910015,0.8772394616841284,1.0,17/61,19.10%,SNAP25;SCFD2;SYT1;NAPB;SYT6;STX16;SYNPR;UNC13B;CPLX2;STXBP2;VAMP3;BAIAP3;PTPN2;CACNA1A;STXBP4;STXBP5;UNC13C
prerank,cholesterol transfer activity (GO:0120020),-0.409419489230056,-1.1532205334760146,0.26785714285714285,0.7679969606120445,1.0,6/16,16.15%,NPC2;PLTP;OSBPL2;ABCG1;GRAMD1C;GRAMD1B
prerank,"phosphatidylinositol-3,4-bisphosphate binding (GO:0043325)",-0.35473744037647664,-1.15225821706872,0.2585227272727273,0.7628062542220242,1.0,6/25,7.70%,HIP1;KIF16B;SESTD1;PLA2G4E;HIP1R;GAB2
prerank,carboxy-lyase activity (GO:0016831),0.3927861399376788,1.1521548884003554,0.25745682888540034,0.8789212994215521,1.0,8/23,19.78%,ECHDC1;PPCDC;CSAD;AZIN2;UXS1;UROD;FAHD1;BCKDHA
prerank,3'-5' DNA helicase activity (GO:0043138),0.42384817731332025,1.150932006342755,0.27104377104377103,0.8760827103324652,1.0,2/16,1.07%,NAV2;MCM5
prerank,epidermal growth factor receptor binding (GO:0005154),-0.3501421483624227,-1.1503569853767346,0.22580645161290322,0.7608326517515839,1.0,12/25,31.93%,HIP1;CNOT9;SNX1;GRB2;SHC1;TGFA;PLSCR1;EGF;SNX2;CCDC88A;FAM83B;EFEMP1
prerank,organic anion transmembrane transporter activity (GO:0008514),0.28039974932789585,1.1484230913662385,0.20345744680851063,0.8780908434667621,1.0,40/134,24.71%,SLC4A8;SLC35A1;SLCO2B1;SLC25A2;SLC5A12;SLC38A2;SLC1A1;SLC2A2;SLC38A9;SLC25A18;SLC38A7;SLC26A4;SFXN1;CFTR;SLC26A7;MFSD10;SLC1A3;SLC39A8;CTNS;SLC1A4;SLC66A1;SFXN2;SLC3A1;SLC6A1;SLC19A1;MPC1;SLC25A23;SLC16A12;SLC35B2;SLC13A3;ABCG2;SLC25A38;SLC6A9;SLC38A3;SLC19A2;SLC6A7;SLC35B1;SLCO4A1;SLC16A7;SLC25A1
prerank,"exodeoxyribonuclease activity, producing 5'-phosphomonoesters (GO:0016895)",0.4884752286975999,1.1473533255480812,0.31497418244406195,0.8743661681298511,1.0,6/10,34.47%,APEX1;FEN1;EXD2;TATDN1;POLD1;MGME1
prerank,nucleosomal DNA binding (GO:0031492),-0.3681214501680364,-1.1471642107542581,0.265625,0.7632563668429027,1.0,10/21,21.97%,GATAD2B;SMARCA4;MBD2;H3-3A;H1-0;HDAC2;HDAC1;HMGA2;HNRNPC;RCC1
prerank,metalloaminopeptidase activity (GO:0070006),0.4382387075717007,1.1469884812028244,0.29064039408866993,0.8684290659081221,1.0,7/16,18.17%,MMP16;RNPEPL1;XPNPEP1;XPNPEP3;TRHDE;ENPEP;MMP17
prerank,transmitter-gated ion channel activity involved in regulation of postsynaptic membrane potential (GO:1904315),0.3737334362875053,1.1441181932104059,0.2718600953895072,0.872201704417974,1.0,6/28,7.91%,GABRG1;GABRG2;GRIK2;GRIK5;GABRA2;GRID2
prerank,nucleotidyltransferase activity (GO:0016779),-0.37243697713319995,-1.1405940648046782,0.2400990099009901,0.776059100571979,1.0,9/19,25.06%,PAPSS2;TENT2;NUDT5;YRDC;TENT4B;TENT4A;THG1L;DNTT;TERT
prerank,histone-lysine N-methyltransferase activity (GO:0018024),-0.3022492793207553,-1.1404416614281563,0.2210242587601078,0.7684653265561358,1.0,19/44,24.00%,NSD2;SETDB2;SETD7;DOT1L;SETD3;PRDM9;WDR82;KMT2C;EHMT1;KMT2D;RBBP5;SMYD3;EED;KMT2B;SETD2;SETD1A;MECOM;KMT2A;EZH2
prerank,aspartic-type peptidase activity (GO:0070001),0.4833613175151631,1.1394508489756934,0.30742049469964666,0.8831474313856191,1.0,2/10,6.03%,ASPRV1;BACE1
prerank,omega peptidase activity (GO:0008242),0.2963690711371064,1.1390329981247358,0.2274618585298197,0.8775169302576808,1.0,25/89,21.47%,MPND;OTUD7A;USP32;USP10;GGT7;USP35;GGT5;USP11;USP50;USP30;USP51;GGH;USP12;USP33;PSMD14;OTUB1;BAP1;OTUD7B;OTUD5;USP48;STAMBP;COPS5;CYLD;USP49;APEH
prerank,tRNA binding (GO:0000049),-0.2981730185919912,-1.1383683797768074,0.21637426900584794,0.7675845222694976,1.0,15/43,16.11%,XPOT;EIF2A;EEF1A1;AIMP1;TRNAU1AP;TRMT10C;FARS2;IGHMBP2;PSTK;YARS2;ALKBH8;SSB;NSUN2;TRMT9B;YRDC
prerank,aminopeptidase activity (GO:0004177),0.38236407064837585,1.1368509492645824,0.27447833065810595,0.8785134914858885,1.0,9/26,18.17%,MMP16;RNPEPL1;XPNPEP1;METAP1D;XPNPEP3;TRHDE;LAP3;ENPEP;MMP17
prerank,four-way junction DNA binding (GO:0000400),-0.3935914345917014,-1.1359979749784057,0.2639225181598063,0.7670290160688666,1.0,3/17,5.48%,RAD51B;HMGB2;YY1
prerank,"3',5'-cyclic-AMP phosphodiesterase activity (GO:0004115)",0.4538937677429147,1.1337893512853972,0.2928452579034942,0.8827656937674915,1.0,3/12,6.72%,PDE8B;PDE4A;PDE3B
prerank,Toll-like receptor binding (GO:0035325),-0.4439551286320339,-1.1333363130977419,0.3196125907990315,0.7678038124097107,1.0,4/11,19.82%,TLR2;CD36;TLR1;MYD88
prerank,transmembrane receptor protein tyrosine kinase adaptor activity (GO:0005068),-0.4230091999418265,-1.1304635266309566,0.31042128603104213,0.7692888946411995,1.0,4/12,7.82%,STAP1;FRS2;GAB2;BLNK
prerank,cysteine-type endopeptidase activity involved in execution phase of apoptosis (GO:0097200),0.4804427694667329,1.130034730901346,0.32149200710479575,0.8895424918059575,1.0,6/10,23.45%,CASP3;CASP4;CASP7;CASP8;CASP2;CFLAR
prerank,protein serine/threonine kinase inhibitor activity (GO:0030291),-0.32924992983729373,-1.1261057998264812,0.2558139534883721,0.7755423229155655,1.0,14/29,27.43%,PKIB;CIT;PRKAG2;CIB1;YWHAG;CDKN2C;SPRY2;HSPB1;CDKN2A;INKA1;INKA2;KAT2B;SPRED1;INCA1
prerank,microtubule motor activity (GO:0003777),-0.28834819972228914,-1.1229517345746138,0.24127906976744187,0.7779524315973732,1.0,17/51,20.57%,KIF3A;KIF16B;KIF23;KIF11;KIFC2;KIF20B;KIF13B;KIFC1;KIF24;KIF21A;KIF4A;KIF20A;DNAH8;KIF18B;KIF19;KIF27;KIF7
prerank,single-stranded telomeric DNA binding (GO:0043047),-0.42810745814528794,-1.122943180656743,0.3069053708439898,0.7705046442229768,1.0,4/11,17.00%,RPA1;HNRNPA2B1;TERF2;RPA2
prerank,transmembrane receptor protein kinase activity (GO:0019199),0.30805214303758827,1.1196011175033072,0.2609351432880845,0.9221697893634669,1.0,18/60,20.51%,MERTK;NTRK1;FLT4;NTRK3;RYK;EPHA1;ERBB4;ACVR1B;TEK;EPHA4;INSR;EPHB2;NTRK2;FLT3;BMPR1B;PDGFRB;ROR1;EPHA5
prerank,tropomyosin binding (GO:0005523),0.42173974307788625,1.1194190489185747,0.3242784380305603,0.9157459941949763,1.0,4/16,12.94%,NEBL;LMOD1;TMOD2;LMOD3
prerank,ephrin receptor binding (GO:0046875),0.3887659699518796,1.118071371459333,0.3027823240589198,0.9138542530441952,1.0,7/21,12.45%,CHN1;EFNA4;EFNB3;PIK3CG;ANKS1B;EFNA1;EFNA3
prerank,L-glutamate transmembrane transporter activity (GO:0005313),0.43141000160776344,1.1178826887981987,0.32482993197278914,0.9075861340631034,1.0,4/14,11.07%,SLC1A1;SLC25A18;SLC38A7;SLC1A3
prerank,regulatory RNA binding (GO:0061980),-0.3065105859642344,-1.1177580599660426,0.2621082621082621,0.7788550690351191,1.0,10/38,15.12%,TLR7;PUM2;ZNF346;ZC3H12A;RC3H1;PIWIL2;HNRNPA2B1;AGO2;DDX21;TRIM71
prerank,S-adenosylmethionine-dependent methyltransferase activity (GO:0008757),0.33469496614997724,1.116242373616891,0.2670807453416149,0.9071486772272478,1.0,12/40,17.70%,LRTOMT;METTL2B;METTL2A;TPMT;MEPCE;METTL4;METTL9;FBLL1;COMT;N6AMT1;ASMT;PCMT1
prerank,RNA binding (GO:0003723),-0.19332909559727154,-1.1158460484413133,0.0,0.7774959729236872,1.0,316/1321,18.61%,APOBEC1;RFTN1;ASCC3;MYO5A;AHNAK;DDX42;RBM47;UTP6;DDX60;PSMA6;HNRNPLL;NOL11;XPOT;ANKRD17;ZCCHC7;MECP2;OAS2;NOVA2;SRSF4;EIF2A;KPNB1;FAM120A;CELF1;NOCT;RCC1L;VCP;SCAF4;RPS26;FTSJ3;MBNL1;TRIM25;RPL39;ZNFX1;MARK2;ZC3H12D;IFIH1;RPS23;HNRNPM;RPL5;CCT6A;HMGB2;RPS24;FAM98B;PPHLN1;GOLGB1;IFIT2;ACTN1;RPS16;SNRPA;TRUB2;EIF4B;RBM34;FAU;WDR43;GNL3L;AGFG1;LGALS1;NCBP1;FAM98A;ZBP1;DHX29;PTPN1;RPL28;EEF1A1;ETF1;ENO1;MKI67;RPGR;TOP2A;AIMP1;SNTB2;PURB;KPNA2;GPATCH1;FNDC3A;RBM8A;RPS14;SNRNP40;DHX33;TLR7;TCOF1;IFIT1;CTNNA1;RPS20;TRNAU1AP;SAMD4A;CLNS1A;DDX49;SLTM;RPL35A;ZCCHC17;FIP1L1;PUM2;RPS12;NOL7;MSN;EIF2S2;SREK1;TRMT10C;RPL18A;OASL;ZNF346;RPS13;GANAB;SLC4A1AP;SNRPD1;RPL27;RPL21;YY1;BAG4;SHFL;RPS7;EIF3I;BST2;DDX52;CRKL;RPF1;RPS5;HSPD1;TBCA;UBAP2L;JMJD6;TFRC;HNRNPAB;LUC7L;FARS2;DDX41;RPL30;PRPF6;PLEC;RPF2;RPL6;DHX38;IFIT3;MBNL3;ILF2;RPL37A;RO60;RRP12;RPP38;SRRT;ACAA2;FNDC3B;HNRNPK;CISD2;UBC;BYSL;TLR8;IGHMBP2;KMT2C;EIF4ENIF1;PSTK;YWHAG;BRCA1;DQX1;RAVER2;EIF3G;TXN;UTP4;RPL10;RPL15;FAM133B;SNRPB;DDX6;ALG13;CAPRIN1;TPT1;S100A4;TRMT1L;DEK;LARP6;CPEB4;AQR;UBE2L3;NOSIP;HNRNPUL2;SNW1;ZC3H12A;MAPRE1;H1-0;DNAJC21;GNL2;UTP11;UTP15;EXOSC10;VIM;MRPL1;RPP21;GDI2;NUSAP1;MRPS30;YARS2;DDX27;RPS10;FASTKD1;ALKBH8;EIF2S1;SSB;RPL14;DCP1B;XRN2;IBA57;GRWD1;SEC63;RPL9;RC3H1;GRB2;ZC3H12B;TENT5A;SPEN;BARD1;RPL32;RPL36;CCT3;TES;NOP58;MTO1;HDAC2;SRP72;RPL31;NUDT5;RBPMS;HNRNPA2B1;RPL23A;CPSF4;LTA4H;TSR1;RPN1;LUC7L2;CSTF2;AGO2;CS;NSUN2;CHCHD1;SLC25A11;LSM2;YLPM1;OAS3;POLR2B;SYNCRIP;LRRFIP1;NSRP1;LRP1;LARP1;RACK1;LSM5;IMMT;CPSF2;UTP18;RPL41;PRPF40A;RPL3;EXOSC9;NPM1;UBTF;NMD3;FRG1;PCF11;PRKRIP1;WDR3;TBL3;PURG;DDX21;TRMT9B;HSPB1;RC3H2;PHF5A;HMGN2;RBM7;RPL8;MYH9;MKRN1;SAP18;DDX20;ZC3H18;RBM27;RBMX;LARP4B;YRDC;PEBP1;FXR2;UPF3B;CCDC9B;ANKHD1;NOP10;SEC23IP;FBL;DUS2;USO1;NOP53;HADHB;CPEB2;POP1;SLC3A2;CCDC59;EIF3A;KRI1;CELF3;HELZ2;FLNA;ZC3HAV1;HNRNPD;EIF1B;SMG6;NUDT7;SNRPC;RPL37;SCAF11;MRPL4;PRPF3;COL14A1;EMG1;TENT4B;MAGOH;MAGOHB;MEX3D
prerank,"4 iron, 4 sulfur cluster binding (GO:0051539)",0.4272165231515242,1.1140448584828346,0.31802721088435376,0.9089327746240168,1.0,6/14,22.65%,IREB2;NDUFS1;CIAO3;ISCU;EXO5;NUBPL
prerank,3'-5' exonuclease activity (GO:0008408),0.327604250432556,1.1129040414205267,0.3052147239263804,0.9067317616424783,1.0,15/45,22.38%,ERI3;REXO2;POLG;ANGEL1;EXD1;ERI2;EXOSC5;CNOT8;APEX1;ANGEL2;WRN;REXO4;APLF;DIS3L;EXD2
prerank,histone deacetylase binding (GO:0042826),0.29336329019356483,1.112128869132702,0.27453769559032715,0.9031826708033308,1.0,24/88,20.79%,YWHAE;NACC2;PKN1;HIC1;RELA;SP2;BEX4;ZMYND15;MEF2C;AKAP8L;PHF6;NCOR2;HDAC5;PRKN;AKAP8;USF1;NUDT21;PRDM1;BHLHE41;HDAC3;DHX36;GLI3;HSP90AB1;YWHAB
prerank,calcium-dependent phospholipid binding (GO:0005544),0.3186949399733756,1.1114262403333026,0.2988338192419825,0.8992406816867122,1.0,9/49,8.83%,SYT4;ANXA8;SYT13;SYT1;SYT6;PLA2G4C;ESYT2;DOC2B;CPNE6
prerank,tubulin binding (GO:0015631),0.2539894845853408,1.1108857183559682,0.21974148061104584,0.8946967618029991,1.0,87/295,22.80%,TPPP;STMN4;GAPDH;STMN3;MAP6;DIP2B;DST;IFT81;BLOC1S2;DLEC1;PAK1;MID2;PSRC1;STMN2;REEP2;BEX4;PRNP;NAV3;PDCD5;MAP1S;ARL4C;CLASP2;CCDC181;TBCE;PHF6;MAPRE2;KIF26A;FSD1;MAP4K4;CKAP5;PRKN;EMD;RAE1;LRPPRC;FGF13;PEX14;RMDN3;TTLL6;DNAL1;CAMSAP1;DNM1L;DCTN1;KIF1C;MTCL1;VASH2;SYBU;TTLL12;KIF2A;HOOK2;NEFM;RCC2;NDRG1;APC2;UXT;TUBGCP2;AGBL4;MAP9;CLIP1;KIF14;TAOK1;HDGFL3;STARD9;ALMS1;EML4;MAST2;TTLL7;HOOK1;ABRAXAS2;EML6;TPGS1;ALDOA;GABARAP;CEP57;TTLL1;TTLL5;KIF1B;KIF9;TUBGCP6;MAP2;KIF17;MAPRE3;DRG1;SPAST;MAP7D3;TOGARAM2;KIF21B;TPPP3
prerank,phosphatidylinositol-3-phosphatase activity (GO:0004438),-0.41040065037862117,-1.1083892436344975,0.3372093023255814,0.7936756425501199,1.0,6/14,15.84%,MTMR14;MTMR2;MTMR4;MTM1;MTMR12;MTMR3
prerank,organic cation transmembrane transporter activity (GO:0015101),0.40704141803191696,1.1083325617820945,0.2962962962962963,0.897735763477313,1.0,6/16,29.22%,SLC44A2;SLC22A4;SLC18A3;SLC22A5;SLC25A26;SLC5A7
prerank,lysine N-methyltransferase activity (GO:0016278),0.38884418515234376,1.1028142594444186,0.3219178082191781,0.912034524463457,1.0,6/20,10.49%,SMYD2;METTL21C;EEF1AKMT2;METTL21A;SETD6;SETD4
prerank,histone demethylase activity (GO:0032452),-0.3285095237803442,-1.1003361264868765,0.3179347826086957,0.8125101952662644,1.0,8/27,15.27%,RIOX2;KDM7A;JMJD6;KDM8;KDM6A;HR;RIOX1;KDM5C
prerank,secondary active transmembrane transporter activity (GO:0015291),0.3146059908336087,1.0993183825432524,0.31718061674008813,0.9180268605987124,1.0,9/51,14.80%,SLC35A1;SLCO2B1;SLC5A12;SLC22A8;SLC46A2;SLC20A1;SLC35C1;TMEM241;SLC22A4
prerank,calcium channel inhibitor activity (GO:0019855),-0.4293154415767385,-1.0992252984417126,0.3473193473193473,0.8085626480307766,1.0,5/11,18.13%,MCUB;ITPR1;PHPT1;CALM2;SLC30A1
prerank,phosphatidylinositol phosphate kinase activity (GO:0016307),0.43369657674714635,1.0984589858784615,0.33276157804459694,0.9148796309081313,1.0,5/13,24.72%,PIK3C2G;PIK3CG;PIK3C2A;PIP4K2B;PIP4K2A
prerank,transition metal ion binding (GO:0046914),0.24204473569053256,1.0970222437840915,0.23007856341189675,0.9139096473527673,1.0,110/397,22.59%,POLR2L;QPCTL;LACC1;NUDT12;TYW5;TET1;ANG;IKZF4;MMP16;MYCBP2;COA6;AFP;NSD1;GPC1;XPNPEP1;PRNP;ZFPM2;ADA;KDM1B;MTPAP;GALT;XPNPEP3;COMMD1;S100A13;ZNF205;SHANK3;WDFY1;ENPP2;PHEX;MPPED2;CHORDC1;MPPE1;GRIN2B;TRHDE;PRKN;AOC2;KLF7;NEK4;ITGB1BP2;MOXD1;KDM2B;SUV39H2;THAP1;RNF8;USP33;PHF8;CHMP1A;MGAT5B;PITRM1;TIMM13;DCT;SEC24D;FBXL19;TRIM8;SEC24B;KDM4A;MSRB3;PGGT1B;ACR;ZBTB32;RNF2;AOC1;ENPEP;FEN1;RPS27;TRAF7;NAPEPLD;POMGNT1;SIAH1;EPRS1;SEC24C;CLIP1;ATOX1;TK1;ESCO1;MT2A;ISCU;ZEB1;PHF2;MT1B;MT1X;MT1A;MT1H;MT1G;MT1M;MT1F;MT1E;IL1A;SNCB;WRN;ADAMTS3;ALAD;ARG2;RABGGTB;CDADC1;GALNT4;GALNT2;PLA2G15;CYLD;CALB1;COX17;FDX1;MDM4;PTGR2;LANCL1;CXXC5;LARGE1;TIMP2;EXD2;ZDHHC15
prerank,mitogen-activated protein kinase kinase kinase binding (GO:0031435),-0.4233328531007866,-1.0945683730766975,0.32599118942731276,0.8163412782559395,1.0,3/11,9.75%,SASH1;STK38;MAP3K11
prerank,cysteine-type endopeptidase activity involved in apoptotic process (GO:0097153),0.45575816282848874,1.0935466035204087,0.3669064748201439,0.9204202603925346,1.0,6/11,23.45%,CASP3;CASP4;CASP7;CASP8;CASP2;CFLAR
prerank,superoxide-generating NAD(P)H oxidase activity (GO:0016175),-0.4485400904623793,-1.093145093782633,0.32860520094562645,0.8132124937029627,1.0,2/10,11.96%,CYBB;CYBA
prerank,"hydrolase activity, hydrolyzing N-glycosyl compounds (GO:0016799)",-0.375130746416374,-1.0915536350173125,0.33906633906633904,0.8109449480789461,1.0,10/16,33.57%,CD38;ADPRH;BST1;NTHL1;NEIL3;TDG;DNPH1;RPS3;MACROD1;SMUG1
prerank,PDZ domain binding (GO:0030165),0.30013575173074425,1.0909334334540435,0.31896551724137934,0.9236112430057849,1.0,24/61,26.40%,F11R;CADM1;TGFBR3;GRIA1;GRID2;PRKN;CFTR;ATP2B3;ACOX1;SLC22A4;DOCK4;KIF14;CXADR;SDC2;LLGL2;PLEKHA2;PLEKHA1;SLC22A5;SSTR2;PDZK1;CXXC4;RAPGEF2;SRR;DLG4
prerank,delayed rectifier potassium channel activity (GO:0005251),0.3516482031126905,1.0897737670422472,0.3248,0.9214121776039064,1.0,4/32,5.60%,KCNH2;KCNA5;KCNE2;KCNC1
prerank,histone methyltransferase binding (GO:1990226),-0.42489692439352167,-1.0865843707082972,0.34823529411764703,0.8199926848729971,1.0,4/11,13.36%,LCOR;LCORL;CTNNB1;PRDM4
prerank,Hsp90 protein binding (GO:0051879),-0.3161622733745803,-1.0865015267950722,0.32345013477088946,0.8130470286211989,1.0,9/33,13.34%,NR3C1;AHR;ERN1;NOD2;HIF1A;HSF1;PACRG;KDR;CYP1A1
prerank,aspartic-type endopeptidase activity (GO:0004190),0.4467974845863945,1.0849826607311561,0.36804308797127466,0.9331983486757256,1.0,4/12,15.39%,ASPRV1;BACE1;SPPL2B;HM13
prerank,potassium ion transmembrane transporter activity (GO:0015079),0.3406346086155353,1.0824873764265257,0.3172302737520129,0.9363693219195224,1.0,8/31,18.56%,HCN1;SLC12A2;KCNK3;PKD2;SLC12A6;ABCC8;KCNK9;KCNQ4
prerank,small GTPase binding (GO:0031267),0.25847941084108966,1.081431614060357,0.2869458128078818,0.9343234606565466,1.0,43/169,16.05%,IFT20;TSC2;RIN3;SRGAP2;GGA3;RAB11FIP3;SGSM2;MYCBP2;PKN1;PAK1;SGSM3;AP3M1;NCKAP1;CHM;PEX5;FGD2;CDC42EP5;RAB8A;CDKL5;MYO1C;OCRL;UNC13B;RAP1GAP;EHD1;RIMS1;KCTD13;ANKRD27;BICD2;USP33;DNM1L;AKAP13;RAB34;HACE1;MICALL1;RALBP1;CYFIP1;FMNL1;EXOC5;RCC2;NDRG1;SH3BP4;RNF152;DOCK4
prerank,metallopeptidase activity (GO:0008237),0.2709697590597743,1.0782119602697522,0.33964817320703655,0.9400883661440493,1.0,28/113,21.27%,ADAM2;MPND;MMP16;MEP1B;ADAMTS20;METAP1D;PSMD7;PHEX;ADAMTSL1;ADAMTS15;ADAM15;LAP3;ADAM12;ADAMTS19;THSD4;PSMD14;CHMP1A;ADAMTS14;PITRM1;MMP1;COPS6;THOP1;ADAMTS4;MMP17;ADAMTS3;COPS5;OMA1;METAP2
prerank,glucuronosyltransferase activity (GO:0015020),0.3785931476970766,1.076981227662917,0.37520938023450584,0.938336854720932,1.0,8/19,22.46%,B4GAT1;CSGALNACT1;B3GAT3;CHSY1;B3GAT2;LARGE1;UGT1A6;EXT2
prerank,cell adhesion mediator activity (GO:0098631),0.36486277657594757,1.0763100520270024,0.34477124183006536,0.9343943314254929,1.0,9/24,19.50%,ROBO4;MYPN;CNTN2;DSCAM;BSG;DSCAML1;JAM3;NTNG1;LRRC4C
prerank,hexosyltransferase activity (GO:0016758),0.2764755609662753,1.0759817159727352,0.3301104972375691,0.9293582218885673,1.0,29/101,23.38%,HEXB;B3GNT9;B4GAT1;B3GNT6;B3GALT2;TMTC4;ALG1;DPY19L4;PIGB;POFUT1;OGT;DPY19L3;B3GALNT1;CSGALNACT1;MGAT4B;POMGNT1;ALG5;GCNT7;B3GAT3;B4GALNT3;GCNT4;B4GALT2;CHSY1;GCNT1;LARGE1;UGT1A6;EXT2;GBA2;RFNG
prerank,death receptor activity (GO:0005035),-0.41922663947478966,-1.075511332858259,0.3669250645994832,0.8424006875389689,1.0,4/11,17.63%,FAS;TNFRSF19;TNFRSF1B;TNFRSF25
prerank,microtubule plus-end binding (GO:0051010),0.37789323957405224,1.0754067228949342,0.3811129848229342,0.9254475129983643,1.0,5/20,16.37%,DST;CLASP2;MAPRE2;DCTN1;CLIP1
prerank,GTPase binding (GO:0051020),0.25293320662077196,1.0751347329189316,0.3025516403402187,0.9204812860552378,1.0,49/194,16.28%,IFT20;TSC2;RIN3;SRGAP2;GGA3;RAB11FIP3;SGSM2;MYCBP2;PKN1;PAK1;GNB3;SGSM3;AP3M1;NCKAP1;CHM;PEX5;FGD2;CDC42EP5;RAB8A;ATG16L1;GNB2;CDKL5;MYO1C;OCRL;UNC13B;RAP1GAP;EHD1;RIMS1;KCTD13;BECN1;ANKRD27;BICD2;USP33;DNM1L;AKAP13;RAB34;HACE1;MICALL1;RALBP1;CYFIP1;FMNL1;SPTBN1;EXOC5;RCC2;NDRG1;SH3BP4;RNF152;DOCK4;EPRS1
prerank,general transcription initiation factor binding (GO:0140296),0.35599010946025855,1.0749592007134838,0.3814935064935065,0.9150989206077814,1.0,4/25,6.30%,HHEX;DRAP1;RELA;AR
prerank,1-phosphatidylinositol binding (GO:0005545),-0.378098886120508,-1.0724657698954407,0.37662337662337664,0.8454126060538315,1.0,6/15,13.64%,SESTD1;ZFYVE16;PICALM;SNX9;WDFY3;EEA1
prerank,"oxidoreductase activity, acting on the CH-CH group of donors, NAD or NADP as acceptor (GO:0016628)",0.39123571041020555,1.0713248520393093,0.36436597110754415,0.9224585658824853,1.0,6/17,21.70%,TM7SF2;AKR1C1;MECR;TECR;DECR2;PTGR2
prerank,metal ion transmembrane transporter activity (GO:0046873),0.3483251228871751,1.0709861052465508,0.3634920634920635,0.9178501706189501,1.0,5/27,5.75%,SLC4A8;ATP2A3;ITPR2;CLDN16;SLC12A2
prerank,nuclear receptor binding (GO:0016922),-0.23804448606838804,-1.070496664332336,0.27413127413127414,0.8451446841919341,1.0,25/111,12.60%,MED13;STAT5B;SMARCA4;MED16;ESR1;PROX1;NCOA7;TAF1;OASL;LCOR;NCOA1;SMAD3;PRPF6;HIF1A;RNF14;RNF6;SNW1;STAT1;EP300;CTNNB1;PRMT2;TRIP12;CRY1;ZNHIT3;HMGN3
prerank,basal RNA polymerase II transcription machinery binding (GO:0001099),0.3386725767510901,1.070335084485365,0.36349453978159124,0.9144850012898362,1.0,5/33,6.30%,CTR9;SMYD2;DRAP1;ELP2;AR
prerank,chloride channel regulator activity (GO:0017081),0.4106388335238911,1.0700521749187386,0.3886986301369863,0.9097570280872984,1.0,7/14,32.39%,CFTR;CHRNA7;WNK1;VTI1B;WNK4;STX8;WNK3
prerank,amyloid-beta binding (GO:0001540),-0.2516482908080852,-1.0697886934398788,0.3262411347517731,0.8403425781989503,1.0,12/79,6.87%,FCGR2B;CD74;APOE;ITM2B;MSR1;TM2D1;TLR2;CD36;LDLRAP1;PICALM;LDLR;PFDN5
prerank,protein tyrosine kinase activity (GO:0004713),-0.23964414326375344,-1.0696931069681301,0.2857142857142857,0.8336124978866498,1.0,28/108,19.08%,PEAK1;AXL;ABL2;CSK;TEC;BAZ1B;MET;LMTK2;FLT1;DYRK1A;SYK;LYN;FYN;HCK;RET;WEE1;HIPK1;LCK;FRK;KDR;EGFR;PTK2B;EPHA2;EPHB4;HIPK2;ZAP70;PDGFRA;PKDCC
prerank,receptor ligand activity (GO:0048018),0.24668529976986914,1.068969970165292,0.302158273381295,0.9078700121371803,1.0,42/245,16.97%,FGF10;WNT4;SEMA7A;FGF16;GDF11;FGF9;IL17F;SLURP1;SEMA6C;WNT3;FGF7;IL6;AREG;DAND5;SEMA6B;NDP;IL2;PPY;SEMA3D;BMP4;TNFRSF11B;SST;TGFB1;TAFA2;WNT8B;CLCF1;FGF2;NRG3;SEMA4F;GREM2;PDGFB;INHA;HMGB1;THPO;TAFA1;WNT7A;SEMA4B;SEMA3C;GDF1;IL7;AGT;ANGPTL3
prerank,channel activity (GO:0015267),-0.2939408408262065,-1.0689402910993782,0.3597733711048159,0.8291932396086583,1.0,18/41,35.57%,BCL2;MCUB;BAX;TMEM120B;TRPV2;TRPV3;AQP11;TMEM120A;TMEM266;ASIC4;PDPN;AQP1;MPV17;SLC14A1;TRPV4;PANX3;CHRNB3;TRPM5
prerank,actinin binding (GO:0042805),-0.34752328269887695,-1.0674183285580556,0.36069651741293535,0.8274002424506443,1.0,6/21,8.30%,PDLIM5;PPARG;RARA;NFKB1;SYNPO2;DAG1
prerank,GTPase activity (GO:0003924),0.2513282476670508,1.065498566129341,0.30440097799511,0.9147152387326061,1.0,54/192,25.30%,TPPP;RAB6B;RAB1B;RAB43;RAB3A;RHOV;GNB3;SEPTIN9;GTPBP1;ATL1;RHOBTB1;RAB8A;GNB2;GNA15;TBCC;RIT2;GNG11;RHOT1;RAB24;NKIRAS2;DIRAS2;RAB5A;RAB38;GFM2;RAP1GAP;RAB28;DNM1L;EEF1A2;GNGT2;GNA11;GNAI3;HRAS;GNAS;RHOQ;GSPT1;RRAS2;RHOBTB2;SRPRA;RHOU;RHEBL1;CDC42;MMAA;RAP2C;DRG1;ATL2;GBP2;RHOBTB3;GNG3;RHOA;IRGM;GNAI1;RNF112;GTPBP10;DDX3X
prerank,phosphate ion binding (GO:0042301),0.45179107338588753,1.0647983018452913,0.3771626297577855,0.9114991215001267,1.0,2/10,7.28%,RELA;PNP
prerank,CCR chemokine receptor binding (GO:0048020),-0.31813262589752705,-1.0637643813231852,0.360313315926893,0.8325403568884979,1.0,7/28,27.31%,CCR2;CCL25;CCRL2;NARS1;NES;CCL7;CCL24
prerank,microtubule minus-end binding (GO:0051011),0.40838041658117263,1.0632968597737606,0.40353982300884955,0.9110755313069823,1.0,6/13,25.17%,HAUS4;CAMSAP3;CAMSAP1;TUBGCP2;TUBGCP6;TUBGCP5
prerank,calcium-release channel activity (GO:0015278),-0.36890407983834916,-1.0625897761619156,0.36243386243386244,0.8298051226874272,1.0,4/17,6.44%,MCOLN2;TPCN2;TPCN1;ITPR1
prerank,L-amino acid transmembrane transporter activity (GO:0015179),0.30108349090558284,1.0623511586513548,0.3475783475783476,0.9086307314284432,1.0,12/53,13.69%,SLC25A2;SLC38A2;SLC1A1;SLC38A9;SLC25A18;SLC38A7;SFXN1;SLC1A3;CTNS;SLC1A4;SLC66A1;SLC3A1
prerank,RNA polymerase binding (GO:0070063),0.3870229795073191,1.061798339574675,0.3968804159445407,0.9050535767151959,1.0,3/18,2.11%,YTHDC2;BIN1;PPIB
prerank,growth factor receptor binding (GO:0070851),-0.2367899179167128,-1.0612264595101786,0.3142857142857143,0.8278232484022136,1.0,37/95,27.04%,HIP1;SDCBP;CNOT9;PIBF1;FRS2;CD300LF;SNX1;IL6ST;ERN1;PDGFD;FYN;IL1B;FGF1;PSEN1;ERAP1;PDGFC;GRB2;TIMM50;SHC1;IL27RA;ADAM17;PDGFRA;ITGB3;TGFA;FGF18;TLR5;VEGFB;PLSCR1;EGF;TLR9;PGF;IL12RB1;PDGFA;TSLP;FGF22;KL;FGF20
prerank,calcium:sodium antiporter activity (GO:0005432),0.45450951369073306,1.061225344283897,0.3856655290102389,0.9016767888726767,1.0,5/10,18.64%,SLC24A5;SLC8A1;SLC8A3;SLC24A3;SLC24A4
prerank,histone demethylase activity (H3-K36 specific) (GO:0051864),-0.4272410875808015,-1.058991285709565,0.38461538461538464,0.8285159790000352,1.0,4/10,14.60%,RIOX2;KDM7A;KDM8;RIOX1
prerank,adrenergic receptor binding (GO:0031690),0.3893004504096672,1.0587662463991232,0.402317880794702,0.9045942961507417,1.0,7/16,26.40%,ADRA2A;APLP1;NEDD4;GNAS;MAGI2;RAPGEF2;DLG4
prerank,androgen receptor binding (GO:0050681),-0.320899496348778,-1.0568554178947436,0.38461538461538464,0.82858026524564,1.0,8/25,14.22%,SMARCA4;PRPF6;RNF14;RNF6;SNW1;EP300;PRMT2;FOXP1
prerank,"racemase and epimerase activity, acting on carbohydrates and derivatives (GO:0016857)",-0.4190030947807708,-1.0557990479027293,0.38990825688073394,0.8253142628691092,1.0,7/10,37.92%,DSEL;DSE;RENBP;FUOM;GALM;GLCE;GNE
prerank,translation initiation factor activity (GO:0003743),-0.29281155839484996,-1.0542213463671493,0.3804347826086957,0.8238962686304219,1.0,14/36,24.80%,EIF2A;EIF2S2;EIF3I;EIF3G;EIF2B2;EIF2S1;EIF3K;AGO2;EIF2B4;EIF3A;EIF1B;EIF3E;EIF3L;EIF4A2
prerank,"phosphotransferase activity, alcohol group as acceptor (GO:0016773)",-0.2551273126221155,-1.0540879351002508,0.35333333333333333,0.8178940545713927,1.0,22/74,15.98%,PIK3C3;FCSK;PAPSS2;FAM20A;DGKK;NADK;PANK1;GALK2;FAM20B;IPPK;PIK3CA;HK1;PANK3;SHPK;FAM20C;GK;SPHK2;GK5;PGM2L1;DGKA;PI4KA;POMK
prerank,endopeptidase regulator activity (GO:0061135),0.3207952016232353,1.0533867380728548,0.37538461538461537,0.9174493190898142,1.0,8/40,13.96%,CST3;VSIR;PSMF1;SPINT2;PSME3;PSENEN;PSMD14;ABCA2
prerank,Hsp70 protein binding (GO:0030544),-0.3063645976221596,-1.0528685149977919,0.3608815426997245,0.8153320341615328,1.0,15/31,28.04%,DNAJC8;ERN1;NOD2;PACRG;DNAJC10;HIKESHI;CYP1A1;FICD;SPN;DNAJB1;GPR37;DNAJB14;RNF207;DNAJB12;TSC1
prerank,symporter activity (GO:0015293),0.43885749805262986,1.0510068182441095,0.40535714285714286,0.9201500936209513,1.0,2/10,7.25%,SLC5A12;SLC46A2
prerank,alpha-actinin binding (GO:0051393),-0.3248353969534993,-1.05050712059211,0.3825,0.8164843106787656,1.0,6/24,8.30%,PDLIM1;PDLIM5;PPARG;RARA;SYNPO2;DAG1
prerank,protein serine/threonine kinase activity (GO:0004674),-0.20181636978229756,-1.0490545111649865,0.22137404580152673,0.8143390851540669,1.0,101/334,25.62%,MAP3K1;STK3;CSNK1G1;SLK;PRKCH;STK38;PRKCE;RAF1;STK17B;CDK6;ALPK1;MARK2;PIK3R4;MAP3K8;CDK8;FAM20A;BRAF;PRKACA;NUAK2;TBK1;STK35;GAK;MKNK1;MAPKAPK2;PIM1;LMTK2;ERN1;STK24;TAF1;PRKD3;MAP3K15;TESK2;RPS6KA6;DYRK1A;SYK;RIPK1;CIT;PRKCQ;CDKL3;TAOK3;CAMK2D;MAP3K11;UHMK1;HIPK1;MAPKAPK3;CDK1;DAPK1;LRRK2;IRAK4;RPS6KA2;FAM20C;SIK2;NLK;SIK1;CDK12;EGFR;PRKAB2;CDK14;PTK2B;MAPK7;PLK1;MAPK8;SQSTM1;HIPK2;MAP4K1;CAMK1G;CLK4;PKN3;SGK3;SGK2;CDK19;MAPK12;MYLK;NEK8;ACVR1;ACVR2A;CDC42BPG;MELK;STK38L;CDK9;MAP3K2;MAP3K20;HUNK;SBK3;BCR;EIF2AK2;MARK4;MAPK11;STKLD1;BRSK1;MASTL;PIM2;HTATIP2;RPS6KA3;STK32C;GRK5;BMPR2;ULK3;ERN2;ILK;CDK13
prerank,acetyltransferase activity (GO:0016407),-0.3015242617472472,-1.0480285352196317,0.3586387434554974,0.8115055264389789,1.0,12/31,22.58%,PAFAH1B2;KAT6B;NAA10;NAA16;GNPNAT1;EP300;DBT;NAT14;PAFAH1B3;NAT10;ESCO2;KAT2B
prerank,gamma-tubulin binding (GO:0043015),-0.3318252588737056,-1.0469771217101496,0.3923076923076923,0.8088825454489996,1.0,11/21,23.75%,CDK5RAP2;GIT1;DIXDC1;RACGAP1;TUBGCP4;RAB11FIP5;TUBGCP3;B9D2;OFD1;MARK4;BRSK1
prerank,cysteine-type endopeptidase inhibitor activity involved in apoptotic process (GO:0043027),-0.35158568892862324,-1.0462737358121785,0.4079601990049751,0.8049454055725856,1.0,4/18,11.77%,GAS6;TNFAIP8;BIRC5;BIRC2
prerank,chemorepellent activity (GO:0045499),0.3448094207353531,1.0459319175608957,0.387263339070568,0.9321368255250446,1.0,8/25,16.53%,SEMA7A;SEMA6C;SEMA6B;SEMA3D;NRG3;SEMA4F;SEMA4B;SEMA3C
prerank,ubiquitin-like protein ligase activity (GO:0061659),-0.21485074870260867,-1.0458216078143256,0.32642487046632124,0.8004526640648156,1.0,68/232,24.19%,ITCH;CBLB;WWP1;RNF149;UBE2D3;MSL2;TRIM25;CUL3;TRIM7;ARIH1;PRPF19;NSMCE2;TRIM14;DTX3L;SIAH2;SMURF2;TRIM17;UHRF2;RNF216;HECW1;EGR2;ARIH2;TRIM62;RNF13;NHLRC3;ZNRF3;RNF14;RNF150;RNF6;RNF157;SH3RF1;RNF220;RC3H1;TRIM44;TRIP12;PIAS2;BIRC2;CBL;RNF38;PELI1;TRIM5;FBXO2;TRIM71;RC3H2;MKRN1;MUL1;TRAF3IP2;DTX4;TRIM3;RNF144A;RNFT1;RNF130;TRIM37;RNF121;RNF24;TRIM21;RNF125;NEURL4;ASB12;KCMF1;BFAR;MEFV;NEURL2;TRIM72;XIAP;TRIM69;PIAS4;PIAS3
prerank,NF-kappaB binding (GO:0051059),-0.31993204512477114,-1.044737256030185,0.3756218905472637,0.7977785076219132,1.0,7/24,14.13%,PSMA6;ANXA4;EP300;BRMS1;HDAC2;HDAC1;NPM1
prerank,protein serine/threonine phosphatase activity (GO:0004722),-0.2634415330441782,-1.0447180868322647,0.34726688102893893,0.792022015136683,1.0,20/60,19.16%,LRRC39;CDC14B;PPM1H;PPP3R1;CTDNEP1;TAB1;LCK;CDKN3;PPP3CA;PPP1R3C;LRRK2;CTDSP1;DUSP1;TIMM50;PPP2CB;RPAP2;MTMR3;PGAM5;PPM1F;PPEF1
prerank,protein kinase C activity (GO:0004697),0.4043569531627618,1.04429111231368,0.3938356164383562,0.9322213289465742,1.0,7/14,17.59%,PKN1;PRKCZ;PRKCI;PRKCA;PRKD1;PRKCG;SMG1
prerank,"DNA-binding transcription repressor activity, RNA polymerase II-specific (GO:0001227)",-0.22062934662957914,-1.0442751523970975,0.35874439461883406,0.7878165527195593,1.0,55/173,24.61%,ZEB2;TRPS1;NR3C1;MITF;TGIF1;ATF3;PPARG;PEG3;ETV6;TFEC;MNT;ERF;ENO1;PATZ1;PROX1;NFKB1;YY1;PPARD;CEBPB;HSF1;MZF1;CTCF;FOXP4;ZBTB18;ZNF148;ZBTB5;LRRFIP1;E2F8;FOXP2;CREB3L1;ZBTB20;FOXP1;DACH1;ZBTB2;FOXK2;DEAF1;HEY2;ZBTB39;SATB1;GATA3;HES1;MYT1L;MXI1;BHLHE40;NFATC3;ZFP90;HEYL;HOXD9;TFAP2C;ZNF3;SKIL;BCL6;MAFK;PLAGL1;IRX2
prerank,"hydrolase activity, hydrolyzing O-glycosyl compounds (GO:0004553)",-0.30871749048787883,-1.0414363935065105,0.38005390835579517,0.7908469952231624,1.0,11/29,16.94%,ACER3;CTBS;GANAB;HEXD;IDUA;HPSE2;HPSE;GLA;GALC;GAA;HYAL3
prerank,potassium ion antiporter activity (GO:0022821),0.39133359307683585,1.0413256774635116,0.38524590163934425,0.9370229366598319,1.0,6/15,23.15%,SLC24A5;SLC9A4;SLC9A5;SLC24A3;SLC24A4;SLC9A1
prerank,GABA-gated chloride ion channel activity (GO:0022851),0.422072127711708,1.041244461765447,0.40397350993377484,0.9318010552627711,1.0,4/12,14.53%,GABRG1;GABRG2;GABRA2;GABRB1
prerank,NADPH binding (GO:0070402),-0.39413652990946035,-1.0397095307686515,0.38990825688073394,0.7901960181631853,1.0,8/13,20.95%,DECR1;CRYZ;CBR3;MTRR;DUS2;KCNAB1;GRHPR;DHFR
prerank,cholesterol binding (GO:0015485),-0.27406026437942815,-1.039709341552394,0.38082191780821917,0.7846312574718952,1.0,11/47,13.76%,OSBPL8;NPC2;STARD3NL;OSBPL1A;CAV1;ERLIN2;OSBPL2;ABCG1;OSBP2;NR1H3;GRAMD1C
prerank,protein kinase A catalytic subunit binding (GO:0034236),-0.3793990742457516,-1.0395529208524028,0.4085510688836104,0.7795858698927653,1.0,2/13,2.53%,CSK;PJA2
prerank,voltage-gated anion channel activity (GO:0008308),-0.3690616626342377,-1.0384589770421242,0.39952718676122934,0.77740585446445,1.0,7/15,22.46%,CLCN1;CLCN5;VDAC3;ANO1;VDAC2;GPR89B;GPR89A
prerank,ubiquitin-protein transferase activity (GO:0004842),-0.2035994932877432,-1.0376050201512939,0.3153846153846154,0.7744161040229682,1.0,64/346,13.02%,ITCH;CBLB;WWP1;RNF149;UBE2D3;MSL2;KLHL20;TRIM25;CUL3;TRIM7;ARIH1;PRPF19;PJA2;TRIM14;CUL4A;UBE2K;DTX3L;BIRC6;FBXL14;SIAH2;RNF213;OBI1;SMURF2;TRIM17;UHRF2;RNF214;TAF1;RNF216;UBE2Q1;RNF146;HECW1;RMND5B;CDC34;ARIH2;TRIM62;BCOR;RNF13;NHLRC3;ZNRF3;BRCA1;RNF14;TTC3;RNF150;LMO7;RNF6;RNF157;UBE2L3;SH3RF1;RNF220;RC3H1;KLHL21;UBE2Q2;BARD1;TRIM44;TRIP12;AKTIP;BIRC2;RNF103;CBL;RNF38;PELI1;UBE2E3;FBXO3;TRIM5
prerank,calcium channel regulator activity (GO:0005246),-0.286682027176147,-1.035965471694144,0.3548387096774194,0.7743942141496362,1.0,15/37,22.28%,MCUB;ITPR1;CACNG4;NRXN2;INAFM2;PHPT1;REM1;CALM2;STIM2;SGK3;SLC30A1;NPY;NPY2R;STIMATE;CACNB3
prerank,metalloendopeptidase inhibitor activity (GO:0008191),0.3984365060805906,1.0343727326088883,0.41578947368421054,0.9503851319581395,1.0,2/14,4.72%,SPOCK3;SPOCK2
prerank,sodium channel regulator activity (GO:0017080),0.32084025919169873,1.0340377105665302,0.41491085899513774,0.946188682384072,1.0,7/37,10.74%,FGF14;FGF12;FGF11;COMMD1;PTPN3;NEDD4;FGF13
prerank,1-acylglycerol-3-phosphate O-acyltransferase activity (GO:0003841),0.40987517538477714,1.0340284972532676,0.4128595600676819,0.9408188988050825,1.0,5/13,14.00%,PNPLA3;LPCAT1;LPCAT2;AGPAT1;ABHD5
prerank,CARD domain binding (GO:0050700),0.39865275968044506,1.0327178590500306,0.40371621621621623,0.9399627677859012,1.0,6/14,24.73%,CARD14;NOD1;CASP4;CARD16;RIPK2;IRGM
prerank,transcription cis-regulatory region binding (GO:0000976),-0.19737855920321073,-1.032542691553499,0.3431372549019608,0.7792431796015684,1.0,112/406,22.97%,TRPS1;NR3C1;NFXL1;ARID4B;SOX6;SP3;ATF3;GABPB2;CDK5RAP2;HMGB2;TCF12;RUNX3;PPARG;CIITA;PEG3;ETV6;MNT;RARA;MEF2D;ENO1;SOX11;PURB;AHR;PROX1;NFKB1;ETV5;YY1;SMAD3;SP1;CEBPB;PRDM9;EGR2;BCOR;YAP1;MLXIP;TBL1X;HIF1A;BRCA1;HSF1;CRY2;SATB2;HINFP;MZF1;CTCF;CREBRF;RFX5;XRN2;ATF5;CUX2;NFE2;SMAD6;ZBTB5;FOXJ1;RXRB;AGO2;TCF7;HDAC1;NR1H3;AHRR;RB1;SCX;E2F8;CREB3L1;ZBTB20;FOS;NPM1;KMT2D;FOXP1;IRF2;LHX1;DACH1;PURG;TNF;FOXK2;DEAF1;E2F7;KLF11;ARID5B;TIPARP;SATB1;RFXANK;SMAD4;GATA3;HMGA2;GLIS2;PER2;ZFP3;FOXN2;RBBP5;TFAP2B;HOXD8;TAF7;MXI1;ESRRB;NCOR1;HMGA1;KLF4;RBAK;BASP1;ZFP90;HDAC4;PSPC1;RREB1;NPAS4;TCF24;ISL1;NR1H4;TWIST1;HOXD9;TBL1XR1;TFAP2C;ZNF3
prerank,dicarboxylic acid transmembrane transporter activity (GO:0005310),0.3316291310581344,1.030941207322116,0.4198717948717949,0.9405590300734796,1.0,7/29,14.50%,SLC1A1;SLC25A18;SLC38A7;SLC26A4;SLC26A7;SLC1A4;SLC19A1
prerank,mannosyltransferase activity (GO:0000030),0.3595934994080601,1.0291485916636902,0.4377049180327869,0.9410810203700326,1.0,5/21,9.93%,TMTC4;ALG1;DPY19L4;PIGB;DPY19L3
prerank,"endoribonuclease activity, producing 5'-phosphomonoesters (GO:0016891)",0.33403933250915807,1.0273030007638497,0.4318555008210181,0.9421554130531978,1.0,7/28,14.96%,RPP40;ELAC2;DROSHA;PRORP;RPP30;APEX1;FEN1
prerank,low-density lipoprotein particle receptor binding (GO:0050750),0.35082690789976795,1.0272871799404877,0.4124203821656051,0.9369777576764498,1.0,12/22,29.73%,SYT1;CLU;APBB1;HSP90B1;APBB3;LANCL1;ANKRA2;SNX17;DNAJA1;CLTC;HSPG2;AP2M1
prerank,ubiquitin-dependent protein binding (GO:0140036),0.43248779957684785,1.0267069862760614,0.4253075571177504,0.9338406634101213,1.0,3/10,11.05%,ANKRD13D;DNAJC2;FAN1
prerank,manganese ion binding (GO:0030145),0.2969150561794829,1.0265587778625533,0.41203703703703703,0.9291722819012285,1.0,20/48,27.74%,XPNPEP1;MTPAP;XPNPEP3;MPPED2;MPPE1;NEK4;MGAT5B;FEN1;POMGNT1;WRN;ARG2;GALNT4;GALNT2;LARGE1;EXD2;SOD2;GALNT3;PAPOLA;NUDT16;PPM1M
prerank,hexose transmembrane transporter activity (GO:0015149),0.42028890818552567,1.0264322582286294,0.4412751677852349,0.9245195299385482,1.0,2/12,6.69%,SLC2A3;SLC2A2
prerank,pre-mRNA binding (GO:0036002),0.3386496272376015,1.0255325662929795,0.41287284144427,0.922215321956696,1.0,4/28,6.02%,DDX5;TRA2B;SRSF6;PTBP1
prerank,phosphoric diester hydrolase activity (GO:0008081),0.3205417815867187,1.025402243051654,0.42902208201892744,0.9175504511722947,1.0,15/35,28.42%,PLCL1;PLCXD1;PLD4;ENPP2;MPPED2;MPPE1;APEX1;NAPEPLD;PLCB2;PLCXD3;GPLD1;PDE11A;SMPD2;PLCXD2;SMPD4
prerank,nucleoside-triphosphatase activity (GO:0017111),0.23512496489392865,1.0235626697311744,0.40380047505938244,0.9187507126660559,1.0,52/248,18.92%,TPPP;RAB6B;KLC1;RAB1B;RAB43;RAB3A;RHOV;GNB3;ABCB6;SEPTIN9;GTPBP1;ATL1;RHOBTB1;CLU;ATAD1;RAB8A;GNB2;GNA15;TBCC;RIT2;MYO6;GNG11;KIF26A;RHOT1;RAB24;NKIRAS2;MYL6;CFTR;DIRAS2;RAB5A;RAB38;GFM2;RAP1GAP;RAB28;DNM1L;EEF1A2;KIF1C;GNGT2;KIF2A;GNA11;GNAI3;KIF14;HRAS;GNAS;RHOQ;GSPT1;RRAS2;RHOBTB2;SRPRA;ABCD2;PIN1;RHOU
prerank,monocarboxylate:sodium symporter activity (GO:0140161),0.433773212132569,1.023463964341025,0.4043321299638989,0.9141542608702079,1.0,3/10,17.78%,SLC10A2;SLC6A1;SLC10A1
prerank,SH3 domain binding (GO:0017124),-0.26023601774651783,-1.022742918912733,0.41118421052631576,0.802912492845899,1.0,18/62,17.24%,CBLB;SH3BP2;PTPN22;SYNJ2;CRK;SOCS7;ADAM9;WIPF1;CABYR;GRB2;DNM2;SKAP1;CYBA;CBL;VASP;GPX1;AKAP5;MICAL1
prerank,ubiquitin-like protein ligase binding (GO:0044389),-0.19855604549861597,-1.0222841825048155,0.35260115606936415,0.798908618560153,1.0,71/269,19.99%,BCL2;ITCH;PTPN22;MAP1LC3B;VCP;CUL3;RPL5;ARIH1;CUL4A;UBE2K;DTX3L;FBXW7;PRKACA;STAT2;PATZ1;BAG4;SMAD3;HSPD1;RIPK1;EGR2;SNX9;MID1;UBC;TXNIP;HIF1A;PSMA3;ERLIN2;BRCA1;BAG6;SPOPL;PACRG;UBE2L3;UBA52;STAT1;FOXO1;SMAD6;TNFRSF1B;RRAGA;PARP9;RB1;STAM;NLK;GPI;RALB;DBT;VCL;EGFR;UBE2L6;MAGEC2;PRKACB;AMBRA1;TRAF1;MUL1;CBS;UBE2C;ASB4;SQSTM1;RPA2;MAP1LC3A;WFS1;RNF20;LAPTM4B;TRAF4;TRIM37;PSMD1;NKD2;GPR37;HSPA1B;CUL5;NPLOC4;PA2G4
prerank,"oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, NAD(P)H as one donor, and incorporation of one atom of oxygen (GO:0016709)",0.33577848281273215,1.0218195543405728,0.405,0.9147741724399232,1.0,5/25,15.41%,AKR1C1;NDOR1;MICAL3;FMO1;CYP27A1
prerank,glutathione transferase activity (GO:0004364),-0.3241604149925426,-1.0216062526538232,0.4015957446808511,0.7955068531764208,1.0,6/23,18.56%,MGST3;GSTA3;GSTZ1;GSTM1;GSTM5;LTC4S
prerank,cytokine receptor activity (GO:0004896),0.27000719164223624,1.0209642641223418,0.3991537376586742,0.9125580082990012,1.0,19/83,17.89%,ACKR4;IL5RA;F3;IL2RA;CSF3R;CNTFR;PRLR;IL1RAP;CCR1;GPR17;CX3CR1;IL13RA1;GFRA1;CCR6;IFNGR1;ACKR2;CCR9;FLT3;IL1RAPL2
prerank,WW domain binding (GO:0050699),0.33291052155008627,1.020683566080743,0.4340567612687813,0.9087095112537699,1.0,3/26,2.65%,TCEAL5;WBP1;SCNN1A
prerank,ubiquitin protein ligase activity (GO:0061630),-0.20924576751974197,-1.0199838307993705,0.38341968911917096,0.7948009243195301,1.0,62/228,23.07%,ITCH;CBLB;WWP1;RNF149;UBE2D3;MSL2;TRIM25;CUL3;TRIM7;ARIH1;PRPF19;TRIM14;UBE2K;DTX3L;SIAH2;SMURF2;TRIM17;UHRF2;RNF216;HECW1;ARIH2;TRIM62;RNF13;NHLRC3;ZNRF3;RNF14;RNF150;RNF6;RNF157;SH3RF1;RNF220;RC3H1;TRIM44;TRIP12;BIRC2;CBL;RNF38;PELI1;TRIM5;FBXO2;TRIM71;RC3H2;MKRN1;MUL1;TRAF3IP2;DTX4;TRIM3;RNF144A;RNFT1;RNF130;TRIM37;RNF121;RNF24;TRIM21;RNF125;NEURL4;ASB12;KCMF1;BFAR;MEFV;NEURL2;TRIM72
prerank,magnesium ion binding (GO:0000287),-0.21951468573271518,-1.0190176620507472,0.3770491803278688,0.7924352652534404,1.0,45/135,24.06%,STK3;DIS3L2;ABL2;STK38;MARK2;IDH3A;RRAGC;NUAK2;TOP2A;NLRC4;IDH1;ERN1;TKT;HMGCL;UBA2;GCLC;EYA2;CERK;NUDT5;LRRK2;CLYBL;SIK2;NLK;SIK1;TESC;PRKACB;FOXK2;ADPRH;PDE2A;PLK1;MAP2K7;MTHFD2;XYLT2;RAP2A;MAPK12;CDC42BPG;STK38L;MVK;MAP3K20;THG1L;PPA2;PLSCR1;BRSK1;PIF1;TDP2
prerank,ATP hydrolysis activity (GO:0140603),-0.271981224280761,-1.0164425239842363,0.37790697674418605,0.7944116161668502,1.0,9/41,11.24%,VCP;VWA8;RNF213;SMCHD1;CHD1L;KIF20B;TOR1B;ABCG4;TOR3A
prerank,ion gated channel activity (GO:0022839),0.3478048934678473,1.0153271151556233,0.42696629213483145,0.9206882207613354,1.0,7/24,16.73%,TMEM63C;TMEM63A;ANO2;TMEM63B;KCNT2;ANO3;KCNT1
prerank,antiporter activity (GO:0015297),0.36105640025195385,1.014925497335293,0.42158516020236086,0.9170446786134369,1.0,9/20,28.65%,SLC35A1;SLC35C1;TMEM241;ATP1A3;SLC25A10;SLC35E2B;SLC35E2A;SLC25A16;CLCN3
prerank,I-SMAD binding (GO:0070411),-0.37883009586348415,-1.0142668492236042,0.45057471264367815,0.7956447907119131,1.0,5/13,17.73%,SMAD3;SMAD9;CTNNB1;SMAD6;SMAD4
prerank,phosphatidylinositol kinase activity (GO:0052742),0.38729209639031253,1.0134269933782336,0.4418604651162791,0.9171110191692512,1.0,3/15,7.51%,PIK3C2G;PIK3CG;PI4K2A
prerank,cytokine receptor binding (GO:0005126),-0.2376237953697568,-1.0126992529438243,0.44912280701754387,0.7950289323502434,1.0,30/83,27.54%,SDCBP;LIFR;PIBF1;CD300LF;IL6ST;KITLG;CCL25;IL27;SMAD3;SYK;IL1B;ERAP1;CCRL2;TIMM50;IL27RA;ADAM17;OSMR;USP15;EPO;CXCL12;TLR5;VEGFB;FADD;TLR9;PGF;IL12RB1;CSF1;TSLP;SPRED1;CRLF1
prerank,muscle alpha-actinin binding (GO:0051371),-0.35219988576684,-1.012055037537267,0.44028103044496486,0.7918406951562936,1.0,3/15,4.69%,PDLIM1;PDLIM5;SYNPO2
prerank,MHC class II protein complex binding (GO:0023026),0.4130935515833082,1.0089232459986757,0.4477124183006536,0.9271347384344668,1.0,3/11,8.51%,YWHAE;ATP1B1;CD81
prerank,nuclease activity (GO:0004518),0.28934340577426165,1.0081585061255702,0.44642857142857145,0.9249328659009284,1.0,15/52,19.27%,ANG;RNASE1;DNASE1L2;DDX1;MAP1S;OGG1;NME1;RNASEL;RNASE7;SND1;APEX1;FEN1;WRN;RNASE12;REXO4
prerank,N-acetyltransferase activity (GO:0008080),0.3618844722774891,1.007674034094172,0.45546218487394957,0.9217574313313994,1.0,4/19,7.12%,SAT2;SMARCE1;NAT8L;ATAT1
prerank,NAD+ ADP-ribosyltransferase activity (GO:0003950),-0.3089281628465042,-1.0045182050735453,0.44533333333333336,0.8089165241750279,1.0,7/25,22.66%,PARP4;PARP14;PARP9;TIPARP;ZC3HAV1;SIRT2;PARP16
prerank,MAP kinase kinase kinase activity (GO:0004709),-0.39920738970294156,-1.001161196716496,0.456575682382134,0.8134306290667807,1.0,4/11,21.40%,MAP3K1;MAP3K15;EGFR;MAP3K20
prerank,GTPase regulator activity (GO:0030695),-0.20428917746947853,-1.0005752819250306,0.43548387096774194,0.8100166224236739,1.0,34/212,12.40%,IQGAP1;VAV3;ARHGAP15;IQGAP2;ARHGAP10;NRP1;TBC1D1;STARD8;ARHGEF10L;ARHGAP17;ARHGAP19;RANBP2;RIC8A;RASA4;RASA1;ARHGEF6;RABGAP1;ARHGAP18;TBC1D2;ASAP1;ARAP1;ARHGAP30;RACGAP1;ARHGAP24;SEC23A;ABR;AGAP2;RALGAPA2;RANBP3;ARHGAP39;ARHGAP28;TBC1D10C;LRRK2;TBC1D10A
prerank,anion transmembrane transporter activity (GO:0008509),0.3979694253069475,0.998949149178334,0.47330960854092524,0.9447365006738864,1.0,7/12,28.60%,SLCO2B1;MFSD10;SLC39A8;SLC19A1;ABCG2;ABCC5;SLC4A2
prerank,solute:proton symporter activity (GO:0015295),0.3716296402111851,0.9976443989844851,0.4735042735042735,0.9442080428085007,1.0,4/16,19.90%,SLC33A1;SLC39A8;CTNS;SLC2A9
prerank,lysophosphatidic acid acyltransferase activity (GO:0042171),0.37589564185940727,0.9974055816645132,0.45546218487394957,0.9401978773799018,1.0,6/15,18.15%,PNPLA3;LPCAT1;LPCAT2;AGPAT1;ABHD5;ABHD8
prerank,myosin binding (GO:0017022),0.2832337093590237,0.9973916387190794,0.4662576687116564,0.9355709057765553,1.0,11/55,14.90%,RAB6B;RAB3A;GIPC1;DMD;MYBPC3;RAB8A;RAB3D;CXCR4;CORO1A;ARFGEF1;HAP1
prerank,cardiolipin binding (GO:1901612),0.4201782207761945,0.9964193564218392,0.4654300168634064,0.9339267489346146,1.0,2/10,9.21%,GSDME;UQCC3
prerank,miRNA binding (GO:0035198),-0.2874358585345088,-0.994606599557821,0.4581005586592179,0.8219583524188717,1.0,10/30,21.03%,PUM2;ZNF346;ZC3H12A;RC3H1;HNRNPA2B1;AGO2;DDX21;TRIM71;PUM1;ZC3H7A
prerank,gap junction channel activity (GO:0005243),0.347081224773735,0.9906842541958839,0.47266881028938906,0.9473406036200894,1.0,3/22,11.76%,GJC3;GJA5;PANX1
prerank,"catalytic activity, acting on a tRNA (GO:0140101)",0.3053860750485879,0.9901334290038033,0.4671875,0.9445334612186147,1.0,16/35,31.83%,NT5C3A;ELAC2;DTWD2;FTSJ1;TARS2;DUS4L;TRIT1;DUS1L;MRPL58;BCDIN3D;FTO;AARS1;QTRT2;GATB;TRPT1;ALKBH1
prerank,phosphatidylinositol bisphosphate binding (GO:1902936),-0.2253478806752959,-0.9899548946613063,0.4911660777385159,0.8302291293208365,1.0,12/91,6.28%,SVIL;HIP1;KIF16B;SDCBP;SESTD1;PLA2G4E;SH3PXD2B;GBF1;FCHO2;HIP1R;LDLRAP1;PICALM
prerank,glucose transmembrane transporter activity (GO:0005355),0.37286079214567447,0.989454997598038,0.4809917355371901,0.9420350348321233,1.0,2/17,6.69%,SLC2A3;SLC2A2
prerank,deoxyribonuclease activity (GO:0004536),0.3823213305511839,0.989428947773806,0.48747913188647746,0.9375435474074373,1.0,6/14,24.18%,DNASE1L2;MAP1S;NME1;APEX1;APLF;ERCC4
prerank,cysteine-type endopeptidase activity (GO:0004197),0.2604264357193938,0.9890548746011545,0.4755747126436782,0.9341780869138341,1.0,15/78,12.50%,USP10;CAPN3;CAPN12;USP35;LGMN;USP11;USP30;CAPNS1;CAPN11;USP12;CASP3;SFRP1;CASP4;USP33;CASP7
prerank,kinase activity (GO:0016301),-0.22001594468040359,-0.9878671444353724,0.45977011494252873,0.8314378294294436,1.0,27/109,15.98%,PIK3C3;FCSK;PAPSS2;DGKK;NADK;TAF1;PRKD3;PANK1;CERKL;LYN;PSTK;IPPK;PIK3CA;TRRAP;CERK;LRRK2;PANK3;SHPK;GK;SPHK2;GK5;FN3KRP;PGM2L1;ITPKA;DGKA;PI4KA;POMK
prerank,RNA polymerase II-specific DNA-binding transcription factor binding (GO:0061629),-0.20394944713456709,-0.9875798067494368,0.5,0.8271048007361704,1.0,34/181,14.13%,RBPJ;MDFIC;PSMA6;RBBP8;PPARG;DTX3L;SMARCA4;PROX1;NCOA7;TAF1;PPARD;BBS7;NCOA1;SMAD3;SP1;EGR2;HIF1A;SNW1;MAD2L2;STAT1;ANXA4;EP300;CTNNB1;SPEN;BRMS1;PIAS2;HDAC2;CRY1;PRRX1;PARP9;HDAC1;RB1;FOS;NPM1
prerank,mRNA 3'-UTR binding (GO:0003730),-0.2315686789937261,-0.9866753994275111,0.47,0.8245777620032639,1.0,24/79,21.58%,CELF1;CPSF1;RPL5;PUM2;RPS7;EXOSC8;CPEB4;ZC3H12A;CRYZ;RC3H1;HNRNPA2B1;LARP1;RPL41;EXOSC9;LARP4B;FXR2;CPEB2;RNF20;MEX3D;CELF2;HNRNPC;HNRNPU;PUM1;CPEB3
prerank,cytokine activity (GO:0005125),0.24584976616519422,0.9859769145599749,0.49805950840879687,0.9392481280360988,1.0,24/131,20.15%,WNT4;GDF11;IL17F;SLURP1;WNT3;IL6;NDP;IL2;BMP4;TNFRSF11B;TGFB1;WNT8B;CLCF1;FGF2;INHA;HMGB1;WNT7A;GDF1;IL7;IL18;IL1A;CCL15;CCL5;IL34
prerank,5'-3' RNA polymerase activity (GO:0034062),0.32686686785693086,0.9847887417062516,0.4806451612903226,0.9384111602930406,1.0,12/27,27.31%,POLR2L;POLR2F;POLR3F;POLR2G;POLR3A;POLR1F;POLR3B;POLR2C;POLR3K;POLR2D;POLR1A;POLRMT
prerank,3'-5'-exoribonuclease activity (GO:0000175),0.30420597996824256,0.9842420006718318,0.4937888198757764,0.9355458273827857,1.0,8/34,15.49%,CNOT2;ERI3;REXO2;ANGEL1;ERI2;EXOSC5;CNOT8;ANGEL2
prerank,calcium-dependent phospholipase A2 activity (GO:0047498),0.36722358598185467,0.9841833647964092,0.4847972972972973,0.931267080070375,1.0,2/15,5.38%,PLA2G3;PLA2G4C
prerank,metal ion binding (GO:0046872),0.21490116610542348,0.9831249052773776,0.5254604550379198,0.9303175944424904,1.0,94/477,18.55%,TPPP;AGRN;NUDT12;SYT4;ANXA8;ANXA8L1;ATP2A2;HMGCLL1;CAPN3;ITPR2;CDH23;EFHD1;NIM1K;DCHS1;STK26;TRIM26;SYT13;SYT1;TNNC1;SPOCK2;NT5C3A;SYT6;STK11;LRP2;SMOC2;DNASE1L2;PLA2G4C;ASPH;PRNP;GSS;NRXN1;TRPM2;ESYT2;MTPAP;KCNIP4;S100A2;FKBP9;S100A13;CDH18;CDC42BPA;PI4K2A;MICU2;NUDT3;ADGRL3;NME1;S100G;OTOF;ENPP2;CPNE6;PKD2;GRIN1;SLC8A1;HPRT1;BGLAP;HSP90B1;PPA1;PDCD6;ADPRS;CCDC47;CISD3;FAN1;CDH4;ITPR3;CSGALNACT1;HSPE1;NUCB1;CLGN;RCN2;BAIAP3;AOC1;APEX1;FEN1;TCHH;NDUFAB1;SLC25A23;HPCA;POSTN;MT2A;SDF4;CDC42BPB;MT1B;MT1X;MT1A;MT1H;MT1G;MT1M;MT1F;MT1E;CANT1;MAST2;SNCB;WRN;LTBP4;DXO
prerank,triglyceride lipase activity (GO:0004806),0.34265365641724044,0.9820282420026254,0.4805414551607445,0.9293072381284979,1.0,6/20,22.69%,PNPLA3;ABHD5;LIPC;PLA2G15;LIPE;DAGLB
prerank,DNA-binding transcription factor binding (GO:0140297),0.23085419834837692,0.9803725229738164,0.5196560196560197,0.9301828759169214,1.0,37/189,16.57%,HHEX;TLE3;ZFPM1;TLE2;LDB2;LDB1;USF2;RELA;PPARA;ZFPM2;CRTC1;CTBP1;MEF2C;AR;MAP3K10;GTF2I;LHX3;LMO2;DGKQ;BBS5;TCF7L2;HDAC5;TAF9;NFE2L2;IFI27;USF1;GABPA;TBX6;PRDM16;RBL2;DMAP1;HMGB1;ZBTB49;RBL1;TCF3;RERE;BHLHE41
prerank,ion channel inhibitor activity (GO:0008200),-0.2732235564483504,-0.980118583245436,0.464,0.8388847425667834,1.0,10/35,18.13%,MCUB;ENSA;RASA1;ITPR1;CAMK2D;PHPT1;CALM2;RACK1;RSC1A1;SLC30A1
prerank,nuclear localization sequence binding (GO:0008139),-0.32503706249835906,-0.9787229820242365,0.49144254278728605,0.8376824305077681,1.0,3/18,8.22%,KPNB1;KPNA2;NUP153
prerank,phosphatidate phosphatase activity (GO:0008195),0.393011711549004,0.9782258693846709,0.49174917491749176,0.9324900452402182,1.0,5/13,25.25%,PLPP5;PLPPR4;PLPP1;PLPP2;PLPPR1
prerank,monocarboxylic acid transmembrane transporter activity (GO:0008028),0.32359199355103424,0.9781281032524447,0.4896,0.9283938703715994,1.0,9/26,29.24%,SLC16A6;SLC5A12;SLC6A1;MPC1;SLC16A12;ABCG2;SLC16A7;SLC16A9;MPC2
prerank,ubiquitin-like protein-specific protease activity (GO:0019783),0.3419687987108675,0.9779765385431075,0.46296296296296297,0.924549794875471,1.0,7/20,28.38%,OTULINL;USP50;OTUB1;OTUD5;COPS5;USP7;SENP2
prerank,metal ion:proton antiporter activity (GO:0051139),-0.3638050683788158,-0.9769247869658807,0.4846335697399527,0.8376355354545831,1.0,7/13,26.94%,SLC9B2;SLC9A9;SLC9A2;SLC11A1;SLC9A6;LETM1;SLC9A3
prerank,ATPase regulator activity (GO:0060590),-0.2649781099642869,-0.9757719860384609,0.5051813471502591,0.8360254429103307,1.0,9/38,17.24%,FNIP2;DNAJC1;TOR1AIP1;BAG4;DNAJC10;FXYD2;DNAJB6;DNAJC15;DNAJB1
prerank,motor activity (GO:0003774),-0.23978109250425214,-0.9757479507372787,0.5327380952380952,0.8311385919699174,1.0,20/60,21.31%,KIF3A;KIF16B;KIF23;KIF11;KIFC2;KIF20B;KIF13B;KIFC1;KIF24;KIF21A;KIF4A;MYH9;GPR88;KIF20A;DNAH8;KIF18B;KIF19;KIF27;KIF7;MYO1E
prerank,zinc ion binding (GO:0008270),0.2195611130512613,0.9718920087327191,0.5376593279258401,0.9388533343916049,1.0,73/293,20.42%,POLR2L;QPCTL;NUDT12;TET1;IKZF4;MMP16;MYCBP2;AFP;NSD1;ZFPM2;ADA;KDM1B;GALT;S100A13;ZNF205;SHANK3;WDFY1;ENPP2;PHEX;CHORDC1;GRIN2B;TRHDE;PRKN;KLF7;ITGB1BP2;KDM2B;SUV39H2;THAP1;RNF8;USP33;PHF8;CHMP1A;PITRM1;TIMM13;SEC24D;FBXL19;TRIM8;SEC24B;KDM4A;MSRB3;PGGT1B;ACR;ZBTB32;RNF2;AOC1;ENPEP;RPS27;TRAF7;NAPEPLD;SIAH1;EPRS1;SEC24C;CLIP1;TK1;ESCO1;MT2A;ZEB1;PHF2;MT1B;MT1X;MT1A;MT1H;MT1G;MT1M;MT1F;MT1E;ADAMTS3;ALAD;RABGGTB;CDADC1;PLA2G15;CYLD;CALB1
prerank,m7G(5')pppN diphosphatase activity (GO:0050072),0.3986474314662403,0.9704319416522139,0.48408710217755446,0.9391345819414646,1.0,5/11,26.71%,NUDT10;NUDT3;NUDT16L1;NUDT4;NUDT16
prerank,"phosphatidylinositol-4,5-bisphosphate binding (GO:0005546)",-0.2308939924684801,-0.969801222198429,0.5296052631578947,0.843122470086657,1.0,18/72,19.24%,SVIL;HIP1;SDCBP;SESTD1;PLA2G4E;FCHO2;HIP1R;LDLRAP1;PICALM;OSBPL2;PLEKHA4;VILL;STXBP6;SNX21;PFN2;GSN;KCNQ1;SDCBP2
prerank,NAD-retinol dehydrogenase activity (GO:0004745),0.36874854064476437,0.9690472650641351,0.48376068376068376,0.9390330326803794,1.0,2/14,11.65%,RDH10;RDH5
prerank,solute:sodium symporter activity (GO:0015370),0.31470582273412273,0.9685781611222847,0.5038759689922481,0.9361735619346893,1.0,4/27,13.41%,SLC4A8;SLC20A1;SLC4A10;SLC4A7
prerank,protein heterodimerization activity (GO:0046982),-0.20060148947096854,-0.9681357931280681,0.5142857142857142,0.8426558332926382,1.0,46/178,22.21%,BCL2;CYBB;HIP1;EXT1;BCL2L1;SDCBP;ZHX2;ATF3;PAFAH1B2;RRAGC;MCL1;BAX;SNX1;TOP2A;TCOF1;AHR;TAF1;HIF1A;HSF1;UBA2;ABCG4;ABCG1;RALGAPA2;BARD1;CYBA;RRAGA;LSM5;GCA;MICU1;FXR2;TLR4;ADRA1A;TPM4;TFAP2B;PAFAH1B3;PAFAH1B1;SDCBP2;TAF7;TUBB2B;BHLHE40;TOP2B;RCC1;VAPB;NPAS4;FZD4;CD3E
prerank,thiol-dependent deubiquitinase (GO:0004843),0.2530998422820291,0.9681031306435525,0.5349162011173184,0.9333190361212131,1.0,21/83,21.39%,MPND;OTUD7A;USP32;USP10;USP35;USP11;USP50;USP30;USP51;USP12;USP33;PSMD14;OTUB1;BAP1;OTUD7B;OTUD5;USP48;STAMBP;COPS5;CYLD;USP49
prerank,nucleobase-containing compound kinase activity (GO:0019205),0.3616896779045638,0.9674906717050689,0.5409836065573771,0.9309528379037139,1.0,7/17,23.54%,NME1;AK5;DTYMK;AK1;AK4;AK3;AK9
prerank,C4-dicarboxylate transmembrane transporter activity (GO:0015556),0.36081784530171174,0.9650726616259578,0.5025125628140703,0.9340596194678038,1.0,6/16,22.22%,SLC1A1;SLC25A18;SLC38A7;SLC1A4;SLC13A3;SLC25A10
prerank,microtubule binding (GO:0008017),0.22582026494136068,0.9637401071340547,0.5565006075334143,0.9337186437867927,1.0,63/222,22.74%,TPPP;GAPDH;MAP6;DST;HAUS4;MID2;PSRC1;REEP2;PRNP;NAV3;MAP1S;CLASP2;CCDC181;MAPRE2;KIF26A;FSD1;MAP4K4;CKAP5;RAE1;LRPPRC;CAMSAP3;FGF13;PEX14;RMDN3;CAMSAP1;DNM1L;DCTN1;KIF1C;MTCL1;VASH2;SYBU;KIF2A;HOOK2;NEFM;RCC2;NDRG1;APC2;UXT;TUBGCP2;MAP9;CLIP1;KIF14;HDGFL3;STARD9;ALMS1;EML4;MAST2;HOOK1;ABRAXAS2;EML6;TPGS1;CEP57;KIF1B;KIF9;TUBGCP6;MAP2;KIF17;MAPRE3;DRG1;SPAST;MAP7D3;TOGARAM2;KIF21B
prerank,5'-3' exonuclease activity (GO:0008409),0.37234879217861283,0.963519643505939,0.5233333333333333,0.9302513915960632,1.0,4/14,18.55%,CPSF3;FAN1;FEN1;DXO
prerank,tau-protein kinase activity (GO:0050321),-0.30902469984040215,-0.9624630317991749,0.5174129353233831,0.8532141139298073,1.0,3/20,6.99%,MARK2;DYRK1A;FYN
prerank,calcium ion binding (GO:0005509),0.21601387401839142,0.9614401698922141,0.5778032036613272,0.9323784385313935,1.0,44/323,11.85%,AGRN;SYT4;ANXA8;ANXA8L1;ATP2A2;CAPN3;ITPR2;CDH23;EFHD1;DCHS1;SYT13;SYT1;TNNC1;SPOCK2;SYT6;LRP2;SMOC2;DNASE1L2;PLA2G4C;ASPH;PRNP;NRXN1;TRPM2;ESYT2;KCNIP4;S100A2;FKBP9;S100A13;CDH18;MICU2;ADGRL3;S100G;OTOF;ENPP2;CPNE6;PKD2;GRIN1;SLC8A1;BGLAP;HSP90B1;PDCD6;CCDC47;CDH4;ITPR3
prerank,protein kinase C binding (GO:0005080),0.2810398449689365,0.9581766329380148,0.5324283559577677,0.9377841230980445,1.0,8/43,11.46%,PKN1;PARD6B;AVPR1A;PARD6G;TWF2;PRKD2;HDAC5;IRS1
prerank,deubiquitinase activity (GO:0101005),0.24782077037350472,0.9566676461783179,0.5563282336578581,0.938215986460523,1.0,16/88,15.26%,MPND;OTUD7A;USP32;USP10;USP35;USP11;USP50;USP30;USP51;USP12;USP33;PSMD14;OTUB1;BAP1;OTUD7B;OTUD5
prerank,ubiquitin conjugating enzyme binding (GO:0031624),0.3085366624478907,0.956663178847319,0.5186991869918699,0.9341189734192107,1.0,7/27,17.99%,RNF19A;PPARA;RNF180;DCUN1D2;PRKN;SIAH1;SIAH3
prerank,sequence-specific DNA binding (GO:0043565),0.2079792358975722,0.9556054975982693,0.6206896551724138,0.9331590926173571,1.0,102/590,18.40%,HOXA5;HHEX;SCRT2;TET1;HSF4;ONECUT2;MYRFL;BPTF;CSRNP3;POU2F2;USF2;HOXD4;TFCP2;ESRRG;LBX2;NEUROG2;NR1I2;FOSL1;NRL;SIX4;NR1I3;ATOH7;HIC1;SKOR1;NEUROD2;NFIB;SP2;SOX10;TFCP2L1;TFAM;PPARGC1A;MEOX2;SOX4;BCL11B;ZBTB12;PPARA;HOXB9;HOXB7;E2F1;XRCC6;FOXD1;NR2F6;MEF2C;RXRG;ZNF35;HOXC10;LHX3;SP4;ZBTB22;TCF7L2;FOXC1;HEY1;TBX2;ZNF23;SNAI2;DMRTA1;GRHL3;HSF2;NFE2L2;ZNF32;ZFP1;KDM2B;ZFP41;HOXB2;POU3F4;THAP1;USF1;GABPA;EPAS1;HLF;TFEB;HOXB5;TBX6;TEF;FBXL19;LHX5;MYRF;PRDM16;ZBTB32;BARX2;LMX1B;UPF1;ZBTB49;ZNF740;IRF5;PRDM1;BATF;ERG;TCF7L1;CALCOCO1;BHLHE41;EN2;KLF16;KLF12;ZIC5;SMG1;BACH2;XBP1;POU3F3;MAX;CHTOP;ZBTB7B
prerank,calmodulin-dependent protein kinase activity (GO:0004683),-0.29870811950661214,-0.9541375017713098,0.4962025316455696,0.8717645302472773,1.0,7/24,17.56%,MKNK1;MAPKAPK2;CAMK2D;MAPKAPK3;DAPK1;PTK2B;CAMK1G
prerank,translation elongation factor activity (GO:0003746),0.3670615534800916,0.9533189554584193,0.5238907849829352,0.9355319142655766,1.0,6/14,20.78%,GTPBP1;GFM2;EEF1A2;EIF5AL1;EIF5A;EIF5A2
prerank,flavin adenine dinucleotide binding (GO:0050660),-0.2522198586863781,-0.9525221413145832,0.5389048991354467,0.871368128345538,1.0,18/53,24.23%,CYBB;ACOX3;XDH;MTHFR;KMO;CRY2;SQOR;MTO1;CRY1;MTRR;ACADL;MICAL1;MICAL2;POR;GSR;NQO2;ACOXL;NOX4
prerank,histone methyltransferase activity (H3-K36 specific) (GO:0046975),-0.3746005568962154,-0.9514592020650952,0.5177304964539007,0.8693268635455311,1.0,3/10,6.22%,NSD2;SETD3;PRDM9
prerank,transcription coactivator binding (GO:0001223),-0.3061687773041102,-0.9509374019769242,0.5104166666666666,0.8658737759896986,1.0,5/20,7.25%,ESR1;AHR;PPARD;SMAD3;CIT
prerank,mRNA 3'-UTR AU-rich region binding (GO:0035925),-0.2986726357307887,-0.9497488982742275,0.5411140583554377,0.8642688263035845,1.0,8/22,22.80%,CPSF1;EXOSC8;ZC3H12A;EXOSC9;CPEB2;MEX3D;CPEB3;ILF3
prerank,"oxidoreductase activity, acting on the CH-NH group of donors, NAD or NADP as acceptor (GO:0016646)",-0.34633277549276986,-0.9489362777706788,0.4898419864559819,0.8614340421606637,1.0,4/14,8.22%,BLVRB;MTHFR;PYCR2;MTHFD1
prerank,mannose binding (GO:0005537),0.3861513505151476,0.9467731100072887,0.5315161839863713,0.9500357992231996,1.0,3/12,18.46%,MBL2;ACR;LMAN2L
prerank,double-stranded DNA binding (GO:0003690),0.20639853059014704,0.9459156093960192,0.6457883369330454,0.9484362409077097,1.0,88/531,18.40%,HOXA5;NUCKS1;SCRT2;HSF4;PQBP1;ONECUT2;POU2F2;USF2;HOXD4;TFCP2;ESRRG;LBX2;NEUROG2;NR1I2;FOSL1;NRL;SIX4;NR1I3;ATOH7;HIC1;SKOR1;NEUROD2;NFIB;SP2;SOX10;TFCP2L1;MEOX2;SOX4;BCL11B;ZBTB12;HOXB9;HOXB7;E2F1;HDGFL2;XRCC6;NR2F6;MEF2C;GTF2H4;RXRG;HOXC10;ZBTB22;HEY1;TBX2;ZNF23;SNAI2;DMRTA1;CGAS;HSF2;ZNF32;ZFP1;DMC1;ZFP41;HOXB2;POU3F4;POLR3F;USF1;GABPA;HLF;TFEB;HOXB5;TBX6;TEF;LHX5;ZBTB32;BARX2;HMGB1;LMX1B;APEX1;FEN1;ZNF740;IRF5;HMGB3;PRDM1;BATF;ERG;TCF7L1;BHLHE41;EN2;KLF16;CENPS;HDGFL3;KLF12;ZIC5;BACH2;XBP1;MAX;PSIP1;ZBTB7B
prerank,protein homodimerization activity (GO:0042803),0.2046701752355188,0.9458316202085024,0.6606574761399788,0.9445768377090711,1.0,153/589,23.39%,TPPP;MYOM1;HHEX;TSC2;HOGA1;STARD3;MKLN1;TYW5;ADCY8;ANG;SRGAP2;KCNH2;RAB11FIP3;NACC2;LDB1;DGAT2;F11R;ADD2;USF2;STK26;MID2;DUSP29;NTRK1;FLT4;IL17F;CADM1;RELA;TENM1;TNNC1;PTPRT;PTPRO;SYT6;XPNPEP1;DEFA6;GSS;MTHFD1L;MTPAP;XPNPEP3;COMMD1;SPPL2B;NDP;MAP3K10;ADRA2A;S100A13;PSMF1;DAB2IP;NOD1;ACSL6;BAK1;PSMD7;NAGA;ACHE;ERBB4;PKD2;NECTIN3;TENM3;GGCT;PAXX;GUCY2D;INPP5F;RBPMS2;PDCD6;RAP1GAP;TRIM9;ZDHHC2;EXD1;TRPC6;STK25;DROSHA;RDH5;KYAT1;THAP1;USF1;RNF8;DNM1L;DCK;CHMP1A;MTCL1;PDGFB;CORO1A;TARS2;MTMR1;CADM3;TRIM8;GADD45A;ACOX1;MAP3K13;NUDT21;MIGA1;TPST2;CRYL1;AOC1;SNX6;DSCAML1;NTRK2;OXA1L;HM13;NAA60;TCF3;PGRMC1;PPCS;EPRS1;BHLHE41;AGXT;GALE;HARS1;SCARB2;TRIM68;UXS1;MFF;ASMT;ALS2;POU3F3;CANT1;ABCD2;ZBTB7B;CHRNA7;WRN;NADK2;HOOK1;CCL5;CAV2;CDADC1;ERP29;SNF8;SRF;CLN6;CR2;HSP90AB1;ABCG2;ABCB7;CEP57;PSPH;SSBP1;MMAA;PEX11B;HPGDS;AXIN1;RAB11FIP2;PIP4K2B;UGT1A6;EXD2;EXT2;KCNN2;FXR1;SPPL2A;CAMK2B;PEX11A;IRF3;GBP2;IL6R;RIPK2;NUDT16L1
prerank,single-stranded RNA binding (GO:0003727),-0.25199479999629004,-0.9455931485378444,0.5730994152046783,0.8658432474790849,1.0,9/43,12.50%,DDX60;IFIH1;EIF4B;TLR7;JMJD6;TLR8;AQR;EXOSC10;AGO2
prerank,RNA polymerase II complex binding (GO:0000993),0.29946676692282753,0.9447166186506678,0.547923322683706,0.9439078476445472,1.0,10/32,23.51%,CTR9;SMYD2;ELP2;BRD4;CCAR2;PAF1;ELOF1;SCAF8;ELP4;GTF2B
prerank,filamin binding (GO:0031005),0.39175284701599855,0.944707542850841,0.5477941176470589,0.9399513628885894,1.0,2/11,4.60%,NEBL;CRMP1
prerank,1-phosphatidylinositol-3-kinase regulator activity (GO:0046935),0.35879901137963527,0.9444197204189314,0.5276292335115864,0.9367231588833386,1.0,5/15,13.79%,SLA2;SOCS3;SOCS2;SOCS6;SOCS4
prerank,disordered domain specific binding (GO:0097718),0.3213605347362074,0.9443670291680465,0.5351882160392799,0.9329000844617195,1.0,3/23,4.71%,GAPDH;HSPA2;PPIL1
prerank,fibroblast growth factor binding (GO:0017134),0.3282589599099715,0.9428834759253972,0.547923322683706,0.9331157180884738,1.0,3/21,7.09%,KLB;GPC1;S100A13
prerank,inorganic cation transmembrane transporter activity (GO:0022890),-0.2483552468628025,-0.9418011158310322,0.554016620498615,0.8713059206276499,1.0,14/48,17.59%,TMEM165;ATP6V1B2;TRPC1;SLC46A1;RHD;TRPM4;TRPV2;TRPM6;PIEZO2;CALHM6;SLC12A7;PKD1L3;MCOLN1;CALHM5
prerank,wide pore channel activity (GO:0022829),0.325631095374947,0.9400762537328066,0.5496794871794872,0.9369764726454852,1.0,3/23,11.76%,GJC3;GJA5;PANX1
prerank,ATPase binding (GO:0051117),-0.22734503197904687,-0.938058711724025,0.5583596214511041,0.8765711867386184,1.0,22/71,19.82%,CHMP4A;ATP6V0A1;TOR1AIP1;ESR1;TRPC1;CAV1;NR1H2;PSEN1;CLPP;DNAJC10;VCPKMT;LCK;S100A1;PPP3CA;NOP58;RALB;EGFR;FBL;DNAJB1;WFS1;NKD2;ATP6V0A4
prerank,O-methyltransferase activity (GO:0008171),0.3993466652836091,0.9372239217144642,0.5371747211895911,0.940962590708542,1.0,6/10,27.14%,LRTOMT;MEPCE;COMT;ASMT;BCDIN3D;CMTR2
prerank,pyrophosphatase activity (GO:0016462),0.27360265681247753,0.9368879920147727,0.5449010654490106,0.9378198459015258,1.0,17/50,26.71%,PLPP5;NUDT10;NUDT9;TRPM2;NUDT3;ENTPD6;ALPL;PPA1;FITM2;DXO;PLPP1;NUDT16L1;ENTPD1;DDX3X;ENTPD2;NUDT4;NUDT16
prerank,dipeptidyl-peptidase activity (GO:0008239),-0.3775550720672526,-0.9368234717131848,0.5176211453744494,0.8747966736762057,1.0,2/10,9.63%,DPP4;PRCP
prerank,amino acid binding (GO:0016597),0.3027883933487304,0.9364405973871127,0.5617977528089888,0.9351827122003128,1.0,7/31,16.80%,GLRA3;GLRB;GRIN1;GRIN2B;GLRA2;DDAH2;AGXT
prerank,phospholipase inhibitor activity (GO:0004859),-0.37427026345329095,-0.9320584802242282,0.5246252676659529,0.8828133498840812,1.0,3/10,12.97%,ANXA1;ANXA4;APOC1
prerank,tRNA methyltransferase activity (GO:0008175),-0.3199719435583662,-0.9290871741266427,0.569377990430622,0.8861164005925581,1.0,7/16,15.31%,TARBP1;THUMPD3;LCMT2;ALKBH8;TRDMT1;TRMT13;TRMT9B
prerank,phosphatidylinositol 3-kinase regulator activity (GO:0035014),-0.31268847266103855,-0.9274678136143821,0.5897435897435898,0.8859463459089969,1.0,7/18,13.40%,SOCS7;SOCS5;AGAP2;WDR91;WDR81;PIK3R6;PIK3R5
prerank,solute:anion antiporter activity (GO:0140323),-0.335629475556447,-0.9270466863834198,0.5267175572519084,0.8824561941901915,1.0,2/14,4.50%,SLC26A11;SLC7A11
prerank,R-SMAD binding (GO:0070412),0.3278386501601991,0.9239564445989664,0.568561872909699,0.9657803995817662,1.0,4/18,11.55%,LDLRAD4;DDX5;PPM1A;DROSHA
prerank,metalloexopeptidase activity (GO:0008235),0.26784922323156846,0.9233461608243652,0.5934718100890207,0.9635378266548452,1.0,14/51,19.04%,MMP16;RNPEPL1;XPNPEP1;METAP1D;XPNPEP3;VASH1;AEBP1;TRHDE;LAP3;VASH2;ENPEP;AGBL4;MMP17;FOLH1
prerank,calcium-dependent cysteine-type endopeptidase activity (GO:0004198),0.35968210216229857,0.9227816737835137,0.5486111111111112,0.9611291937825077,1.0,4/14,10.32%,CAPN3;CAPN12;CAPNS1;CAPN11
prerank,vitamin D receptor binding (GO:0042809),-0.32859205867247093,-0.9210809666139991,0.5619047619047619,0.8938600370399192,1.0,3/14,9.37%,MED13;MED16;SNW1
prerank,endopeptidase activator activity (GO:0061133),0.3913691340789209,0.9187957970760405,0.5826086956521739,0.9679773035974918,1.0,4/10,12.50%,VSIR;PSME3;PSENEN;PSMD14
prerank,RNA polymerase II cis-regulatory region sequence-specific DNA binding (GO:0000978),0.1967170812579507,0.917490715002026,0.7602956705385427,0.9676519442295285,1.0,163/731,23.78%,ZFHX3;HOXA5;HHEX;SCRT2;HSF4;SALL3;IKZF4;NACC2;ONECUT2;BPTF;POU2F2;USF2;HOXD4;TFCP2;ZNF394;ESRRG;KDM6B;ZBTB3;NEUROG2;NR1I2;FOSL1;NRL;SIX4;NR1I3;SOX21;ATOH7;HIC1;SKOR1;NEUROD2;NFIB;ZKSCAN7;RELA;DMRT2;SP2;KCNIP3;SOX10;TFCP2L1;NSD1;MEOX2;WBP2;SOX4;BCL11B;ZBTB12;PPARA;HOXB9;HOXC6;PBX2;HOXB7;E2F1;FOXD1;NR2F6;RFX6;MEF2C;AR;RXRG;ZNF205;MAZ;HOXC10;SP4;EBF1;TCF7L2;FOXC1;HEY1;HDAC5;ZFP82;TBX2;ZNF23;ZKSCAN8;SNAI2;KLF7;DMRTA1;GRHL3;HSF2;NFE2L2;ZNF32;ZFP1;HOXB2;POU3F4;PBX3;ZNF383;THAP1;USF1;GABPA;HLF;TFEB;HOXB5;TBX6;TEF;PLAG1;PRDM16;ZSCAN12;ZBTB32;MYNN;ZBTB49;NKX2-2;IKZF2;ZNF740;IRF5;PRDM1;BATF;ERG;REST;TCF3;TCF7L1;PRDM15;CALCOCO1;BHLHE41;EN2;KLF16;BACH1;KLF12;ZIC5;ZNF750;ZFP30;ZEB1;BACH2;ZBTB34;XBP1;POU3F3;TEAD3;MAX;ZFP92;ZBTB7B;FOSL2;SNAPC3;REL;RORA;POU5F2;SRF;DHX36;PRDM5;IRX5;SMAD2;SMAD1;GLI3;GRHL2;KLF5;HOXC5;PRMT5;NFE2L3;ZNF467;ZFAT;TOP1;TEAD2;EBF3;ZNF628;NFYB;ZSCAN18;NPAS2;SKOR2;CC2D1A;ZIK1;HDX;CREB3L4;IRF3;SOX13;EBF4;HOXB3;NKRF;CREB3;HES6;MEF2A;MAFB
prerank,intracellular calcium activated chloride channel activity (GO:0005229),-0.3161088209817352,-0.9157700010069534,0.5552884615384616,0.8991603108794188,1.0,6/16,26.65%,TTYH2;ANO5;ANO8;ANO1;ANO10;ANO4
prerank,intracellular chloride channel activity (GO:0061778),-0.3161088209817352,-0.9157700010069534,0.5552884615384616,0.8991603108794188,1.0,6/16,26.65%,TTYH2;ANO5;ANO8;ANO1;ANO10;ANO4
prerank,protein binding involved in heterotypic cell-cell adhesion (GO:0086080),-0.37333017316062744,-0.9145092477399298,0.5513392857142857,0.8977036156509451,1.0,1/10,2.04%,CD47
prerank,neuropeptide receptor binding (GO:0071855),0.3516251464405895,0.9133724212561789,0.5716666666666667,0.9750059422069239,1.0,3/14,17.85%,PPY;GAL;SHANK1
prerank,"3',5'-cyclic-nucleotide phosphodiesterase activity (GO:0004114)",0.3253020721663838,0.9123958651002432,0.5930807248764415,0.973740951532586,1.0,3/21,6.72%,PDE8B;PDE4A;PDE3B
prerank,proton transmembrane transporter activity (GO:0015078),0.2758521993057971,0.910176294496404,0.6131045241809673,0.9753722916864332,1.0,10/39,23.98%,UQCRC1;SLC33A1;NDUFA4;CTNS;UQCR11;COX4I1;COX6B1;SLC9A1;UQCR10;COX10
prerank,MAP kinase tyrosine/serine/threonine phosphatase activity (GO:0017017),-0.35847175813668947,-0.908792978643225,0.5714285714285714,0.9030689545822911,1.0,7/10,37.98%,DUSP16;DUSP1;DUSP7;DUSP4;DUSP8;DUSP9;DUSP6
prerank,protein tyrosine/threonine phosphatase activity (GO:0008330),-0.35847175813668947,-0.908792978643225,0.5714285714285714,0.9030689545822911,1.0,7/10,37.98%,DUSP16;DUSP1;DUSP7;DUSP4;DUSP8;DUSP9;DUSP6
prerank,voltage-gated chloride channel activity (GO:0005247),-0.3692112682826867,-0.908179789015958,0.5727272727272728,0.9002125591940752,1.0,3/10,19.11%,CLCN1;CLCN5;ANO1
prerank,protein-lysine N-methyltransferase activity (GO:0016279),0.2842189783868215,0.9079007836674667,0.5925925925925926,0.9774275952241197,1.0,11/34,18.50%,SMYD2;METTL21C;EEF1AKMT2;METTL21A;SETD6;SETD4;TTLL12;SMYD1;N6AMT1;KMT2E;SETDB1
prerank,phospholipase activity (GO:0004620),0.24608628526773593,0.907666579607615,0.6366279069767442,0.9741310808383884,1.0,9/67,8.83%,PLCL1;PRDX6;PLAAT5;PLA2G4C;PNPLA3;ABHD12;LYPLA1;PLD4;ENPP2
prerank,cell-cell adhesion mediator activity (GO:0098632),-0.24312532892071037,-0.906421478094841,0.6382978723404256,0.8999428614395357,1.0,7/42,10.06%,EMB;PDLIM1;CD47;PDLIM5;NPTN;ANXA1;RAB10
prerank,lysophospholipase activity (GO:0004622),0.31558663447962726,0.9059255615219514,0.6048780487804878,0.9749293157897887,1.0,4/20,8.83%,PLA2G4C;ABHD12;LYPLA1;ENPP2
prerank,TBP-class protein binding (GO:0017025),0.3114541870933645,0.9046780498727612,0.6026936026936027,0.9744042089263852,1.0,2/21,1.61%,HHEX;DRAP1
prerank,cis-regulatory region sequence-specific DNA binding (GO:0000987),0.19376185413318495,0.9031391177860563,0.8037974683544303,0.974739757912602,1.0,161/732,23.78%,ZFHX3;HOXA5;HHEX;SCRT2;HSF4;SALL3;IKZF4;NACC2;ONECUT2;BPTF;POU2F2;USF2;HOXD4;TFCP2;ZNF394;ESRRG;KDM6B;ZBTB3;NEUROG2;NR1I2;FOSL1;NRL;SIX4;NR1I3;SOX21;ATOH7;HIC1;SKOR1;NEUROD2;NFIB;ZKSCAN7;RELA;DMRT2;SP2;KCNIP3;SOX10;TFCP2L1;NSD1;MEOX2;WBP2;SOX4;BCL11B;ZBTB12;PPARA;HOXB9;HOXC6;PBX2;HOXB7;E2F1;FOXD1;NR2F6;RFX6;MEF2C;AR;RXRG;ZNF205;MAZ;HOXC10;SP4;EBF1;TCF7L2;FOXC1;HEY1;HDAC5;ZFP82;TBX2;ZNF23;ZKSCAN8;SNAI2;KLF7;DMRTA1;GRHL3;HSF2;NFE2L2;ZNF32;ZFP1;HOXB2;POU3F4;PBX3;ZNF383;THAP1;USF1;GABPA;HLF;TFEB;HOXB5;TBX6;TEF;PLAG1;PRDM16;ZSCAN12;ZBTB32;MYNN;ZBTB49;NKX2-2;IKZF2;ZNF740;IRF5;PRDM1;BATF;ERG;REST;TCF3;TCF7L1;PRDM15;CALCOCO1;BHLHE41;EN2;KLF16;BACH1;KLF12;ZIC5;ZNF750;ZFP30;ZEB1;BACH2;ZBTB34;XBP1;POU3F3;TEAD3;ZFP92;ZBTB7B;FOSL2;SNAPC3;REL;RORA;POU5F2;SRF;DHX36;PRDM5;IRX5;SMAD2;SMAD1;GLI3;GRHL2;KLF5;HOXC5;NFE2L3;ZNF467;ZFAT;TOP1;TEAD2;EBF3;ZNF628;NFYB;ZSCAN18;NPAS2;SKOR2;CC2D1A;ZIK1;HDX;CREB3L4;IRF3;SOX13;EBF4;HOXB3;NKRF;CREB3;HES6;MEF2A;MAFB
prerank,SUMO binding (GO:0032183),0.3553237348670878,0.9025360907132955,0.5716945996275605,0.9725526348985781,1.0,3/13,11.18%,HERC2;SIMC1;CBX4
prerank,"acyltransferase activity, transferring groups other than amino-acyl groups (GO:0016747)",0.24443275884405422,0.9016472737079848,0.6340425531914894,0.9710710038479473,1.0,15/69,17.17%,DGAT2;PLAAT5;AWAT2;PLA2G4C;SOAT2;ZDHHC8;CERS4;ZDHHC1;ZDHHC2;KAT8;CERS5;CERS6;CERS1;ESCO1;NMT1
prerank,nucleoside diphosphate kinase activity (GO:0004550),0.3547601314703919,0.9002041762918945,0.6116666666666667,0.9709761444013725,1.0,6/14,23.54%,NME1;AK5;DTYMK;AK1;AK4;AK9
prerank,nucleoside monophosphate kinase activity (GO:0050145),0.32118530530486755,0.9001582512384247,0.6057233704292527,0.9673626113767906,1.0,7/20,23.54%,DLG2;LRGUK;DTYMK;AK1;AK4;AK3;AK9
prerank,platelet-derived growth factor receptor binding (GO:0005161),-0.3305733775772518,-0.899643396077824,0.6036036036036037,0.9130037339896049,1.0,5/13,19.22%,ERN1;PDGFD;PDGFC;PDGFRA;ITGB3
prerank,sequence-specific double-stranded DNA binding (GO:1990837),0.19450933249723074,0.8987122211975306,0.7997870074547391,0.9674244837430158,1.0,90/597,16.65%,HOXA5;HHEX;SCRT2;MCM5;HSF4;KCNH2;ONECUT2;POU2F2;USF2;HOXD4;TFCP2;ESRRG;LBX2;NEUROG2;NR1I2;FOSL1;NRL;SIX4;NR1I3;ATOH7;HIC1;SKOR1;NEUROD2;NFIB;RELA;SP2;SOX10;TFCP2L1;TFAM;MEOX2;SOX4;BCL11B;ZBTB12;HOXB9;HOXB7;E2F1;GABPB1;XRCC6;NR2F6;RFX6;MEF2C;AR;RXRG;MCM3;HOXC10;ZBTB22;TCF7L2;ERBB4;FOXC1;HEY1;HDAC5;TAF9;ZW10;TBX2;ZNF23;SNAI2;DMRTA1;HSF2;NFE2L2;ZNF32;ZFP1;ZFP41;HOXB2;POU3F4;SUV39H2;USF1;GABPA;HLF;TFEB;HOXB5;TBX6;TEF;LHX5;PRDM16;ZBTB32;BARX2;HMGB1;LMX1B;MLH3;ZNF740;IRF5;PRDM1;BATF;ERG;REST;TCF7L1;CALCOCO1;BHLHE41;EN2;KLF16
prerank,peptidase inhibitor activity (GO:0030414),0.2813113891960157,0.8983559889997069,0.6159638554216867,0.9646254637305868,1.0,4/33,10.33%,CST3;PSMF1;SPINT2;SIMC1
prerank,1-phosphatidylinositol-3-kinase activity (GO:0016303),0.3799256463576828,0.897726825410113,0.5888689407540395,0.9625653919618278,1.0,2/10,6.57%,PIK3C2G;PIK3CG
prerank,thyroid hormone receptor binding (GO:0046966),0.29452530905420893,0.8975033532692622,0.6282894736842105,0.9595676674637396,1.0,5/28,6.24%,MED24;NSD1;MED4;BRD8;TRIP6
prerank,transmembrane receptor protein serine/threonine kinase binding (GO:0070696),-0.339729094354324,-0.8974548014419861,0.5845410628019324,0.9138220525516856,1.0,4/13,20.01%,BMP5;BMP2;BMP3;BMP7
prerank,ubiquitin-specific protease binding (GO:1990381),0.32093634861421866,0.8945679751110668,0.6179966044142614,0.9634776177338765,1.0,8/19,28.40%,SELENOS;PRKN;DERL1;RHBDD2;AMFR;CLTC;SUMO1;PTEN
prerank,RNA polymerase II transcription regulatory region sequence-specific DNA binding (GO:0000977),0.1902584355277312,0.8938694391293387,0.828125,0.9616850963396194,1.0,184/831,23.78%,ZFHX3;HOXA5;HHEX;SCRT2;HSF4;ZFP57;SALL3;IKZF4;NACC2;ONECUT2;BPTF;POU2F2;USF2;HOXD4;TFCP2;ZNF394;ESRRG;KDM6B;ZBTB3;NEUROG2;NR1I2;FOSL1;NRL;SIX4;NR1I3;SOX21;ATOH7;HIC1;SKOR1;NEUROD2;NFIB;ZKSCAN7;RELA;DMRT2;SP2;KCNIP3;SOX10;TFCP2L1;NSD1;MEOX2;WBP2;SOX4;BCL11B;ZBTB12;PPARA;HOXB9;HOXC6;PBX2;HOXB7;E2F1;FOXD1;NR2F6;RFX6;MEF2C;AR;RXRG;ZNF35;ZNF205;MAZ;HOXC10;LHX3;SP4;EBF1;ZBTB22;TCF7L2;FOXC1;HEY1;HDAC5;ZFP82;TBX2;ZNF23;AEBP1;ZKSCAN8;SNAI2;KLF7;DMRTA1;GBX1;GRHL3;HSF2;NFE2L2;ZNF32;ZFP1;ZFP69;ZFP41;HOXB2;RFXAP;POU3F4;PBX3;ZNF383;THAP1;USF1;GABPA;EPAS1;HLF;TFEB;HOXB5;TBX6;TEF;LHX5;PLAG1;PRDM16;ZSCAN12;RBL2;ZBTB32;MYNN;BARX2;LMX1B;ZBTB49;RBL1;NKX2-2;IKZF2;ZNF740;IRF5;PRDM1;BATF;ERG;BHLHA9;REST;TCF3;TCF7L1;PRDM15;LHX2;CALCOCO1;BHLHE41;EN2;KLF16;BACH1;KLF12;ZIC5;ZNF750;ZFP30;ZEB1;BACH2;ZBTB34;XBP1;POU3F3;TEAD3;MAX;ZFP92;ZBTB7B;FOSL2;SNAPC3;REL;RORA;POU5F2;SRF;DHX36;PRDM5;IRX5;SMAD2;SMAD1;GLI3;GRHL2;KLF5;HOXC5;NFE2L3;ZNF467;TFDP2;LHX4;ZFAT;TOP1;TEAD2;NPAS3;EBF3;ZNF628;ZBTB46;NFYB;ZSCAN18;NPAS2;SKOR2;CC2D1A;ZIK1;HDX;CREB3L4;IRF3;SOX13;EBF4;HOXB3;GTF2B;NKRF;CREB3;HES6;MEF2A;MAFB
prerank,endoribonuclease activity (GO:0004521),-0.2600052587021315,-0.8923414160449458,0.6524216524216524,0.9223129007627716,1.0,11/32,25.45%,ZC3H12D;ERN1;ZC3H12A;ZC3H12B;PIWIL2;AGO2;ENDOG;SMG6;RNASEK;RIDA;ERN2
prerank,protein tyrosine phosphatase activity (GO:0004725),-0.2165774234554863,-0.8917606940020664,0.6952380952380952,0.9190328285497589,1.0,24/71,22.20%,PTPN22;PTPN23;PTPRC;PTPN1;CDC14B;PTPN21;EYA1;PTPN7;DUSP18;EYA3;EYA2;CDKN3;DUSP1;TIMM50;TNS2;CDC25A;MTMR3;HACD2;PTP4A3;PTPRZ1;PTPRH;CDC25C;PTPN4;CDC14A
prerank,ATP binding (GO:0005524),-0.1764726710396616,-0.8912111952967587,0.8484848484848485,0.9158140514063925,1.0,41/266,13.62%,PEAK1;STK3;OAS2;STK38;STK17B;CDK6;HSPA4;MARK2;OLA1;ATP7A;RUNX3;P2RX4;RRM1;NUAK2;MKNK1;PTPA;NLRC4;MYO1F;RTEL1;PIM1;LMTK2;ERN1;PRKAG2;IGHMBP2;KIFC1;EIF2B2;UBA2;HASPIN;ABCG1;YARS2;UHMK1;AGAP2;CAD;LIG4;DAPK1;PANK3;OAS3;N4BP2;SIK2;FICD;NLK
prerank,nucleotidase activity (GO:0008252),-0.31020580946104764,-0.8907798838169113,0.6067961165048543,0.9123850463338149,1.0,4/15,18.92%,NT5DC1;NT5E;NT5DC2;BPNT2
prerank,lipoprotein particle receptor binding (GO:0070325),0.29061173132578394,0.8891134978809948,0.6114754098360655,0.9697889008871449,1.0,12/27,29.73%,SYT1;CLU;APBB1;HSP90B1;APBB3;LANCL1;ANKRA2;SNX17;DNAJA1;CLTC;HSPG2;AP2M1
prerank,damaged DNA binding (GO:0003684),-0.23780299937048927,-0.8872615659186087,0.678343949044586,0.9166135076353549,1.0,11/44,19.68%,RBBP8;HMGB2;PCNA;NBN;CRY2;EP300;RPA1;NTHL1;RPA2;XPC;NEIL3
prerank,BMP binding (GO:0036122),0.3604353568251817,0.8872076634168308,0.6275510204081632,0.9709034190392116,1.0,3/11,22.61%,GREM2;ENG;UCMA
prerank,U6 snRNA binding (GO:0017070),0.33366569477629826,0.885174420353002,0.6230636833046471,0.9724051919405472,1.0,6/14,22.72%,METTL16;LSM8;DDX39B;EIF5A;LSM4;LSM3
prerank,retinoic acid receptor binding (GO:0042974),-0.30289315279487655,-0.8822149146487963,0.6340852130325815,0.9246850057614198,1.0,8/17,28.56%,PPARG;SNW1;PRMT2;TACC1;NRIP1;HMGA1;ARID5A;ACTN4
prerank,protein-arginine N-methyltransferase activity (GO:0016274),0.3641238248349901,0.881388183154339,0.6130742049469965,0.9780559141737917,1.0,4/11,21.18%,FBXO11;PRMT9;PRMT3;PRMT5
prerank,5'-nucleotidase activity (GO:0008253),-0.3224907695420518,-0.8803232424380504,0.6234718826405868,0.9244400133788251,1.0,3/13,13.42%,NT5DC1;NT5E;NT5DC2
prerank,enoyl-CoA hydratase activity (GO:0004300),0.37479170145324686,0.8779531609702826,0.6170212765957447,0.9828762755418109,1.0,3/10,24.57%,ECHDC1;ECHS1;ECHDC2
prerank,GDP binding (GO:0019003),-0.21316553917752673,-0.8772682100606464,0.7476340694006309,0.9270935885717523,1.0,14/63,18.63%,RAB8B;RRAGC;RAB7A;KRAS;RAB10;RAB21;RALB;RASL12;RAP1B;RAP1A;NRAS;MIEF1;RAB31;RAP2A
prerank,phosphatase activity (GO:0016791),0.2372274924746991,0.8759334345814138,0.6699857752489331,0.9841405861838961,1.0,24/73,27.15%,PLPP5;PTPRO;ENOPH1;SACM1L;PPP1CC;ALPL;OCRL;PPP5C;PTPMT1;PLPPR4;FRA10AC1;NT5C;PLPP1;PSPH;PPP1CA;NUDT16L1;DUSP28;DUSP26;ACP4;PLPP2;PLPPR1;MDP1;NUDT16;ACP2
prerank,BMP receptor binding (GO:0070700),-0.3397416461294111,-0.8749621254151874,0.6289156626506024,0.9279502518431688,1.0,4/12,20.01%,BMP5;BMP2;BMP3;BMP7
prerank,nuclear export signal receptor activity (GO:0005049),-0.3367039894580056,-0.874479885974491,0.6225961538461539,0.9245293668709716,1.0,2/11,10.00%,EIF4ENIF1;XPO1
prerank,transforming growth factor beta binding (GO:0050431),0.29772470098496384,0.8712832913153156,0.6644628099173554,0.9918755796305037,1.0,5/23,18.49%,LTBP3;TGFBR3;TGFBR1;ENG;LTBP4
prerank,methylation-dependent protein binding (GO:0140034),0.24328296784913506,0.869955439981744,0.7062937062937062,0.9915040039647932,1.0,22/57,27.48%,BPTF;CBX2;SPIN1;NCAPD3;KAT8;PHF8;KDM4A;MORC4;KMT2E;PHF1;PHF2;CBX5;TDRD3;MPHOSPH8;ING2;ING3;WDR5;MBTD1;PHF13;CHD1;CHD8;LRWD1
prerank,exonuclease activity (GO:0004527),0.2570285927484441,0.8698199075220375,0.658284023668639,0.9882383437748694,1.0,13/46,19.72%,REXO2;POLG;ENPP2;CPSF3;FAN1;EXD1;EXOSC5;APEX1;FEN1;WRN;DXO;REXO4;APLF
prerank,metalloendopeptidase activity (GO:0004222),0.23311568530649737,0.868371588632081,0.7155555555555555,0.9880770698492423,1.0,15/76,18.60%,MMP16;MEP1B;ADAMTS20;PHEX;ADAMTSL1;ADAMTS15;ADAMTS19;THSD4;ADAMTS14;PITRM1;MMP1;THOP1;ADAMTS4;MMP17;ADAMTS3
prerank,transition metal ion transmembrane transporter activity (GO:0046915),-0.25619508510787026,-0.8660084677407887,0.7081081081081081,0.9400532812061959,1.0,4/30,6.09%,TMEM165;SLC39A10;ATP7A;SLC30A5
prerank,neutral amino acid transmembrane transporter activity (GO:0015175),0.2757331853497986,0.8659030030771635,0.6830427892234548,0.9901448421987962,1.0,11/32,22.87%,SLC38A2;SLC1A1;SLC38A9;SLC38A7;SFXN1;SLC1A4;SFXN2;SLC25A38;SLC6A9;SLC38A3;SLC6A7
prerank,ATPase activator activity (GO:0001671),-0.2802355258851475,-0.8657304681236904,0.6842105263157895,0.9362601740601108,1.0,7/20,17.24%,DNAJC1;TOR1AIP1;DNAJC10;FXYD2;DNAJB6;DNAJC15;DNAJB1
prerank,store-operated calcium channel activity (GO:0015279),-0.34391248274291963,-0.8650386469968336,0.6494382022471911,0.9334150871539674,1.0,4/10,16.39%,TRPC5;TRPC1;ORAI2;STIM2
prerank,phosphatidylinositol monophosphate phosphatase activity (GO:0052744),-0.30712841988808154,-0.8644458500851125,0.65807962529274,0.9303984389287937,1.0,6/16,15.84%,MTMR14;MTMR2;MTMR4;MTM1;MTMR12;MTMR3
prerank,telomerase RNA binding (GO:0070034),-0.2783999709072936,-0.864175344149064,0.6876456876456877,0.9266462393654656,1.0,14/22,30.44%,SNRPB;EXOSC10;NOP10;SMG6;TENT4B;DKC1;TEP1;HNRNPC;HNRNPU;NAF1;NHP2;TERT;PINX1;SMG5
prerank,methylated histone binding (GO:0035064),0.237528402678378,0.8639206938890864,0.7164591977869986,0.9912392348163709,1.0,24/62,27.48%,BPTF;CBX2;DPF2;SPIN1;NCAPD3;KAT8;PHF8;KDM4A;TTLL12;MORC4;KMT2E;PHF1;PHF2;CBX5;TDRD3;MPHOSPH8;ING2;ING3;WDR5;MBTD1;PHF13;CHD1;CHD8;LRWD1
prerank,frizzled binding (GO:0005109),0.2653215161261611,0.8632845037046472,0.6917057902973396,0.9892118621303989,1.0,6/34,11.53%,WNT4;WNT3;RYK;NDP;WNT8B;SFRP1
prerank,transforming growth factor beta receptor binding (GO:0005160),0.31327303291186176,0.8628067619205606,0.660245183887916,0.9867627944533891,1.0,5/18,20.58%,TGFBR3;TGFBR1;TGFB1;ENG;SMAD2
prerank,MHC class I protein binding (GO:0042288),-0.31629825898283936,-0.8623178878971458,0.6267605633802817,0.9263013456384918,1.0,6/13,31.91%,TAPBP;LILRB1;PILRA;TUBB4B;CD8B;CD8A
prerank,cation transmembrane transporter activity (GO:0008324),0.24988063255331328,0.8585127146757265,0.7084592145015106,0.9934615543840759,1.0,9/48,13.33%,SLC25A2;SLC38A2;SLC1A1;SLC38A9;SLC38A7;SFXN1;SLC1A4;SLC66A1;SFXN2
prerank,retinoid binding (GO:0005501),0.2949648097738805,0.8583772971014935,0.6736672051696284,0.9901683061791995,1.0,2/22,3.95%,PTGDS;CYP26C1
prerank,peptidoglycan binding (GO:0042834),0.36195690683491066,0.856817200029511,0.6771929824561403,0.9903703674198249,1.0,3/10,10.19%,PGLYRP2;NOD1;RNASE7
prerank,bHLH transcription factor binding (GO:0043425),0.30860083854596854,0.8565848962423448,0.6787479406919276,0.9873848528632047,1.0,6/19,16.57%,USF2;MAP3K10;LMO2;USF1;TCF3;BHLHE41
prerank,purine ribonucleoside triphosphate binding (GO:0035639),-0.161619228300221,-0.8562294236968426,0.96,0.9357420730294171,1.0,90/431,20.15%,PEAK1;STK3;PSMA6;OAS2;STK38;STK17B;CDK6;HSPA4;MARK2;OLA1;ATP7A;RUNX3;P2RX4;RRAGC;TUBB6;RRM1;NUAK2;EEF1A1;RAB7A;MKNK1;PTPA;NLRC4;MYO1F;RTEL1;PIM1;LMTK2;TUBA4A;ERN1;TUBD1;ARF3;MTG2;PRKAG2;GBP3;IGHMBP2;KIFC1;RAB6A;EIF2B2;TUBE1;UBA2;HASPIN;ABCG1;KRAS;GNL2;RHOJ;RAB10;YARS2;UHMK1;AGAP2;DNM2;CAD;LIG4;DAPK1;TSR1;LRRK2;RRAGA;RAB21;PANK3;REM1;OAS3;N4BP2;SIK2;FICD;NLK;GBP4;RALB;SIK1;RASL12;PRKACB;RAP1B;RAP1A;MYH9;ARHGEF5;PLK1;NRAS;PFKL;RAB31;ZAP70;MAP4K1;TBCK;TRIP13;RAP2A;LANCL2;TUBB2B;HSPA13;MYO9B;ACVR1;HSPA1B;GBP6;HNRNPU;CDC42BPG
prerank,methyl-CpG binding (GO:0008327),-0.27368673003030064,-0.856195886568764,0.6495956873315364,0.9314063278480041,1.0,5/22,12.33%,MECP2;ZCWPW1;MBD2;MBD1;TET3
prerank,peptide N-acetyltransferase activity (GO:0034212),0.35708404318584996,0.8560192091932163,0.6478102189781022,0.9852026702436613,1.0,2/10,15.67%,NAA30;NAA60
prerank,actin binding (GO:0003779),0.20303299192509622,0.8550889565964449,0.7959183673469388,0.9837571622286398,1.0,34/170,17.43%,KCNMA1;ADCY8;FSCN1;ANG;ADD2;EPS8L3;GIPC1;TNNI3;CORO2B;DMD;MYH10;RUSC1;MAP1S;MICAL3;MYO6;TWF2;VASH1;LDB3;PRKN;EMD;CXCR4;KLHL2;CORO1A;LMOD3;VASH2;EPS8L2;PHACTR3;PAWR;TWF1;SSH1;HPCA;PTK2;SSH2;SSH3
prerank,E-box binding (GO:0070888),0.26580847207393155,0.8540807824056236,0.7093596059113301,0.9825312725591481,1.0,8/34,18.31%,SCRT2;NEUROG2;NEUROD2;SNAI2;TCF3;BHLHE41;ZEB1;MAX
prerank,"DNA-binding transcription activator activity, RNA polymerase II-specific (GO:0001228)",0.19453395388287475,0.8539065155873857,0.8422939068100358,0.979469876578356,1.0,40/254,15.99%,HOXA5;HHEX;ONECUT2;HOXD4;TFCP2;NR1I2;NRL;NR1I3;NFIB;RELA;SOX10;TFCP2L1;MEOX2;SOX4;PPARA;PBX2;HOXB7;RFX6;MEF2C;AR;GTF2I;HOXC10;LHX3;FOXC1;KLF7;GRHL3;HSF2;SMARCD3;HOXB2;RFXAP;GABPA;HLF;PLAG1;PRDM16;BARX2;NKX2-2;IRF5;ERG;TCF3;PRDM15
prerank,endopeptidase activity (GO:0004175),0.19317868740720043,0.8513036582955298,0.8426698450536353,0.9819329785770051,1.0,51/257,21.54%,F3;USP10;PSMB1;PLAT;MMP16;RHBDL3;PRSS56;ASPRV1;MEP1B;GZMM;ADAMTS20;USP35;BACE1;LGMN;USP11;USP30;PSMA1;PHEX;ADAMTSL1;ADAMTS15;PSMA8;USP12;CASP3;SFRP1;ADAMTS19;CASP4;THSD4;USP33;CASP7;ADAMTS14;PITRM1;MMP1;ACR;PIK3IP1;KLK2;HPN;THOP1;ADAMTS4;MMP17;PSMB4;PCSK2;ADAMTS3;CTSK;USP48;CASP8;TYSND1;OMA1;USP49;APEH;CASP2;CTSS
prerank,single-stranded DNA binding (GO:0003697),0.22281869674861085,0.8498091125472512,0.75,0.9818171850363047,1.0,23/93,24.18%,TOP3A;NUCKS1;MCM5;RTF1;RNF138;FUBP3;MCM3;DMC1;POLR2G;RAD52;MLH1;SUB1;HMGB1;HNRNPA1;REXO4;DHX36;SSBP1;NABP1;TOP1;POLA1;SSBP2;POLR2D;ERCC4
prerank,DNA-(apurinic or apyrimidinic site) endonuclease activity (GO:0003906),-0.3287118409243419,-0.8469428940231588,0.6582914572864321,0.9474953354807466,1.0,4/11,19.68%,APEX2;NTHL1;HMGA2;NEIL3
prerank,transmembrane receptor protein tyrosine kinase activity (GO:0004714),0.2330871361401406,0.8458714479034782,0.746969696969697,0.9869705493269603,1.0,16/60,20.51%,MERTK;NTRK1;FLT4;NTRK3;RYK;EPHA1;ERBB4;TEK;EPHA4;INSR;EPHB2;NTRK2;FLT3;PDGFRB;ROR1;EPHA5
prerank,"exoribonuclease activity, producing 5'-phosphomonoesters (GO:0016896)",0.26370437055728546,0.8451271491120318,0.7123076923076923,0.9851906407973435,1.0,7/33,15.49%,ERI3;REXO2;ANGEL1;ERI2;EXOSC5;CNOT8;ANGEL2
prerank,monovalent cation:proton antiporter activity (GO:0005451),-0.32200948431342036,-0.844948495808146,0.6658986175115207,0.9475770827379297,1.0,6/12,26.94%,SLC9B2;SLC9A9;SLC9A2;SLC9A6;LETM1;SLC9A3
prerank,phosphatidylinositol 3-kinase activity (GO:0035004),0.34160626097712965,0.8440081838617423,0.6510791366906474,0.9842849490029968,1.0,3/12,12.24%,PIK3C2G;PIK3CG;IPMK
prerank,iron ion binding (GO:0005506),-0.2176799094433054,-0.8426414978121,0.797583081570997,0.9480062032803473,1.0,16/48,26.35%,ALOX5;TET2;KDM7A;JMJD6;ALKBH8;NFU1;LCN2;RIOX1;FTL;LTF;HEPH;DOHH;FBXL5;ALOX15;PHYH;EGLN1
prerank,transaminase activity (GO:0008483),0.3511967391130147,0.8411543313351292,0.6853526220614828,0.9868125172841773,1.0,3/11,19.90%,BCAT1;AGXT;ABAT
prerank,adenine nucleotide transmembrane transporter activity (GO:0000295),0.3407995292403735,0.8403627931758954,0.6864864864864865,0.9850700633016726,1.0,4/12,19.47%,SLC25A5;SLC19A1;SLC25A23;SLC35B2
prerank,G protein-coupled receptor binding (GO:0001664),0.20852470538603776,0.8401003578929868,0.8169398907103825,0.9823078848286564,1.0,37/132,27.42%,WNT4;INSL3;REEP2;WNT3;RYK;NDP;ARRB2;GNA15;PPY;UTS2B;WNT8B;PRKN;HOMER2;SFRP1;USP33;GNA11;WNT7A;GNAI3;ADM;GNAS;BICD1;GHRL;RSPO1;DVL2;CCL5;ARRB1;RNF43;TULP3;TAFA5;GNAI1;ITGB4;WNT5B;STUB1;PSMC5;GNAQ;HSPA8;DNAJA1
prerank,kinase activator activity (GO:0019209),0.27412903550161805,0.8391910430685716,0.7292307692307692,0.9809536979389887,1.0,5/30,10.74%,RPTOR;NCKAP1L;STK11;IL2;FGF13
prerank,ribonuclease P activity (GO:0004526),0.34842404017197354,0.8391618267926565,0.6743295019157088,0.9777053738255079,1.0,3/11,13.22%,RPP40;PRORP;RPP30
prerank,ubiquitin-like protein conjugating enzyme binding (GO:0044390),0.25750577960798127,0.8388706574774148,0.7163009404388715,0.9751285993108697,1.0,5/33,9.79%,RNF19A;PPARA;RNF180;DCUN1D2;PRKN
prerank,protein phosphatase 1 binding (GO:0008157),-0.2707845052277393,-0.8384952126171747,0.7005208333333334,0.9526673258922091,1.0,9/21,22.19%,SHOC2;AKAP11;PPP1R3C;PPP1R3F;PPP1R3E;LILRB1;PPP1R15A;KCNQ1;SMTNL2
prerank,"oxidoreductase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor (GO:0016616)",0.22484763159979604,0.8369230293921814,0.7747875354107648,0.9760108302282139,1.0,16/75,21.32%,RDH10;AKR1C1;PRXL2B;NSDHL;CBR4;HSD17B11;MDH1;RDH5;SDR42E1;CRYL1;LDHD;KDSR;HSD17B10;HPGD;PHGDH;PGD
prerank,inorganic anion transmembrane transporter activity (GO:0015103),0.27439004359454194,0.8367583769246931,0.7059748427672956,0.9730910212936131,1.0,5/27,12.61%,SLC22A8;SLC26A4;SLC26A7;SLC39A8;GET3
prerank,alkali metal ion binding (GO:0031420),0.3290970603590118,0.8366531810297924,0.6951871657754011,0.9700802574426891,1.0,3/13,22.19%,CAPN3;ATP1A1;DRG1
prerank,cyclic-nucleotide phosphodiesterase activity (GO:0004112),0.29080279603061604,0.8353189266075792,0.6864951768488746,0.9694436451320115,1.0,3/23,6.72%,PDE8B;PDE4A;PDE3B
prerank,estrogen receptor binding (GO:0030331),0.26537702251440126,0.830298471279158,0.7403225806451613,0.9765416968095962,1.0,3/32,4.37%,DCAF1;NSD1;WBP2
prerank,acylglycerol lipase activity (GO:0047372),0.3410456843280817,0.828944114752534,0.6868512110726643,0.9760943530276875,1.0,5/11,29.71%,ABHD12;ABHD2;LIPE;MGLL;FAAH
prerank,"phosphotransferase activity, phosphate group as acceptor (GO:0016776)",0.28324778441948306,0.8275151243272476,0.7236024844720497,0.9757557591407736,1.0,8/24,23.54%,IP6K1;NME1;AK5;DTYMK;AK1;AK4;AK3;AK9
prerank,ubiquitin protein ligase binding (GO:0031625),0.19076246628775173,0.8268079814870924,0.8829915560916767,0.9739998932248857,1.0,43/254,16.03%,WRAP53;YWHAE;PRDX6;FHIT;UBE2B;UQCRC1;KCNH2;RELA;CASC3;PPARGC1A;HERC2;CLU;UBE2G1;FBXO7;TRIB1;TRIB2;ARRB2;APBB1;FAF1;PRKN;SUMO2;LRPPRC;UBE2N;HSPA9;BECN1;CXCR4;ACVR1B;MC4R;CUL2;RNF8;DERL1;SLC25A5;DNM1L;OTUB1;ARRDC1;KDM4A;BLZF1;RFFL;HSPBP1;JKAMP;HM13;UBXN1;HLTF
prerank,ribonuclease activity (GO:0004540),-0.2084609842482591,-0.8259595193230179,0.8365384615384616,0.974883350958798,1.0,15/56,18.88%,DIS3L2;RNASE3;ZC3H12D;ERN1;EXOSC8;ZC3H12A;EXOSC10;ZC3H12B;PIWIL2;AGO2;ENDOG;EXOSC9;RNASEH2A;SMG6;RNASEH1
prerank,ankyrin binding (GO:0030506),0.2940335062062833,0.8258586673958257,0.7066666666666667,0.9725678417585134,1.0,4/19,14.31%,SLC8A1;CACNA1D;NRCAM;SPTBN1
prerank,DNA binding (GO:0003677),0.17754759234589793,0.8257320190581875,0.9505263157894737,0.9696479357799273,1.0,141/694,22.10%,CCDC25;TOP3A;HOXA5;HHEX;NUCKS1;TET1;MCM5;ANG;DRAP1;SURF6;DENND4A;RTF1;PQBP1;MYRFL;BPTF;CSRNP3;POU2F2;USF2;RNF138;TFCP2;DNASE1;NRL;TRIM26;SOX21;HIC1;NFIB;RELA;SOX10;TFAM;PPARGC1A;MEOX2;POLG;PPARA;DNASE1L2;E2F1;HDGFL2;XRCC6;FOXD1;NR2F6;MAP1S;GTF2H4;RBM5;BCLAF3;SMC1A;FUBP3;ZNF35;MCM3;OGG1;REPIN1;TIMELESS;LHX3;SP4;ZBTB22;TCF7L2;FOXC1;TAF9;TSHZ2;TBX2;SNAI2;CGAS;GRHL3;ZDHHC1;TRNP1;NFE2L2;FAN1;KDM2B;DMC1;HOXB2;POLR3F;POLR2G;RAD52;THAP1;USF1;MBD6;EPAS1;HLF;MLH1;TSN;TBX6;SUB1;MYRF;DDB2;ACR;PRDM16;ZBTB32;BARX2;HMGB1;SPTY2D1;ZBTB49;APEX1;FEN1;RPS27;ERCC6;IRF5;HMGB3;BATF;ERG;APLP2;HNRNPA1;TCF3;TCF7L1;CALCOCO1;SETX;CENPS;BRIP1;HDGFL3;KLF12;PHF1;XBP1;POU3F3;TSNAX;TFPT;MAX;PSIP1;WRN;ZMYM6;POGK;SNAPC3;ARID4A;REXO4;ZMYM3;RORA;DHX36;CENPC;CR2;PRDM5;SMAD2;XRCC5;SSBP1;NABP1;GRHL2;UNG;MPG;LHX4;XRCC4;TOP1;ING2;CXXC5;TAF4;NFYB;NPAS2
prerank,G protein-coupled peptide receptor activity (GO:0008528),0.2233987333075918,0.8257262031240423,0.7955555555555556,0.9665349621531277,1.0,8/73,11.75%,AVPR2;NMUR1;AVPR1A;LTB4R2;SORCS1;ADCYAP1R1;CX3CR1;MC4R
prerank,H4 histone acetyltransferase activity (GO:0010485),-0.3301277614389313,-0.8250813544513907,0.7092198581560284,0.9723022124276486,1.0,5/10,26.43%,EP300;HAT1;MSL3;NAA40;ATF2
prerank,K63-linked polyubiquitin modification-dependent protein binding (GO:0070530),-0.2606844581390426,-0.8245906996186771,0.7578125,0.9689077247365,1.0,7/22,17.12%,ZRANB3;ATRIP;WDR81;FAAP20;OPTN;SQSTM1;UIMC1
prerank,quaternary ammonium group transmembrane transporter activity (GO:0015651),0.3367738092481745,0.8240073964138328,0.6803418803418804,0.9668840725838526,1.0,4/11,29.51%,SLC22A4;SLC22A5;SLC25A45;SLC25A29
prerank,rRNA binding (GO:0019843),-0.22027190513039363,-0.8204892442502183,0.7830188679245284,0.9730402683434641,1.0,20/42,32.29%,RCC1L;RPL5;RPS14;RPS13;RPS5;RPF2;DDX21;NOP53;GTF3A;EMG1;FASTKD5;RPL11;MRPS27;DDX28;MRPS18C;MRPL11;MDM2;RPL23;RPS3;CAVIN1
prerank,tRNA-specific ribonuclease activity (GO:0004549),0.3194046593237625,0.8192122165324133,0.7073608617594255,0.9733605428276906,1.0,5/14,18.44%,RPP40;ELAC2;PRORP;RPP30;TSEN34
prerank,cAMP-dependent protein kinase regulator activity (GO:0008603),-0.32841850888549873,-0.818491963942274,0.6742596810933941,0.9728228779343472,1.0,2/10,7.35%,PKIB;PRKAG2
prerank,ribosomal large subunit binding (GO:0043023),-0.31921736527891054,-0.8169167751997364,0.6837416481069042,0.9716359536309502,1.0,5/11,17.19%,MALSU1;DHX33;NPM1;NMD3;CPEB2
prerank,protein kinase regulator activity (GO:0019887),-0.18203257585831364,-0.8155526725355532,0.8804347826086957,0.9699033390883572,1.0,31/95,25.89%,GMFG;MARK2;NCK1;CCND1;PRKAG2;TAOK3;SMCR8;GPRC5B;CCNH;AGAP2;CCNA2;CCNL1;CCND2;NPM1;QARS1;PRKRIP1;SPRY4;DUS2;RGCC;TPX2;SOCS1;EPO;CNPPD1;GSKIP;DUSP19;CCNY;CCNB1;ITPRIP;KIDINS220;CCNJ;CCNF
prerank,death receptor binding (GO:0005123),-0.2897294875686117,-0.8153837678561333,0.7333333333333333,0.9659410056522297,1.0,6/15,25.80%,RIPK1;PIDD1;EDA;MYD88;FADD;TMBIM1
prerank,aminoacyl-tRNA ligase activity (GO:0004812),-0.22877627770818254,-0.81501250256761,0.7956403269754768,0.9624556479508612,1.0,12/37,21.77%,FARS2;IARS2;YARS2;PARS2;EARS2;QARS1;NARS1;WARS2;VARS2;WARS1;FARSA;LARS1
prerank,cyclin-dependent protein serine/threonine kinase regulator activity (GO:0016538),-0.21820472367416013,-0.8144475971485342,0.8163841807909604,0.9592777970436116,1.0,14/42,27.43%,CCND1;CDKN2C;CCNH;CCNA2;CCNL1;CCND2;CDKN2A;CNPPD1;CCNY;KAT2B;CCNB1;CCNJ;CCNF;INCA1
prerank,ubiquitin binding (GO:0043130),0.2174902329687843,0.8142165027155437,0.8192419825072886,0.9800439323438707,1.0,15/73,16.31%,GGA3;FBXO7;OTULINL;FAF1;PRKN;RAE1;NEDD4;UBE2N;CXCR4;RNF168;USP33;OTUB1;TOM1L1;UBXN1;UBAP1
prerank,hexosaminidase activity (GO:0015929),0.32620575160944515,0.8117958958277064,0.7165492957746479,0.9816284421267832,1.0,6/12,27.57%,HEXB;NAGA;HYAL4;OGA;SPAM1;CEMIP
prerank,ADP binding (GO:0043531),-0.2488725662740916,-0.8111986140588374,0.75,0.9610661170236747,1.0,7/25,19.45%,ERN1;PRKAG2;ABCG1;GCLC;MYH9;MIEF1;MYO9B
prerank,histone methyltransferase activity (GO:0042054),-0.23318757046187905,-0.810693299410656,0.774869109947644,0.9578876253709232,1.0,10/32,20.71%,SETD7;DOT1L;PRDM9;KMT2C;PRMT2;EHMT1;FBL;SMYD3;EED;SETD2
prerank,"steroid dehydrogenase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor (GO:0033764)",0.2900613208775026,0.8095672451951823,0.7357259380097879,0.9827358745624654,1.0,4/18,17.85%,HSD17B2;AKR1C1;RDH5;HSD17B10
prerank,NADH dehydrogenase (quinone) activity (GO:0050136),-0.23526789074382598,-0.808842052425072,0.8,0.9531534574490705,1.0,7/34,11.44%,NDUFS4;NDUFV2;NDUFA5;NDUFS8;NDUFB3;NDUFB10;NDUFS7
prerank,NADH dehydrogenase (ubiquinone) activity (GO:0008137),-0.23526789074382598,-0.808842052425072,0.8,0.9531534574490705,1.0,7/34,11.44%,NDUFS4;NDUFV2;NDUFA5;NDUFS8;NDUFB3;NDUFB10;NDUFS7
prerank,methyltransferase activity (GO:0008168),0.23881700213239604,0.8087617975256702,0.7886676875957122,0.9811367569338417,1.0,12/46,22.29%,LRTOMT;EEF1AKMT2;MEPCE;FTSJ1;METTL4;AMT;COMT;N6AMT1;ASMT;PRMT3;PRMT5;BCDIN3D
prerank,polynucleotide adenylyltransferase activity (GO:0004652),-0.31055872454486266,-0.8045241629763301,0.7351485148514851,0.9573811168174078,1.0,5/12,23.12%,TENT2;TENT5A;TENT4B;TENT4A;TENT5C
prerank,hormone receptor binding (GO:0051427),0.3066860728140682,0.8018568675570441,0.7166947723440135,0.9908284355297152,1.0,2/14,8.74%,SOCS2;ADCYAP1
prerank,"hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in cyclic amides (GO:0016812)",0.3370142029233326,0.800885282516389,0.7455516014234875,0.9894641442898008,1.0,2/10,14.38%,CRMP1;DPYSL2
prerank,N-methyltransferase activity (GO:0008170),-0.2675375042465058,-0.8002509115096351,0.7638190954773869,0.9612353515669114,1.0,10/20,32.13%,SETD3;TRMT1L;PEMT;ZCCHC4;METTL15;GNMT;RNMT;TRMT1;PRMT1;TFB1M
prerank,phospholipase binding (GO:0043274),-0.3020106584890359,-0.7992630479991804,0.7454954954954955,0.9588434576023666,1.0,4/13,10.62%,SYK;FYN;BLNK;LCK
prerank,endodeoxyribonuclease activity (GO:0004520),-0.2525867215410423,-0.7979870332705563,0.7486486486486487,0.9570212585526603,1.0,2/20,4.99%,RBBP8;ZRANB3
prerank,NADP binding (GO:0050661),-0.23523862499412868,-0.7956593118359306,0.7988826815642458,0.9571126579751088,1.0,11/32,20.95%,DECR1;CRYZ;CBR3;HSD17B1;MTRR;GMDS;HSD11B1;DUS2;KCNAB1;GRHPR;DHFR
prerank,adenyl ribonucleotide binding (GO:0032559),0.18182790641149787,0.7950404983543151,0.9334916864608076,0.9966355337020985,1.0,68/291,22.52%,HCN1;NIM1K;STK26;ABCG8;KCNJ8;HSPA2;ABCB6;DDX25;PDE4A;MYH10;STK11;GSS;MTHFD1L;TRIB1;MTPAP;PRKCI;CDC42BPA;PI4K2A;TGFBR1;PRAG1;MYO6;NME1;STK36;TWF2;CDKL5;MAP4K4;MPPED2;HSPA9;BTK;MINK1;ACVR1B;P2RY1;COQ8A;PFKM;PPP5C;ABCA2;SLC19A1;INSR;ERCC6;ACLY;HSPA14;GALK1;TWF1;DMPK;KIF14;TAOK1;HARS1;CDC42BPB;AKT3;MAST2;PEX6;ABCD2;MAP4K2;WNK1;BMPR1B;ABCC6;ATP1A3;ATP1A1;PFKP;DHX36;HSP90AB1;TOP1;LATS1;SIK3;TRNT1;PNPLA8;PIP4K2B;TLK2
prerank,tau protein binding (GO:0048156),0.2395283463054131,0.7944712573948471,0.8126888217522659,0.9945503574618144,1.0,12/40,21.28%,BIN1;CLU;LGMN;DCTN1;PPP5C;ROCK1;TAOK1;PIN1;ACTB;SMAD2;HSP90AB1;MAP2
prerank,glutamate receptor binding (GO:0035254),0.2914418742892598,0.7941658328869452,0.7483333333333333,0.9918815342979698,1.0,5/17,17.85%,IGSF11;SHANK3;HOMER2;GNAS;SHANK1
prerank,monocarboxylic acid binding (GO:0033293),0.2876373017803396,0.793316492956762,0.7400346620450606,0.9904102391134156,1.0,2/18,3.95%,AKR1C1;CYP26C1
prerank,carbohydrate kinase activity (GO:0019200),0.3295754833272385,0.7903360754967681,0.7381756756756757,0.9926861813424183,1.0,4/11,16.01%,FGGY;KHK;HK2;GALK1
prerank,CoA-ligase activity (GO:0016405),0.30365663661742326,0.7897108728553075,0.7665441176470589,0.9905961030123336,1.0,4/14,19.16%,ACSS3;ACSF3;ACSBG1;ACSS1
prerank,sodium ion transmembrane transporter activity (GO:0015081),0.25897278827728204,0.7894795025852749,0.8003194888178914,0.9879352849478042,1.0,7/27,19.86%,SLC4A8;SLC9A4;SLC8A1;SLC9A5;SLC8A3;ASIC3;CNNM4
prerank,RNA polymerase II CTD heptapeptide repeat kinase activity (GO:0008353),-0.2974594765881087,-0.7893161906398136,0.7471264367816092,0.9640299656030977,1.0,6/12,20.61%,CDK6;CDK8;CDK1;CDK12;CDK19;CDK9
prerank,sulfotransferase activity (GO:0008146),0.2473100883100483,0.7859370427706308,0.7993630573248408,0.991066334997571,1.0,6/33,14.66%,CHST10;CHST1;HS6ST1;GAL3ST4;GAL3ST1;TPST2
prerank,leucine zipper domain binding (GO:0043522),0.3353094922352717,0.7853734057575545,0.7465753424657534,0.9890541444501437,1.0,5/10,30.26%,NRL;PAWR;MRTFA;ATF4;DDIT3
prerank,ligand-gated calcium channel activity (GO:0099604),0.28174496066761934,0.7841706236035128,0.7893030794165316,0.9881458728326948,1.0,4/19,11.85%,TRPM2;GRIN1;GRIN2B;ITPR3
prerank,nuclear receptor coactivator activity (GO:0030374),0.22939997068969775,0.783484512078912,0.8328358208955224,0.9861997868444481,1.0,7/52,10.73%,MED24;PKN1;PPARGC1A;MED4;BRD8;SS18;FGF2
prerank,cation:chloride symporter activity (GO:0015377),0.33550071967834727,0.7813344306137672,0.7551020408163265,0.9867439695841954,1.0,3/10,14.19%,SLC12A2;SLC12A6;SLC6A1
prerank,insulin-like growth factor receptor binding (GO:0005159),-0.2923486005900957,-0.779171410924357,0.7692307692307693,0.9772629133846543,1.0,5/12,20.49%,IGF1;YWHAG;IGF2;SHC1;SOCS1
prerank,peptide alpha-N-acetyltransferase activity (GO:0004596),0.3136107805241246,0.7786541464759581,0.7816901408450704,0.9882072912716073,1.0,2/11,15.67%,NAA30;NAA60
prerank,protease binding (GO:0002020),0.20010173523896732,0.7771669109354838,0.8774373259052924,0.9876441443309161,1.0,8/99,5.52%,SELENOS;F3;BIN1;ATP9A;CST3;INSL3;POLG;PRNP
prerank,FAD binding (GO:0071949),-0.24570868216820602,-0.7758921418882592,0.803030303030303,0.9786218479499195,1.0,8/24,17.51%,MTHFR;KMO;CRY2;SQOR;CRY1;MTRR;MICAL1;MICAL2
prerank,exopeptidase activity (GO:0008238),0.22328984430588752,0.7728728084574136,0.8477611940298507,0.9916243593210149,1.0,18/50,26.71%,XPNPEP1;CNDP1;METAP1D;XPNPEP3;GGH;TRHDE;LAP3;ENPEP;DPP8;FOLH1;NAALAD2;METAP2;DPEP3;NPEPPS;RCE1;CTSH;DPP3;NUDT16
prerank,guanyl ribonucleotide binding (GO:0032561),0.1822114479172989,0.7707184759667149,0.958179581795818,0.992231657592772,1.0,64/196,29.52%,RAB1B;RHOV;RAB26;ATL1;ARL5A;RHOBTB1;RAB8A;ARL4C;ARL4A;RIT2;CNGB1;NME1;RHOT1;MPPED2;DIRAS2;ARL4D;RAB5A;RAB38;RAB28;RAB39A;RAB12;TUBB2A;SLC19A1;INSR;GNAI3;HRAS;RHOQ;RRAS2;RHOBTB2;RHOU;RHEBL1;CDC42;MMAA;TUBA8;RAP2C;DRG1;PIP4K2B;ARF1;ARL5B;RANBP17;ATL2;GBP2;RHOBTB3;PDE11A;RHOA;GNAI1;RNF112;RAPGEF2;GTPBP10;RRAGD;TUBA1B;NUDT16;TGM2;TUBA1A;MRAS;RAB13;ARL11;RRAD;GBP5;BMS1;ADSS1;RRAS;TUBA1C;RND3
prerank,MAP kinase kinase activity (GO:0004708),-0.2679736954393243,-0.7705635899663746,0.8118811881188119,0.9831649103097874,1.0,6/15,24.77%,MAPKAPK3;LRRK2;MAP2K4;MAP2K7;MAP2K3;SBK2
prerank,cysteine-type endopeptidase inhibitor activity (GO:0004869),-0.22975033546618595,-0.7686693559012439,0.8376068376068376,0.9819256917603763,1.0,5/30,11.77%,GAS6;TNFAIP8;BIRC6;BIRC5;BIRC2
prerank,carboxylic ester hydrolase activity (GO:0052689),0.20152683827631654,0.7682314167815709,0.9005681818181818,0.9931639912570418,1.0,19/85,22.69%,PRDX6;CA1;PLAAT5;PLA2G4C;PNPLA3;ABHD12;LYPLA1;ENPP2;ACHE;TARS2;ABHD5;LYPLAL1;LIPC;ABHD8;ABHD2;PLA2G15;MRPL58;LIPE;DAGLB
prerank,"phosphotransferase activity, for other substituted phosphate groups (GO:0016780)",-0.2977127980481763,-0.7673146462038779,0.754257907542579,0.9799821157811048,1.0,3/11,15.09%,GNPTAB;PIGF;PIGO
prerank,histone acetyltransferase binding (GO:0035035),-0.245302156212166,-0.7656538469141578,0.8121951219512196,0.9783455913994644,1.0,10/21,31.07%,PCNA;HIF1A;STAT1;TAF7;BCAS3;SIRT2;PAX6;EGR1;KANSL1;EID1
prerank,carboxylic acid transmembrane transporter activity (GO:0046943),0.21739846276348962,0.7649982083401322,0.8693759071117562,0.995145418586287,1.0,14/55,24.46%,SLC16A6;SLC38A2;SLC38A9;SLC38A7;SLC3A1;SLC19A1;SLC22A4;SLC16A12;SLC13A3;SLC38A3;SLC25A10;SLC19A2;SLC38A10;SLC16A7
prerank,ubiquitination-like modification-dependent protein binding (GO:0140035),0.32530403639708627,0.7638587571224434,0.7684210526315789,0.993908381540062,1.0,2/10,11.05%,ANKRD13D;FAN1
prerank,sodium:proton antiporter activity (GO:0015385),-0.29496771922464743,-0.7586168620900029,0.7648401826484018,0.9848359314833365,1.0,3/11,11.79%,SLC9B2;SLC9A9;SLC9A2
prerank,Notch binding (GO:0005112),0.2595459209928297,0.7562892786545606,0.8198347107438017,1.0,1.0,4/22,11.08%,TCIM;NCOR2;AAK1;KCTD10
prerank,phosphatidylglycerol binding (GO:1901611),0.2953424029959022,0.7535576905543958,0.7886855241264559,1.0,1.0,2/13,9.21%,GSDME;UQCC3
prerank,signal sequence binding (GO:0005048),0.23324882808893338,0.753512710956335,0.8429878048780488,1.0,1.0,8/35,15.64%,KDELR3;PEX5;CABP1;SEC61A2;TIMM22;IPO5;TOMM70;KDELR2
prerank,intracellular ligand-gated ion channel activity (GO:0005217),0.3098844202420421,0.7531234016536541,0.7910189982728842,0.9981167875563967,1.0,2/11,11.85%,TRPM2;ITPR3
prerank,2-oxoglutarate-dependent dioxygenase activity (GO:0016706),0.23832242996360753,0.7511175161285999,0.868421052631579,0.9980497334942782,1.0,11/32,25.06%,TYW5;TET1;PHYHD1;KDM2B;PHF8;KDM4A;ALKBH4;ALKBH5;ALKBH3;HIF1AN;FTO
prerank,pseudouridine synthase activity (GO:0009982),-0.27844061836082934,-0.7500552306497063,0.7937649880095923,0.9932810310802802,1.0,10/13,45.41%,TRUB2;DKC1;PUS3;RPUSD3;RPUSD2;RPUSD1;PUSL1;PUS10;TRUB1;PUS1
prerank,AMP binding (GO:0016208),-0.29124593448220765,-0.7497475045823488,0.7782909930715936,0.9896841802842667,1.0,2/11,7.35%,ACSS2;PRKAG2
prerank,protein-cysteine S-palmitoyltransferase activity (GO:0019706),0.256941979299237,0.7485401695096693,0.8432343234323433,0.998805789950878,1.0,10/24,26.99%,ZDHHC22;ZDHHC8;ZDHHC1;ZDHHC2;ZDHHC23;GOLGA7;ZDHHC15;GLUL;ZDHHC19;ZDHHC12
prerank,cyclin-dependent protein serine/threonine kinase inhibitor activity (GO:0004861),-0.2978377109317517,-0.7484386882947974,0.7956989247311828,0.9874848120789579,1.0,5/10,30.60%,CDKN2C;CDKN2A;KAT2B;INCA1;CDKN2D
prerank,GTP binding (GO:0005525),0.17928322952894082,0.7447463814495776,0.9673776662484316,1.0,1.0,58/172,29.85%,RAB1B;RHOV;RAB26;ATL1;ARL5A;RHOBTB1;RAB8A;ARL4C;ARL4A;RIT2;NME1;RHOT1;DIRAS2;ARL4D;RAB5A;RAB38;RAB28;RAB39A;TUBB2A;INSR;HRAS;RHOQ;RRAS2;RHOBTB2;RHOU;RHEBL1;CDC42;MMAA;TUBA8;RAP2C;DRG1;PIP4K2B;ARF1;ARL5B;RANBP17;ATL2;GBP2;RHOBTB3;RHOA;GNAI1;RNF112;GTPBP10;RRAGD;TUBA1B;NUDT16;TGM2;TUBA1A;MRAS;RAB13;ARL11;RRAD;GBP5;BMS1;ADSS1;RRAS;TUBA1C;RND3;ARF5
prerank,cGMP binding (GO:0030553),0.3036986790390711,0.7438988028322645,0.795774647887324,0.9992963958454136,1.0,4/11,31.66%,CNGB1;PDE11A;RAPGEF2;PDE10A
prerank,vascular endothelial growth factor receptor binding (GO:0005172),0.2965087035535592,0.7435433067381745,0.8090277777777778,0.9969109779133452,1.0,3/12,15.53%,DAB2IP;ITGA5;CADM4
prerank,protein serine/threonine phosphatase inhibitor activity (GO:0004865),-0.288320705010809,-0.7423254615452234,0.843400447427293,0.9919006564293182,1.0,3/11,15.27%,PPP1R1A;PPP1R2;PPP1R14C
prerank,protein kinase A regulatory subunit binding (GO:0034237),-0.24057658709067187,-0.7421534583932156,0.8688118811881188,0.9881269863641168,1.0,7/21,21.11%,PJA2;PRKACA;WASF1;AKAP5;KCNQ1;AKAP9;GSKIP
prerank,hormone activity (GO:0005179),-0.1935261172846215,-0.7383646996093081,0.9233449477351916,0.9889967630271697,1.0,23/54,36.81%,IGF1;METRNL;CCL25;AGRP;PTHLH;NPY;GNRH1;CRH;NMB;VIP;SPX;INHBB;PNOC;NPPC;EDN3;CORT;EDN2;NPPA;POMC;EDN1;GHRH;C1QTNF12;CALCB
prerank,GABA receptor binding (GO:0050811),0.3053941990835863,0.7378039179807295,0.8078291814946619,1.0,1.0,2/11,9.48%,LHFPL4;JAKMIP1
prerank,cytochrome-c oxidase activity (GO:0004129),0.2805183855901402,0.7371040143883838,0.8411053540587219,0.9996973717443217,1.0,4/15,23.98%,NDUFA4;COX4I1;COX6B1;COX10
prerank,"oxidoreductase activity, acting on NAD(P)H, quinone or similar compound as acceptor (GO:0016655)",0.2966298411623026,0.7368307497750787,0.8177339901477833,0.9971536884373868,1.0,2/12,8.07%,AKR1C1;CBR4
prerank,phosphatidylcholine transporter activity (GO:0008525),0.27378380440998074,0.7356153253323896,0.8426573426573427,0.9958722688149579,1.0,10/17,33.68%,ABCB4;MTTP;ATP8B1;ABCA7;ATP8B2;ATP10B;ABCA3;PITPNA;PITPNC1;PITPNM1
prerank,C2H2 zinc finger domain binding (GO:0070742),0.3060296674439329,0.7344328240604647,0.8230088495575221,0.9946403261040829,1.0,2/11,9.40%,SRRM2;TAF9
prerank,"oxidoreductase activity, acting on the aldehyde or oxo group of donors, NAD or NADP as acceptor (GO:0016620)",-0.2460494844661841,-0.7308863185614295,0.8942307692307693,0.9947142146853221,1.0,7/18,28.50%,HSD17B12;ALDH1A1;ALDH3A2;ALDH1A2;ALDH2;ALDH1A3;ALDH8A1
prerank,peptidase activator activity (GO:0016504),0.2526281674125365,0.7298102959032916,0.8456692913385827,0.997500029219743,1.0,9/22,25.68%,VSIR;EBAG9;PSME3;PSENEN;PSMD14;PSME1;MAL;PCOLCE2;CLPX
prerank,potassium channel regulator activity (GO:0015459),0.21407020906513083,0.729322496652931,0.9016393442622951,0.9951958343397672,1.0,4/49,6.34%,YWHAE;KCNE2;KCNIP3;KCNIP4
prerank,snRNA binding (GO:0017069),0.21595900483000496,0.7292348818104184,0.8836140888208269,0.9924995460533675,1.0,14/42,25.29%,SNRNP70;MEPCE;HEXIM2;LSM8;SF3B3;DDX39B;GEMIN5;SNRPD3;EIF5A;LSM4;SNRPB2;SNU13;HEXIM1;COIL
prerank,poly(A)-specific ribonuclease activity (GO:0004535),0.2906408839100031,0.7286213985580908,0.8388704318936877,0.9904100691399385,1.0,2/12,13.34%,CNOT2;CNOT8
prerank,dynactin binding (GO:0034452),0.2967215541719299,0.7284440163493489,0.8151408450704225,0.9878177409330626,1.0,3/12,17.34%,BICD2;SNX6;BICD1
prerank,serotonin receptor activity (GO:0099589),-0.2358266855397641,-0.7265246180947792,0.8668478260869565,0.9883088036666343,1.0,3/22,11.79%,HRH1;CHRM2;HTR1B
prerank,G protein-coupled serotonin receptor activity (GO:0004993),-0.2358266855397641,-0.7265246180947792,0.8668478260869565,0.9883088036666343,1.0,3/22,11.79%,HRH1;CHRM2;HTR1B
prerank,G protein-coupled amine receptor activity (GO:0008227),-0.2358266855397641,-0.7265246180947792,0.8668478260869565,0.9883088036666343,1.0,3/22,11.79%,HRH1;CHRM2;HTR1B
prerank,transcription coregulator binding (GO:0001221),0.20945944778284303,0.7247639525929113,0.9195230998509687,0.9896509393410486,1.0,14/50,21.90%,CNOT2;RELA;CTBP1;AR;USP11;LMO2;ZBTB49;UBE2I;MED25;PHF1;HDAC3;RORA;TEAD2;CHD6
prerank,galactosyltransferase activity (GO:0008378),0.3027202726860796,0.7210508184702482,0.8458844133099825,0.9908898175385502,1.0,3/11,18.85%,B3GNT6;A3GALT2;B4GALT2
prerank,aldehyde dehydrogenase [NAD(P)+] activity (GO:0004030),0.27149563285730605,0.7182686999222243,0.8310580204778157,0.99116564496273,1.0,3/15,14.38%,ALDH9A1;ALDH1L1;ALDH4A1
prerank,Lys63-specific deubiquitinase activity (GO:0061578),0.3034916356126723,0.7173818272290549,0.8293103448275863,0.9893813204072611,1.0,3/10,20.39%,OTUD5;STAMBP;CYLD
prerank,palmitoyltransferase activity (GO:0016409),0.23657251426281045,0.7143423198566664,0.8871473354231975,0.9900032326783506,1.0,11/28,27.25%,ZDHHC22;ZDHHC8;ZDHHC1;ZDHHC2;ZDHHC23;GOLGA7;ZDHHC15;GLUL;ZDHHC19;ZDHHC12;ZDHHC5
prerank,lipid phosphatase activity (GO:0042577),-0.25573476644700255,-0.7127874371565638,0.8756218905472637,1.0,1.0,6/14,31.16%,PLPP7;SGPP1;INPP5K;PLPPR3;PLPP3;PLPPR5
prerank,sialyltransferase activity (GO:0008373),0.25019140307494026,0.7121158809555943,0.8786407766990292,0.9897501597921549,1.0,5/20,22.64%,ST3GAL5;ST6GALNAC2;ST3GAL6;ST3GAL3;ST6GALNAC4
prerank,sulfuric ester hydrolase activity (GO:0008484),0.28875940090956287,0.7114772457141119,0.8386023294509152,0.9877041107365525,1.0,2/12,5.78%,ARSB;ARSG
prerank,RNA 7-methylguanosine cap binding (GO:0000340),-0.26747559420664874,-0.7026756407602481,0.8591885441527446,1.0,1.0,3/12,13.48%,NCBP1;AGO2;LARP1
prerank,cyclin-dependent protein serine/threonine kinase activity (GO:0004693),0.24774064922855477,0.7021655823307745,0.9028006589785832,0.9922590856411028,1.0,2/21,1.65%,CDK7;CDK15
prerank,cyclin-dependent protein kinase activity (GO:0097472),0.24774064922855477,0.7021655823307745,0.9028006589785832,0.9922590856411028,1.0,2/21,1.65%,CDK7;CDK15
prerank,lysine-acetylated histone binding (GO:0070577),-0.23013894707044713,-0.7018553901345003,0.8981233243967829,1.0,1.0,3/20,6.01%,SMARCA4;TAF1;MLLT3
prerank,acetylation-dependent protein binding (GO:0140033),-0.23013894707044713,-0.7018553901345003,0.8981233243967829,1.0,1.0,3/20,6.01%,SMARCA4;TAF1;MLLT3
prerank,protein phosphatase 2A binding (GO:0051721),-0.21555267253064642,-0.6965514439443703,0.8995098039215687,1.0,1.0,5/23,14.69%,ENSA;PTPA;BOD1;FOXO1;ARPP19
prerank,RNA stem-loop binding (GO:0035613),-0.26554520843506363,-0.6906695101828205,0.8925438596491229,1.0,1.0,6/12,24.48%,LARP6;ZC3H12A;RC3H1;RC3H2;CPEB3;CSDE1
prerank,serine-type endopeptidase activity (GO:0004252),0.18221449644710452,0.6869348614026287,0.9631205673758865,1.0,1.0,5/80,4.45%,F3;PLAT;RHBDL3;PRSS56;GZMM
prerank,aldehyde dehydrogenase (NAD+) activity (GO:0004029),0.26868082553301426,0.6851329273937763,0.8643478260869565,1.0,1.0,3/13,14.38%,ALDH9A1;ALDH1L1;ALDH4A1
prerank,G protein-coupled receptor activity (GO:0004930),0.15757377793734745,0.684704244100827,0.9963325183374083,1.0,1.0,34/239,19.56%,GPR34;P2RY12;AVPR2;GABBR1;NTSR2;ADGRG4;NMUR1;AVPR1A;GPR12;LTB4R2;GRM3;ADRA2A;ADGRL3;GPR17;ADCYAP1R1;CXCR6;CX3CR1;CXCR4;MC4R;LPAR4;P2RY1;GPR171;GABBR2;ELOVL4;P2RY10;OPRM1;MTNR1B;MTNR1A;ADGRL1;OPRD1;GPR174;PDGFRB;GPR63;HCAR2
prerank,phosphatidic acid binding (GO:0070300),-0.22781630462524766,-0.684077290152072,0.9195979899497487,1.0,1.0,4/19,16.15%,SESTD1;PLTP;PACSIN2;GRAMD1B
prerank,telomeric DNA binding (GO:0042162),-0.19303097755078996,-0.6827980576915501,0.930835734870317,1.0,1.0,11/32,26.20%,UPF3A;RPA1;HNRNPA2B1;TERF2;UPF2;HNRNPD;SMG6;TINF2;PIF1;TERT;PURA
prerank,single-stranded DNA helicase activity (GO:0017116),0.24472231710960238,0.6824987908275928,0.909710391822828,1.0,1.0,1/19,1.07%,MCM5
prerank,"hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in linear amides (GO:0016811)",0.1939609881463799,0.6778732498334304,0.9691358024691358,1.0,1.0,18/54,30.64%,PM20D1;ACY1;HDAC5;NTAQ1;AGA;ACR;HDAC3;ASPA;HDAC8;NIT1;GLS2;TGM2;NTAN1;NADSYN1;AMDHD2;HINT3;FAAH;ACER2
prerank,UDP-galactosyltransferase activity (GO:0035250),0.29368961910900676,0.6759024251837263,0.8686131386861314,1.0,1.0,2/10,12.99%,B3GALT2;A3GALT2
prerank,sulfate transmembrane transporter activity (GO:0015116),-0.23837197339464988,-0.6757845180917015,0.8970588235294118,1.0,1.0,1/14,0.98%,SLC26A11
prerank,oxidoreduction-driven active transmembrane transporter activity (GO:0015453),0.19194254459816543,0.6736865477969555,0.9718934911242604,1.0,1.0,14/57,23.98%,NDUFA6;UQCRC1;NDUFA4;NDUFS1;UQCR11;NDUFA8;NDUFS6;CYB561A3;NDUFS2;NDUFB6;COX4I1;COX6B1;UQCR10;COX10
prerank,postsynaptic neurotransmitter receptor activity (GO:0098960),0.23410827312407917,0.6624759574940392,0.9041322314049587,1.0,1.0,3/21,18.41%,GRIA1;CHRNA7;CHRFAM7A
prerank,retinoid X receptor binding (GO:0046965),-0.25857797195812365,-0.6604064476072544,0.9061784897025171,1.0,1.0,9/11,41.02%,PPARG;TACC1;NRIP1;HMGA1;ARID5A;NCOA6;VDR;NR4A2;RARG
prerank,NAD+ binding (GO:0070403),0.26333379594940876,0.6586427120311033,0.9108061749571184,1.0,1.0,3/12,19.02%,CRYL1;UXS1;HPGD
prerank,serine-type peptidase activity (GO:0008236),0.17002839977622924,0.6583693210051716,0.9804741980474198,1.0,1.0,22/96,26.57%,F3;PLAT;RHBDL3;PRSS56;GZMM;TMPRSS7;ACR;PIK3IP1;KLK2;HPN;PCSK2;NAALAD2;TYSND1;APEH;RHBDD3;PCSK7;HTRA3;TPP1;CTSH;TMPRSS4;MASP2;RHBDL2
prerank,phosphoric ester hydrolase activity (GO:0042578),0.18964926247571226,0.6556236786335005,0.9574468085106383,1.0,1.0,18/49,31.26%,PLCXD1;PTPRO;SACM1L;PPP1CC;MPPED2;PPP5C;APEX1;FRA10AC1;PLCXD3;PPP1CA;DUSP28;ACP4;ACP2;PLCXD2;DUSP10;DUSP5;DUSP11;EPHX2
prerank,histone methyltransferase activity (H3-K9 specific) (GO:0046974),-0.26157293492581446,-0.6525773110264419,0.8993135011441648,1.0,1.0,2/10,12.28%,SETDB2;EHMT1
prerank,carbohydrate:cation symporter activity (GO:0005402),-0.2567810099921791,-0.6521864716409674,0.9207459207459208,1.0,1.0,2/11,14.01%,SLC17A5;SLC5A3
prerank,neuropeptide hormone activity (GO:0005184),0.22484891298968343,0.649747538873625,0.9249201277955271,1.0,1.0,5/22,23.33%,PPY;ADCYAP1;GAL;GRP;CCK
prerank,retinoic acid binding (GO:0001972),0.26033535475072067,0.6485011673233319,0.9128113879003559,1.0,1.0,1/12,3.95%,CYP26C1
prerank,ribonuclease P RNA binding (GO:0033204),0.27516588325496827,0.6471129029906872,0.8802281368821293,1.0,1.0,2/10,13.22%,RPP40;RPP30
prerank,excitatory extracellular ligand-gated ion channel activity (GO:0005231),0.2246710502442703,0.6430887881971639,0.9259259259259259,1.0,1.0,2/21,7.65%,GLRB;GRIK2
prerank,lipase activity (GO:0016298),0.19102279849786233,0.6417707226162913,0.9625585023400937,1.0,1.0,16/43,30.22%,PNPLA3;ABHD12;LYPLA1;ABHD5;LIPC;LDAH;ABHD2;PLA2G15;LIPE;PNPLA8;DAGLB;SMPD2;MGLL;FAAH;CEL;LIPA
prerank,peptide hormone receptor binding (GO:0051428),0.26373412342926283,0.6381755354172061,0.9023972602739726,0.9999666923339636,1.0,3/11,25.75%,ADCYAP1;CCK;PSMC5
prerank,acid-thiol ligase activity (GO:0016878),-0.23169125930973367,-0.6312238867798462,0.9300699300699301,1.0,1.0,1/13,1.97%,ACSS2
prerank,endonuclease activity (GO:0004519),0.18402790758699503,0.6298953397139652,0.969208211143695,1.0,1.0,13/49,24.18%,ANG;OGG1;RNASEL;CPSF3;SND1;APEX1;FEN1;TSNAX;REXO4;APLF;INTS11;LACTB2;ERCC4
prerank,receptor antagonist activity (GO:0048019),0.23105566147521084,0.6280358285637617,0.9378238341968912,1.0,1.0,3/17,19.31%,PXDN;IL18BP;CCL5
prerank,mRNA methyltransferase activity (GO:0008174),-0.24135331579659386,-0.6276732292058798,0.926605504587156,1.0,1.0,3/12,12.70%,TRMT10C;METTL8;NSUN2
prerank,protein serine/threonine/tyrosine kinase activity (GO:0004712),-0.18650501272168896,-0.6274662314006169,0.9731182795698925,1.0,1.0,6/28,17.21%,PRKACA;MAPKAPK3;LRRK2;RPS6KA2;MAP2K4;MAP2K7
prerank,LRR domain binding (GO:0030275),0.242443578728684,0.6260006209255066,0.939935064935065,0.9996390049818766,1.0,6/14,30.26%,NRL;PAWR;MRTFA;ATF4;ROBO1;DDIT3
prerank,adenyl nucleotide binding (GO:0030554),-0.23996138563641495,-0.6242607122072159,0.9349240780911063,1.0,1.0,1/11,5.51%,BAG4
prerank,adenyl-nucleotide exchange factor activity (GO:0000774),-0.23996138563641495,-0.6242607122072159,0.9349240780911063,1.0,1.0,1/11,5.51%,BAG4
prerank,acyl-CoA hydrolase activity (GO:0047617),-0.21872907864319766,-0.624246674312792,0.9572446555819477,1.0,1.0,2/17,7.34%,ACOT8;ACAA2
prerank,MHC protein binding (GO:0042287),-0.2032070279457132,-0.6224554439816854,0.9718670076726342,1.0,1.0,9/20,31.91%,CD74;TAPBP;LILRB1;PILRA;TUBB4B;KIR3DL2;CD8B;CD4;CD8A
prerank,transcription corepressor binding (GO:0001222),0.20376138948673098,0.6220312201582946,0.9545454545454546,0.9993239711798471,1.0,6/27,19.60%,CNOT2;CTBP1;USP11;PHF1;HDAC3;RORA
prerank,protein tyrosine kinase activator activity (GO:0030296),0.21756818150153795,0.6148861006222508,0.9471890971039182,1.0,1.0,5/19,19.31%,DGKQ;NRG3;ERCC6;GHRL;CCL5
prerank,purine ribonucleotide transmembrane transporter activity (GO:0005346),0.2554454136881576,0.6123436560931078,0.9434306569343066,0.9992806160568423,1.0,3/11,19.47%,SLC19A1;SLC25A23;SLC35B2
prerank,phospholipase activator activity (GO:0016004),-0.24316648101957053,-0.6080373046642888,0.9262672811059908,1.0,1.0,2/10,10.62%,FYN;LCK
prerank,basic amino acid transmembrane transporter activity (GO:0015174),0.24247684753257237,0.6075007284004724,0.947098976109215,0.9989832039105905,1.0,3/13,13.69%,SLC38A7;SLC66A1;SLC3A1
prerank,pentosyltransferase activity (GO:0016763),-0.17004279349956544,-0.6057347451774647,0.9887323943661972,1.0,1.0,2/36,1.44%,PARP4;PARP14
prerank,"hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in linear amidines (GO:0016813)",-0.23755051094887614,-0.6036196686505191,0.9541284403669725,1.0,1.0,6/11,40.05%,PADI4;DDAH1;ARG1;AGMAT;PADI1;PADI2
prerank,CoA hydrolase activity (GO:0016289),-0.21450881963237892,-0.599532137197916,0.9557109557109557,1.0,1.0,2/16,7.34%,ACOT8;ACAA2
prerank,kinesin binding (GO:0019894),-0.1762292564029616,-0.5986088630227951,0.9919137466307277,1.0,1.0,4/27,17.87%,PRC1;TOR1B;MAPK8IP3;KIF18B
prerank,neuropeptide receptor activity (GO:0008188),0.19643795497437366,0.5969805554168842,0.9772727272727273,1.0,1.0,4/29,16.91%,NMUR1;SORCS1;GAL;OPRM1
prerank,phospholipid transfer activity (GO:0120014),-0.19566306768520286,-0.5965305101033693,0.9775,0.9975164471200552,1.0,3/21,9.15%,PLEKHA3;PLTP;OSBPL2
prerank,MAP kinase activity (GO:0004707),0.22487218779114604,0.5952361275964523,0.9611486486486487,0.9993347298637497,1.0,3/14,15.76%,MAPK15;MAPK10;MAPK3
prerank,transferrin receptor binding (GO:1990459),0.2524356662424428,0.5950417802708209,0.9436619718309859,0.9968750964895763,1.0,4/10,29.17%,CD81;RGMA;HFE;CHUK
prerank,MAP kinase phosphatase activity (GO:0033549),-0.2204272806557775,-0.5946427924097158,0.955607476635514,0.9947369681561057,1.0,8/12,37.98%,DUSP16;DUSP1;DUSP3;DUSP7;DUSP4;DUSP8;DUSP9;DUSP6
prerank,neurexin family protein binding (GO:0042043),0.24485830964056998,0.5926070652957552,0.9430604982206405,0.9953108260343682,1.0,1/10,3.45%,SYTL4
prerank,histone deacetylase activity (GO:0004407),-0.19093142964241483,-0.5920375757890243,0.9530026109660574,0.9922131003135901,1.0,7/19,32.74%,HDAC2;HDAC1;SIRT2;HDAC4;MIER1;HDAC11;HDAC6
prerank,DNA-directed DNA polymerase activity (GO:0003887),0.20725551593944314,0.587722452570549,0.9669565217391304,0.994794784049555,1.0,3/21,12.91%,POLG;POLD3;POLM
prerank,zinc ion transmembrane transporter activity (GO:0005385),0.20656991482107864,0.5801599623865764,0.9676375404530745,0.9950074787615465,1.0,4/20,17.77%,SLC39A4;SLC39A8;SLC30A3;SLC39A3
prerank,"intramolecular oxidoreductase activity, transposing C=C bonds (GO:0016863)",-0.21233937743615927,-0.5774832412750781,0.9803439803439803,0.9942250968428962,1.0,4/13,37.24%,IDI1;HSD3B2;EBP;DDT
prerank,serine-type endopeptidase inhibitor activity (GO:0004867),-0.15934089075219934,-0.5726577911031144,0.9915492957746479,0.9924830686667484,1.0,14/38,35.77%,SERPINC1;SERPIND1;SERPING1;SERPINF2;APP;TFPI2;SERPINB2;SPINK5;SLPI;SERPINB9;SERPINB5;HRG;SERPINA10;WFDC3
prerank,lipase activator activity (GO:0060229),-0.2298812785229669,-0.5694133513844858,0.9663461538461539,0.9900490629696046,1.0,2/10,10.62%,FYN;LCK
prerank,potassium:proton antiporter activity (GO:0015386),0.2403705975392405,0.5646283956076462,0.9607843137254902,0.9978522445250029,1.0,3/10,23.15%,SLC9A4;SLC9A5;SLC9A1
prerank,DNA polymerase activity (GO:0034061),0.19392528962719954,0.557455177081477,0.9810344827586207,0.9974082776557691,1.0,3/22,12.91%,POLG;POLD3;POLM
prerank,histone demethylase activity (H3-K9 specific) (GO:0032454),0.22161810352960204,0.5522234345675433,0.9655765920826161,0.9963714239181147,1.0,3/12,17.87%,PHF8;KDM4A;PHF2
prerank,nucleoside-diphosphatase activity (GO:0017110),0.22024794634908298,0.5508915025771918,0.9770723104056437,0.9942615008585883,1.0,7/12,35.30%,ENTPD6;CANT1;ENTPD1;ENTPD2;ENTPD3;ENTPD7;NUDT18
prerank,ferrous iron binding (GO:0008198),-0.17687331197789083,-0.5479739538339996,0.9920634920634921,0.9926388751659179,1.0,21/21,82.34%,TET2;FTL;HEPH;PHYH;EGLN1;ALKBH2;FECH;SNCA;EGLN3;EGLN2;FXN;CDO1;ACP5;FTH1;DNAJC24;ALKBH1;HAAO;FTO;HIF1AN;ALKBH3;ISCU
prerank,alanine transmembrane transporter activity (GO:0022858),0.2156872349562582,0.5394416772010864,0.9774696707105719,0.9944613048159772,1.0,2/12,11.60%,SLC38A7;SLC1A4
prerank,Wnt-activated receptor activity (GO:0042813),0.19293489602087288,0.5192743620158781,0.9819494584837545,0.9958622090413827,1.0,3/15,19.61%,RYK;PKD1;ROR1
prerank,pyridoxal phosphate binding (GO:0030170),-0.16505464137671147,-0.5123511533460698,0.9947229551451188,0.9963185116607064,1.0,20/20,83.52%,CBS;THNSL2;CTH;GLDC;SDS;SHMT2;PDXK;OAT;PLPBP;PNPO;ALB;SHMT1;PYGB;ACCS;PYGL;PSAT1;SRR;ABAT;AGXT;PYGM
prerank,Lys48-specific deubiquitinase activity (GO:1990380),-0.1788860403469522,-0.5067675348838219,0.9949109414758269,0.993614663957499,1.0,6/14,35.68%,USP9X;MINDY3;USP15;YOD1;ATXN3;USP27X
prerank,thioesterase binding (GO:0031996),0.20650972815780982,0.5060044802079228,0.9822695035460993,0.995495459377044,1.0,1/11,6.94%,ADRA2A
prerank,myosin II binding (GO:0045159),0.20955407582751034,0.4882999603796718,0.9881154499151104,0.9951810382233895,1.0,5/10,28.13%,STXBP5;LLGL2;SHROOM1;LLGL1;STXBP5L
